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PART I.

EVIDENCE FOR AN ACTION OF ANTICHOLINESTERASES ON THE

CENTRAL NERVOUS SYSTEM OF RABBITS NOT ATTRIBUTABLE TO
ENZYME INHIBITION

18
I.

INTRODUCTION

Electrocorticographic responses to the administration
of DFP to cats and monkeys consisted of EEG arousal which
was attenuated by atropine (Wescoe et al. 1948).

Johns et

al. (1951) found that the amount of theophylline required
to induce cortical EEG seizure activity was decreased by as
much as one-sixth when given after DFP.

Atropine blocked

the convulsions but its effectiveness was a function of the
Johns et al. concluded that

ratio of DFP to theophylline.
-.

atropinic antagonism of DFP-theophylline convulsions occurred
when the concentration and hence the effect of theophylline
was minimal.

Bouzarth and Himwich (1952) evaluated the

mechanisms of seizures induced by DFP.

They noted that the

order of appearance of seizures was thalamus, caudate, limbic
cortex, and finally motor cortex.

However, later findings

have indicated the hippocampus as a primary site of convulsant action in the CNS due to its low epileptogenic
threshold (Liberson and Akert 1955).

Sarin-induced convul-

sions were attenuated by atropine and by PAM (2-pyridinaldoxime methiodide), which antagonized the convulsive
phase of sarin but not the EEG desynchronization.

The latter

finding with PAM is of interest since it is a quaternary

19
compound which probably does not gain access to the CNS.
Wills (1963) discussed the pharmacological antagonism of
anticholinesterases and suggested that the EEG seizure activity was the result of stimulation of diencephalic brain
sites.
Eserine, in low doses has been shown to evoke a
transient EEG arousal that is associated with the reversible
nature of enzyme inhibition (Longo and Silvestrini 1957).
Holmstedt (1963) pointed cut that neostigmine had an excita-

.

tory effect on the neuromuscular junction after cholinesterase had been inactivated by DFP.

Other experiments were

discussed that utilized the neuromuscular junction responses
as evidence of anticholinesterase drug effects that were independent of cholinesterase inhibition.
Benesov~ et al.

(1964) reported that amitryptyline and

other thymoleptics decreased the duration of Eserine-induced
arousal and that chlorpromazine and reserpine pretreatment
prolonged it.

The authors attributed the prolonged response

to the antiadrenergic effects of Eserine.

However, Benson

(1948) had shown "adrenalin" of the swine caudate to inhibit
butyrylcholinesterase and acetylcholinesterase as measured
manometrically.

He proposed the adrenalin-potentiating

effect on ACh was attributable to inhibition of cholin-

20

esterase as well as promoting the synthesis of ACh.
Goldberg et al. (1963, 1965) found that cholinesterase
had to be inhibited greater than 21 to 50 per cent in order
to observe behavioral effects.

Also they found that Eserine

and Carboryl (naphthyl N-methyl carbamate) had central
agonist properties in addition to inhibition of cholinesterase.

These responses were antagonized by atropine.
Bito et al. (1967) noted that chronic administration of

ecothiophate failed to produce enduring effects, but blocked
the response to the presence
dog.

~f

carbachol in the eye of the

Other responses of the iris were normal and blocked

by atropine.

They concluded that ecothiophate had anti-

parasympathomimetic effects.
The present study evaluates EEG changes in the presence
of protected and of markedly inhibited cholinesterase.

These

findings are correlated with biochemical determinations of
cholinesterase activities as well as with histochemical
evidence for irreversible enzyme inhibition.

21

I.

LITERATURE REVIEW

Survey of the literature of CNS effects of anticholinesterases and its antagonism by anticholinergics was
facilitated by existent reviews, which were extensively
utilized due to the excessive number of publications on
cholinesterases and anticholinesterases that have appeared
in recent years (250-300 per year, Augustinsson 1963).
Diamant (1954) tabulated the results of investigation
of CNS effects from:

(1) the reversible inhibitors, Eserine

and neostigmine, and (2) the.irreversible organophosphorus
inhibitors, DFP, TEPP, parathion, and tabun.

Miller et al.

(1938 op.cit.) observed that Eserine induced an increase in
electrical activity of the cortex when applied topically to
the cortex of cats.

Anticholinesterase action on spinal cord

reflex activity of dogs was shown by Bulbring and Burn (1941
.2J2.cit.).

These investigators administered Eserine arterially

into the spinal cord and noted that the effects on the lower
leg reflexes were antagonized by atropine but were enhanced
by "aarenalin".

Williams (1941 ..£E_.cit.) notea that Eserine

enhanced petit mal EEG paroxysms in humans (cf. Williams and
Russel (1941 .££.cit.), who also observed atropinic antagonism
of Eserine).

Darrow et al. (1944 op.cit.) observed an

22

increase in the fast frequencies of the EEG of cats and a decrease in high amplitude slow waves.

Atropine antagonized

Hyde et al. (1947 op.cit.) found that

the responses.

topically applied Eserine potentiated the effects of
strychnine and pentylenetetrazole on the EEG.

Bradley and

Elkes (1953 .£E_.cit.) noted only a moderate increase in
electrocortical activity subsequent to the intraperitoneal
administration of 0.5-1.0 mg/Kg of Eserine.

EEG responses

to the administration of DFP consisted of cortical desynchronization followed by con"'lUlsive activity (Wescoe et al.

1948 .£E_.cit., Freedman et al. 1949 .£E_.cit., Essig et al.
1949 .£E_.cit., Bouzarth and Himwich 1952 op.cit. and Johns
et al. 1951).

Furthermore, mechanisms of action in addition

to cholinesterase inhibition were proposed by several
authors (Verbeke 1949 £2.· cit., Koppanyi and Karczmar 195,1
op.cit., Michaelis et al. 1949 op.cit. and Brooks et al.

1949 .£E_.cit.).
concluded to be:

In general, the mechanisms of action were
(1) of a direct pharmacodynamic nature on

the effector cells, (2) inhibition of cholinesterase along
with the pharmacodynamic action, (3) histological cellular
damage, or (4) metabolic effects on cellular respiration.
Holmstedt (1959) reviewed the effects of organophosphorus cholinesterase inhibitors on EEG activity.

The

23
literature revealed a prolonged EEG arousal with subconvulsant doses of DFP and sarin while higher doses provoked
diffuse convulsive EEG patterns.

Holmstedt pointed out that

the CNS effects of these anticholinesterases cculd be
obtained without damage of the blood brain barrier (BBB).
In addition to inhibition of cholinesterase, sarin, DFP,
and Eserine had been reported to evoke pressor responses.
Heath (1961) discussed the protective effect of
reversible inhibitors (Eserine) on the subsequent administration of irreversible inhibitors (TEPP, DFP).

He also

proposed that reversible anticholinesterases, given in the
presence of irreversible inhibitors, would enhance the degree
of enzyme inhibition.

However, he pointed out that these

results varied with species, drugs, and doses.
Loshadkin and Smirnov (1962), in a review of chemical
and toxicological aspects of organophosphorus anticholinesterases, discussed drug action on choline-reactive systems.
They defined a choline-reactive system as that sequence of
biochemical events through which ACh is released from nerve
terminals and acts on "choline receptors".

They then

equated the choline receptor with choline-reactive system.
Two features common to AChE and choline receptors were
suggested; first, both were highly specific for the same
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substrate (ACh); second, excess concentrations of substrates prevented inhibition of ChE by organophosphorus inhibitors.

Karasik et al. (1946, 1947, 1948 £E_.cit.) as well

as Zupancic (1953 op.cit.), proposed that cholinesterases
and choline receptors were one and the same.

The reviewers

pointed out that while the function of choline receptors
was specific and associated with the presence of sulfhydryl
groups, the action of sulfhydryl containing inhibitors of
ChE was non-specific.

Loshadkin and Smirnov proposed that

organophosphorus agents which competed with ACh for ChE,
could react with the choline'receptors.

Similar to the

review of Diamant (1954), the hypothesis for a combined
enzyme inhibition with pharmacodynamic action on cholinereactive systems was suggested.

Examples from the litera-

ture were cited by Loshadkin and Smirnov (1962) to include:

(1)

McNamara et al. (1954 op.cit.), who compared the

response to DFP and TEPP with the histochemical demonstration of ChE in various organs.

They concluded that inhibi-

tion of enzyme alone was insufficient to account for
mechanisms of toxic action.
(2)

Holaday et al. (1954 op.cit.), who investigated

pre- and postganglionic action potentials in the presence of
DFP and compared their findings with the degree of inhibition
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of total and specific cholinesterases.

It was concluded

that changes in transmission of the superior cervical
ganglion under the influence of DFP could not be explained
by inhibition of enzyme alone and a direct action of DFP
on choline receptors was proposed.

(3) Roeder and Kennedy (1955 .£E_.cit.), who showed that
sarin, tabun, and soman competed with ACh for choline
receptors at synaptic junctions.

(4) Liljestrand and Zotterman (1954 .££.cit.), who found
that DFP sensitized choline receptors of the carotid body
to the action of choline esters.

(5) Turpaev and Putintseva (1957 .£E_.cit.), who showed
Fosfakol (diethyl p-nitrophenyl phosphate) to act on
isolated intestine in the presence of totally inactivated
cholinesterase.

(6) Komissarov (1957 .£e_.cit.), who concluded that the
action of Fosfakol on reflex conduction in rabbit spinal
cord, would not be explained on the basis of enzyme inhibition alone.

(7) Seminov (1957 £E_.cit.), who showed that the bronchospasm induced by Armin (ethyl p-nitrophenyl ester of ethylphosphonic acid), included a cholinomimetic action along with
the inhibition of enzyme.
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(8) Murtha et al. (1955 .£E_.cit.), Feldberg (1954
~.),

.££_.

and Hobbiger (1954 .£E_.cit.) were also listed as con-

cluding that the action of anticholinesterases was in some
way associated with a direct action on choline receptors.
It should be emphasized that direct actions of the
anticholinesterases were proposed in addition to the
evidence for inhibition of enzyme.
Handbuch der Experimentellen Pharmakologie 15:

11

Cholin-

esterases and Anticholinesterase Agents" provided considerable information

pertin~nt

to the present investigations.

Evaluation of brain AChE activities by biochemical and histochemical methods was adequately reviewed (Koelle 1963
.£E_.cit. and Augustinsson 1963 op.cit.).
Machne and Unna (1963) reviewed the CNS effects of anticholinesterases.

Their discussion revealed that desyn-

chronization of the EEG, attenuation of recruited potentials
and convulsive EEG patterns could be evoked by the i.v.
administration of irreversible or reversible inhibitors.
They pointed out that anticholinesterases enhanced the level
of spontaneous electrical activity while depressing the
response to electrical stimulation in isolated cortex.
Topical application of inhibitors yielded conflicting results also.

However, Sigg et al. (1965) observed an enhance-
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ment of the cortical dendritic response following the
intrapial administration of Eserine in cats.

They postu-

lated a muscarinic effect on dendrites since the response
was sensitive to the blocking action of atropine.
The review of Machne and Unna (1963) was controversial
in that continued reference was made to the CNS effects of
quaternary compounds, atropine methyl nitrate and neostigmine.

It has been established that these drugs

penetrate the blood brain barrier (BBB) to little if any
extent (Longo 1962).
Longo (1962) presented the most significant information of pharmacological EEG research in rabbits.

He

reviewed the effects of reversible and irreversible inhibitors
of cholinesterases and his discussion was in agreement with
Machne and Unna with regard to the responses to Eserine,
DFP, atropine, and scopolamine.

However, Longo and others

(Hance et al. 1963) have failed to support the contention of
Machne and Unna with regard to quaternary compounds.
Karczmar (1966) reviewed the pharmacology of anticholinesterases in extenso.

Actions of anticholinesterases on the

reticular formation and cortex were included and EEG desynchronization was seen as a characteristic feature of i.v. or
topically applied Eserine.

Cholinergic mechanisms in the

28
reticular formation responsible for EEG desynchronization
were discussed (Rinaldi and Himwich 1955 £E_.cit.).

The

effect of anticholinesterases on cholinergic thalamocortical pathways was also presented.

Recent studies of

Shute and Lewis (1963, 1965, 1966) have shown that cholinesterase-containing fibers exist throughout the brain.
particula~

In

these fibers run through the ascending reticular

activating system from the medulla-pons (Holmes and Wolstencroft 1964) through the forebrain.

Acetylcholine release

at the cortex has been evoked by electrical stimulation of
the midbrain reticular formation as well as "spontaneously"
(Mitchell 1963 and Krnjevic 1967).

A cholinergic nature of

CNS transmission has been implied by the nicotinic
pharmacological responses of Renshaw cells, (Curtis and
Eccles

1958) which were associated with the early responses

of motor axon stimulation, while late muscarinic responses
have also been observed (Curtis and Ryall 1964).

However,

motoneuron firing has been shown to be depressed by NE in
the lumbar spinal cord of cats (Weight and Salmoiraghi

1967).

Therefore, sites of action for anticholinesterases

exist throughout the CNS and their activity can be evaluated
at all levels from cord to telencephalon.

In addition,

•
functional interaction with adrenergic systems is probably
a factor in CNS responses to anticholinesterase drugs
(Marczynski 1967).
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II.
A.

METHODS AND MATERIALS

GENERAL
Experimental animals 1 were adult, male, New Zealand

albino rabbits of approximately 2.5-3.5 Kg body weight.
Larger animals were used for the experimental preparations
in which the basilar artery was ligated at the midpontine
level in order to facilitate the required surgical approaches.
A standard laboratory animal diet was provided with food and
water available ad libitum.

The animals were retained in the

animal quarters for a minimum-of one week prior to use and
were brought to the laboratory on the day of the experiment.
B.

HISTOLOGICAL METHODS

1.

Thionin and Eosin Staining Procedure
A combination thionin and eosin staining procedure was

used that revealed cell bodies and fibers in the central
nervous system.

This staining procedure was compatible for

use with frozen sections (Conn et al. 1962).

Sagittal

sections were prepared from brain tissue of untreated rabbits
sacrificed by air embolism via the marginal ear vein.

The

brains were kept intact and rapidly removed beginning at the
1 sc1ent1fic Small Animal Laboratory and Farm, Inc.,
Arlington Hts., Ill.
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olfactory bulbs and extending to the calamus scriptorius,
placed in a beaker of saline for removal of excess blood and
bone fragments, and then transferred to a saline dampened
gauze square for removal of meninges.

The removal of these

membranes prevented the knife from snagging during sectioning
which would result in artifacts across the surface of the
section.

The brains were then divided in halves by passing

a large spatula through the midsagittal plane.

A flattened

piece of freezer wrap was placed on the floor of the cryostat
chamber and the half brain specimen was placed on it with
the medial surface directed down.

This last procedure froze

the brain with the medial surface flat and permitted
orientation of the plane of section parallel to the knife
edge.

The result was a marked reduction in the loss of

important midline structures during the sectioning procedure.
Brains were frozen at -20°c to -30°c at least 4 hours and in
most cases 24 hours.

Sections were cut at a thickness of

32 microns and were mounted in permount medium.
Verification of electrode implantation site was visualized after the staining procedure had been completed.

How-

ever, it was possible to trace the electrode tracts while
sectioning and the subsequent staining procedures were not
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required.

Details of the staining schedule are listed in

appendix A.
2.

Thiocholine Histochemical Procedure
The in vitro histochemical procedure as outlined

by

Koelle (1951, 1955) for the localization of cholinesterases
was modified to include in vivo and in vitro procedures
(Koelle 1957).

Control sections were obtained from rabbits

sacrificed by air metabolism.

Brains were prepared in the

same manner as described above except that the frozen
sections were 16 microns in thickness.

Details of the

staining schedule are listed in appendix A.
Irreversible inhibition of cholinesterase was induced
by the intravenous administration of DFP (l.0-3.0 mg/Kg ) or
of sarin (20.0-50.0 mcgm/Kg ).

Brains were quickly removed

after the animals had convulsed and died.

Frozen brain

sections from these animals were processed through the same
staining procedure as controls (vide supra).

Untreated

control sections were run concurrently with the sections
that had been exposed to anticholinesterases in vivo and
served as internal controls for the histochemical demonstration of the enzyme.
Physostigmine (100.0-150.0 mcgm/Kg
inhibit cholinesterase reversibly.

i.v.) was used to

It was given 5 minutes
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prior to DFP or sarin which were given in the doses indicated above.

After the animals convulsed and died, the

brains were removed for histochemical analyses.

The same

staining procedure for cholinesterases was used throughout.
C.

BIOCHEMICAL METHODS

1.

Warburg Procedure
A standard manometric procedure for the determination

of cholinesterase activity was used (Koppanyi and Karczmar

1964).

Brains of animals sacrificed by air embolism were

divided at the midsagittal pl?ne and one-half was added to
bicarbonate buffer (1:50 w/v).

Ultrasonic homogenization

of the tissue required less than 2 minutes and a chilled
solution was used to reduce the effects of heat.

Acetyl-

cholinesterase (AChE) and butyrylcholinesterase (BuChE,
ChE) activities were determined using methacholine and
butyrylcholine as substrates.

Control untreated brain

samples were included with the experimental samples and
readings were taken at ten-minute intervals for up to an
hour.

Microliters

co 2

formed per unit time are expressed as

percentages.
Experimental samples from animals included those
treated (1) with sarin (20.0 mcgm/Kg
(l.O mg/Kg

i.v.), (2) with DFP

i.v.), (3) with sarin in the presence of atropine
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methyl nitrate (l.O mg/Kg

i.v.), and (4) with sarin

followed by atropine sulfate (5.0 mg/Kg

i.v.).

The rabbits

were prepared for EEG recording (vide infra) and were maintained with artificial respiration after exposure to toxic
amounts of the anticholinesterases.

Histochemical analysis

(vide supra) was carried out on the other half of these
brains.

The biochemical determination of AChE and BuChE

activities served as a control measure to correlate with
histochemical findings and electrophysiological responses
during conditions in which the.enzyme activity was irreversibly inhibited.
D.

PHYSIOLOGICAL METHODS

1.

Electroencephalography
EEG recordings from unanesthetized restrained animals

in acute experiments necessitated development and modification of equipment.

An animal restraining board fitted with

a headholder was used for immobilization of the rabbits
during the recording sessions.

Openings cut into the bottom

of the board permitted access to the ventral anatomy of the
rabbit.

Thus, tracheotomy as well as arterial and venous

cannulation could be carried out under local anesthesia.

The

rabbit could then be returned to the supine position for
implantation of brain electrodes without being released from

Figure 1
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Legend for Figure 2

Steps in the Construction of EEG Electrodes:
of an electrode are laid out in figure 2.

The components

The electrode hub

(cf. Electrode Hub Diagram) two twisted 0.010 inch diameter
formvar insulated nichrome wires, and three insulated
stranded wires are assembled as indicated to form the completed electrode as seen on the right side of the figure
according to the scale.
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the restraining board.
The steps in the construction of the concentric tripolar
cortical and subcortical EEG electrodes are illustrated in
figure 2.

A detailed description is provided in appendix A.

The procedure for implantation of electrodes was carried
out under local anesthesia.

An incision was made in the

scalp that extended from the nasion, caudally to the cervical
vertebra.

After the calvarian surface was exposed and local

tissue and bone bleeding controlled, the coronal and midsagi ttal bone sutures were located.

The interstice of the

sutures was used as an anterior-posterior zero (AP zero)
reference point.

Sawyers• atlas for the rabbit diencephalon

(1954) was used as a guide for the coordinates.

The skull

was trephined at selected sites by a No. 51 drill held in an
X-Acto model makers pin vise.

This size of opening in the

bone permitted a tight fit of the electrode shank so that
further fixation of the electrode to the skull was generally
unnecessary.

However, dental acrylic could be used to affix

the electrode to the bone.

After cutting the nichrome wire

depth electrodes to the appropriate length, they were manually
implanted according to selected stereotaxic coordinates (see
appendix A).

The electrode hub recorded EEG activity from

the cortex while the depth electrodes in that same assembly
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recorded activity from selected subcortical structures.
Bipolar electrical stimulation of brain sites was carried
out through the appropriate depth electrodes.

The co-

ordinates of brain sites for recording and for stimulating
are designated in appendix A.

They are:

basal olfactory

area (BOA), lenticular nucleus (LN), left or right anterior
motor cortex (L,RAC), left or right posterior cortex
(L,RPC), reticular formation of the brain stem (RF),
occipital cortex
nuclei (ADN).

(o.c.), and anterior dorsal thalamic

Electrode

pla~ement

was verified histo-

logically at the termination of ·the experiment.

During the

experiment, the characteristics of the EEG patterns as well
as the responses to electrical stimulation of the brain
were used as an index of the accuracy of electrode placement.

Bipolar recording technique was routinely used and

the electrode combinations are as indicated in the relevant
figures.
A minimum of 30 minutes was allowed for the recovery
of the experimental subjects after the implantation procedure was completed.
recording sessions.

A dimly lighted room was used for
A seven channel, ink writing Grass

Model IIID electroencephalograph was used.

Recording

speed and amplification are as indicated by the calibra-

40
tions in the figures.

Six of the seven channels were used

for obtaining EEG information and the remaining channel
recorded either blood pressure or heart rate.

Heart rate

was obtained from leads placed across two limbs.

The

blood pressure was recorded directly from the femoral
artery via a Statham pressure transducer and was amplified
by a low level D.C. Grass preamplifier.

Pressure was

usually recorded as a mean value by using the 1/2 amplitude
high frequency control on the recorder.

Periodic control

recordings were obtained at a full frequency amplification
in order to observe the wave form.

Blood clotting was

controlled by the use of heparinized saline (20 units/ml)
in the cannula.
After recovery, EEG activity was evaluated to determine if the implantation of electrodes had produced extensive
brain damage.

EEG alerting responses to stimuli of sound

(clapping of the hands), touch (lightly stroking the anima1 1 s
back), and pain (pinching the hind leg of the rabbit) were
observed.

These also gave an indication of the general

condition of the animal.

Saline injections were given as a

control measure with the volume equivalent to the volume of
the drug to be given.
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2.

Ligation of the Basilar Artery

/'

Drug injections into the arterial circulation of the
brain minimizes effects due to peripheral actions of
drugs.

Procedures used include injections into either the

vertebral or carotid arterial blood supplies in animals
with their basilar artery ligated at the midpontine level
(Jolly 1956 and Magni 1962).

This method was applied to the

present study.
The animals were anesthetized with diethyl ether and
2% procaine local anesthesia

p~ior

to a tracheotomy.

Following surgery, ether was expelled in the respired air
and the local anesthesia was maintained at wound sites.

The

rabbits were immobilized with curare and supported by
artificial respiration.

The trachea above the point of in-

sertion of the cannula and the larynx were removed.

The

musculature at the base of the brain was retracted to expose
the basi-occipital bone.

Ligation of veins encountered

during this procedure was critical.

An 8mm x 5mm rectan-

gular area of outer bone was removed by drilling two holes
through the outer layer, 2 mm anterior to the foraman
magnum and then working cephalad with rongeurs.
ing was controlled by the use of bone wax.

Bone bleed-

The basilar was

exposed by removing the rectangular inner layer of bone
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beginning at the caudal border of the opening and exposing
the artery through the dura along the ventral midline of
the pons.

After rupturing the dura, the basilar was freed

by a small blunted dental pick.

Caution was required at

this point, to prevent rupture of the artery or of its
penetrating branches.

The artery was ligated by passing a

6-0 suture under it with a miniature blunted "U" shaped
needle and then tying the suture with forceps.

The opening

in the basioccipital bone was packed with gelfoam.

Implan-

tation of electrodes (vide suera) required that the rabbit
be placed on its abdomen after which it was placed on its
back for the remainder of the experiment.
The jugular and subclavian veins were exposed and
separated from the underlying subclavian and innominate
arteries.

The origin of the vertebral artery was exposed

and the omocervical and internal mammary arteries ligated.
The subclavian artery was cannulated (PE#60); so that the
tip of the cannula rested approximately 5.0 mm from the
origin of the vertebral artery.

Intravertebral arterial

injections were carried out by occluding the subclavian
artery between the carotid and the vertebral arteries and
then injecting retrogradly through the cannula.
injection, the subclavian was released.

After the

The bifurcation of
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the common carotid was exposed and the external branch
cannulated (PE#lO) with the tip of the cannula at the
bifurcation.

Intracarotid arterial injections were then

made without interruption of the blood flow (fig. 17).
Electrical activity of the brain stem posterior to the
position of the tie could be obtained by inserting an
electrode through the opening used to approach the basilar.
Mineral oil was applied in place of the gelfoam.

Blood

pressure could also be recorded by cannulating the contralateral external carotid.
The functional state of the brain was revealed by the
spontaneous EEG and its response to the control EEG arousal
stimuli of sound, touch, and pain.

Physiological saline at

room temperature injected intracarotidly or intravertebrally
served as a control for EEG responses to anticholinesterases
(AntiChE's).
The distribution of materials injected into these two
arterial paths was shown in two different preparations
(fig. 18) by the administration of a monastral blue dye
diluted 1:1 with saline.

The aorta was clamped about 5

seconds after the dye had been given and prevented a generalized distribution by recirculation.
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E.

PHARMACOLOGICAL METHODS

1.

Drugs and Dosages
Atropine methyl nitrate was used as a peripherally acting

anticholinergic that does not readily penetrate the blood
brain barrier (BBB).

Untoward cardiovascular responses to

centrally acting anticholinesterases were adequately
attenuated by intravenous doses of 0.5- 2.0 mg/Kg.
Physostigmine (Eserine) was used as a reversible inhibitor of cholinesterases that readily penetrated the BBB.
EEG desynchronization without seizure activity was found,
during preliminary studies, to
of 100-150 mcgm/Kg.

b~

evoked by intravenous doses

EEG and classical grand mal convulsive

episodes resulted from doses of 200.0 mcgm/Kg or greater.
DFP and sarin, which are irreversible inhibitors of
cholinesterase that readily penetrate the BBB, have marked
effects on the electrical activity of the CNS (Diamant

1954).

DFP was diluted with saline prior to injection and

used within 15 minutes.

EEG desynchronization was evoked

by 0.5 mg/Kg i.v. and convulsions and death by 2.0-3.0 mg/Kg
i.v. as determined in preliminary studies.

If additional

doses were to be given, artificial respiration was usually
needed.
minutes.

Sarin was diluted with saline and used within 15
EEG arousal was elicited by 10.0 mcgm/Kg i.v.
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while 20 mcgm/Kg i.v. evoked an alert pattern followed by
convulsive activity.

Doses of 50.0 mcgm/Kg i.v. or greater,

evoked a prompt EEG alert pattern followed by convulsions.
Death occurred within minutes.
In the preparation with the basilar artery ligated at
the midpontine level, doses were given via the internal
carotid (i.ct.) or the vertebral artery (i.vt., cf.
figs. 21, 23).

Drugs were not administered on the basis of

unit body weight because preliminary studies showed that
the responses to the drugs were determined by the specific
dose given and not by drug wt. per unit body wt.
is referred to in the figures as

11

This dose

total dose".

The dosages of anticholinesterases included (1) Eserine
given alone as well as in the presence of the irreversible
inhibitors and (2) DFP or sarin given alone as well as in the
presence of Eserine.

The administration of Eserine was

given to protect cholinesterase from irreversible inhibition
by subsequent injections of DFP or sarin even in amounts
that evoked convulsions and death.

On the other hand,

initial administration of DFP or sarin permitted the observation of the effects of Eserine in the presence of irreversibly inhibited enzyme.
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III.
A.

CONTROL OBSERVATIONS

1.

Histological

RESULTS

The results of the thionin and eosin staining procedure
on the rabbit brain sections are revealed in figures 3a
through 3d.

Line drawings accompany these figures and pro-

vide an identification of relevant anatomical sites.

Veri-

fication of sites of electrode implantation in experimental
animals was readily obtained after this master set of control
sections had been prepared.

A~atomical

sites of electrode

implantation for recording and/or stimulation are as indicated in the appropriate sections.

In addition, this

sagittal section atlas of the rabbit brain served as an
orientation for histochemical studies of cholinesterase
localization.

The results of the thiocholine procedure are

illustrated in figures 5a through 5c.

These sections are

also accompanied by line drawings to indicate significant
anatomical areas.

The areas with the most intense stain

reveal the highest concentration of cholinesterase.

These

sites are the caudate nucleus, lenticular nucleus, anterior
dorsal nuclei of the thalamus, pulvinar and reticular
thalamic nuclei, superior colliculus, amygdaloid nuclei,

--~--·--·-----
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and hippocampus.

Other areas that revealed an intense

stain are the nuclei cuneatus and gracilis of the pontomedullary area as well as midbrain masses such as the
nucleus rubra and substantia nigra.
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SAGITTAL BRAIN SECTIONS
LIST OF ABBREVIATIONS:
a.c.

anterior commissure

a.c.p.

anterior cerebellar peduncle

a.d.n.

anterior dorsal thalamic nuclei

a.m.n.

anterior medial thalamic nuclei

amyg. n.

amygdaloid nuclei

a.n.

anterior thalamic nuclei

caps.e.

external capsule

caps.1.

internal capsule

cblm.

cerebellum

c.c.

corpus callosum

cen.ctx.

central cortex

cen. gr.

central grey matter

cen. ov.

centrum ovale

cer. pea.

cerebral peduncle

claus.

claustrum

1.coll.

inferior colliculus

s.coll.

superior colliculus

cor. rad.

corona radiata

fim.

fimbria of the hippocampus

forn.

f ornix
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fr.ctx.

frontal cortex

d.hpc.

dorsal hippocampus

v.hpc.

ventral hippocampus

i.m.l.tr.

intermediolateral thalamic tract

l.gen.

lateral geniculate body

l.t.n.

lateral thalamic nuclei

lemn.

lemnisci

ma.b.

mamillary bodies
~:

mam.th.tr.

mamillothalamic tract

m.lat.n.

mediolateral thalamic nuclei

med.n.

medial thalamic nuclei

medulla

medulla oblongata

meyn.tr.

Meynert's tract

m.c.p.

mid-cerebellar peduncle

n.amb.

nucleus ambiguous

n.cau.

caudate nucleus

n.gr., cun.

cuneate and/or gracilis nuclei

n.1.p.

interpenduncular nucleus

n.lent.

lenticular nucleus

n.ol.

olivary nuclei

occ.ctx.

occipital cortex

op.rad.

optic radiation

p.c.

posterior commissure

I

i
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p.c.p.

posterior cerebellar peduncle

pons

pons

pul. n.

pulvinar nucleus

pyrm. tr.

pyramidal tract

r.n.

red nucleus

ret. sub.

reticular substance

ret.th.n.

reticular thalamic nuclei

thalamus

thalamus

sep. pel.

septum pellucidum

III.N.tr.

oqculomotor nerve tract

III.n.

occulomotor nucleus

VI.n.

abducents nucleus

Figure ;a
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medulla
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. Figure 3b
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Figure 3c
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Figure

4

MODE OF ACTION OF THIOCHOLINE PROCEDURE
11 11
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Legend for Figure 4

Postulated Sequence of Events for Histochemical Thiocholine
Procedure that Reveals the Distribution of Cholinesterase:
The mode of action of the thiocholine procedure is postulated
to occur as two reactions.

Reaction

11

A11 involves the inter-

action of acetylthiocholine with-cholinesterase in the
incubation medium that contains copper glycinate.

The inter-

mediate copper thiocholine thus formed takes part in reaction
11

B11 with the ammonium sulfide (developer solution).

Copper

sulfide is the resultant product that is present at those
sites in which cholinesterase is to be found.

,,
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Figure 5b
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Figure 5c
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Irreversible inhibition of cholinesterase is shown in
the results of the thiocholine procedure applied to animals
injected with DFP 2.0-5.0 mg/Kg i.v. or with sarin 20.0100.0 mcgm/Kg i.v.

Brain sections of these experimental

subjects are shown in figures 6a through 6c.

The blank

stained sections appeared as a translucent film on the
microscopic slides after the thiocholine staining procedure
and necessitated marked overdevelopment and overexposure
during photographic processing.
were

avoi~ed

Counterstaining procedures

.

so that only the localization of cholin-

esterases was revealed.

Areas of ·shading that appear on the

blank sections reflect differences in tissue density and
outline anatomical structures but do not indicate a deposition of copper sulfide which would suggest the presence of
cholinesterase.

On the other hand, reversible inhibition of

cholinesterase by Eserine in amounts of 50.0-150.0 mcgm/Kg
i.v. did not prevent the selective staining of brain
cholinesterase.

These sections stained similar to the un-

treated controls (cf. fig. 29 and fig. 5a).
The brain sites supplied by the vertebral and carotid
blood supplies are shown by the distribution of monastral
blue dye as seen in figure 18.

The position of the arterial

pressure deadpoint that results from the meeting of the
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Figure 6c
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two pressure heads of cerebral arterial blood flow, the
vertebral supply and the internal carotid supply, was
firmly established by ligation of the basilar artery at
the midpontine level.

Dye injection through the vertebral

artery produced the results shown in figure 18 upper
section.

The vertebral arterial contribution to the blood

supply of the brain and drugs injected into this artery
initially infuse upper spinal cord and the bulbar pontine
reticular substance in the caudal brain stem.
of brain in the lower half

o~

The section

figure 18 reveals that brain

sites cephalad to the position bf the ligature receive
blood from the internal branch of the carotid via the circle
of Willis.

Thus, the more rostral brain stem and the

cerebral hemispheres are exposed initially to drugs given
by the intracarotid route of administration.

Diagrammatic

illustration of the ventral surface of the rabbit brain is
shown in figure 17 and is described in the legend for that
figure.
2.

Biochemical
The results of the manometric determination of the

activity of AChE and of BuChE are expressed in Table I and
appendix A.

Raw data was expressed as microliters of

co 2

evolved from brain tissue read at the times and under the

TABLE I.

CORRELATION OF HISTOCHEMICAL AND BIOCHEMICAL CHOLINESTERASE DATA

Drug

Histochemical
ChE Stain

Biochemical
AChE Activityl

100.0

BuChE Activity 1

100.02

Control

Present

Sarin

Absent

1.6

44.6

DFP

Absent

8.2

17.1

Sarin and
Atropine Methyl Nitrate

Absent

7.7

39.2

Sarin and
Atropine Sulfate

Absent

10.6

34.3

1

Expressed as per cent of control (100.0%).
2BuChE activity at 100.0% was only 10-15% of AChE control (cf. text
and appendix A) .

-.:i
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conditions referred to in the figures and Methods.

Brain

tissue controls as well as reagent controls were run with
each experimental determination.

The

enzyme activity of

the control samples was arbitrarily designated as 100%.
Experimental values were expressed as a percentage of
their respective control.

While the enzyme activity of

BuChE and of AChE is set equal at 100% (Table I), actual
BuChE activity was far less than that of AChE (appendix
A).

BuChE activity was only 10% to 15% of the activity of

AChE.

3.

Electrophysiological
The electrodes as constructed provided few difficulties

and artifact free recordings were constantly obtained.
Verification of the site of implantation was determined
histologically as well as from the characteristic type of
EEG pattern or of response to electrical stimulation.
Thus, cortical slow waves and spindle activity, hippocampal theta rhythm, occasional olfactory bursts, and
classical recruitment were all used as indices of accurate
placement.

Typical EEG patterns in the control animal are

represented by the tracings found in figures

7 through 10.

In general, a spectrum of EEG activity was shown in the
rabbit.

The predominant pattern was one of slow wave sleep

Figure 7

CONTROL EEG - RESPONSE TO SOUND
LN-BOA~--..-..,......._.....,,,._.~--.-...~"-'""J"'W"'""""''*""._._,,,,.,_,....,..,..._"""""~""""--.,.._.....w......,..._.,....._,,.,.._-...,,,,.............,,.-_,,..~~.,.,.....,.,.._.........,..._.,,,_-...,.,......_,.....,.......,~

1
LAC-BOA-W~i/./01.~~('f~J~~~.
•
¥\l~-.{·/v"'.,
1 ~'. /~,~~~.,,r~'t".~'.....:1-..·~11i~v,vj
'fl'
y ~
~ 1•/.i

.,..

:\

J.1UhJJl1rilc ' ~J. I ,1 ' ' /\"I. !
"l'f''ll('flfli{V" ''"' '; :/i \111\11••

'v

•l .1
RAC-LN~~v

.it/·""'J

I

I

'

< '.
1

/

'J

l ' I'' 1/li

·~JJJi1.~."f~........,.,..,.....-lw'.',\~.J;.ll(ti'';'flfJ.\,,11,'•··.;"'·"·"""""'1/..V.""il•"f"•v../~.~.,/v...:•...
I 1 1•11 1q'

' (l

~( . , , , , (

I' I

~

•,\~

'·I

~

1,!..~A.ilr...~M!IJ M

LH-LN-M'r~~'*~.\iJ•;/·.~j 1\\1~. . . \w>.iY.,. )".•i11•\lr"';\..;;'lJ11'{1~wflt',;~.' ',i..,;"t.:.';;~r--r~v 1.~··~ \ 1IY\\ \~1rN.Jv~V. ,~x\ ~\".1·/f/1 :'··1. l."•/,',".'(;"r't,"t.~~Jl11>'!fi~.~- U/'"'"I\~~·~,Mr~W"'~~ 'i rrvr- l'lj
-

•

I

l

~

I

~

:

•

M

I

i

' "

1I

I

yW

l

I.

RH-soA-.~1'~..~~~"Miv~ 1\V 111,1t·;·/J.itl':'¥..v~Jt.i..~1..,,.Ml'/~v-r;.•,\V1/. !1 y11 ~11 ; 1~:~\ 1,\\¥\rvi;~1,V1\\\'.'!~·~N~.. "'.\V1~·\"·'1 \~·4~•,,\'.1..,LlV1;'-J~,~.'fll~,lflN~""'v~~!'tr~#~rMM/1\¥1 \
(

•

I

•

.

I

I

l

.'

I' I

1'

''',,

"

/
L-RPC--.i....,..Jv\A~~~. frJ". "'';,'~""...,,~j)J; / ' "•\ .v·: ·\V,)',,1•1"'
(

'

v

.

..

...

· ' u!J 'J.1111!'1 ,,,.., Ni 11,i \ ~illi{'V!' i·\
11"'•' ,yv •."-:14/o'I.·,'/,. ,-l"N'i\i~J,,.,~t•'-""',' ,'•r.'Y~!'·-~··>:.'·...,-1A.•·.~·riN~1
lf'?' ",I.I \.A.I VJ 11.rVv. Vi
J\{ 1 \ ~.\ 1

I i ...

\

j

tf

0

I

I'

' I•

I

I 00 µV L__

•

.J

sec '

EKG~..·~..---~~,u.i.~~M.-J.......~....A.~.~~»~~....

Control EEG Pattern Response to Stimulation:

The resting EEG pattern (left side

of tracings) is interrupted by the sound of hand clapping (arro~s) to evoke a
desynchronized EEG alert pattern.

This is brief in duration (right side of figure)

as the pattern returns to one of slow wave sleep.
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Control EEG Pattern Response to Stimulation:

Pain stimulation induced by pinching

the hind leg of the rabbit evokes a desynchronized EEG pattern (arrows).

Note

that the response persists after the stimulation has terminated.
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Control EEG Pattern Response to Stimulation:

m~

Electrical stimulation of the

mesodiencephalic reticular formation (arrows, 200 c/s 2.0 volts, 0.7 msec duration)
elicits an EEG arousal response that outlasts the period of stimulation.
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with random 8-14 c/s activity appearing in the cortices.
This synchronized pattern was periodically interrupted by
an abrupt desynchronization evoked by either an uncontrolled
stimulation or by the presence of sound, tactile, or painful
stimuli (figs. 7, 8, 9), as well as by the direct electrical
stimulation of the reticular formation of the midbrain.

As

is seen in figure 7, the response to sound was generally
not an enduring one and the tracings reverted back to the
synchronized state within a few seconds after the stimulus
was withdrawn.

Hippocampal leads showed a marked hyper-

synchronization during the presentation of the stimulus as
contrasted to the cortical responses during the EEG arousal
state.

The other control figures showed a similar pattern

of response.

Tactile stimuli provided an EEG alert pattern

but this desynchronization generally was more persistent as
shown in figure 8 in which a painful stimulus was used to
elicit an abrupt arousal as indicated by the arrows.

Direct

electrical stimulation of the midbrain reticular formation
at the parameters indicated in figure 10 elicited a response
similar to that from painful stimuli in that the desynchronization was long lasting.
All animals were tested for these responses as indica-

tions of a general physiological state during a control

82
period.

The characteristics of the tracings as well as

histological identification verified site of implantation.
And the responsitivity of the rabbit to the several stimuli
as indicated above showed whether or not extensive damage
had occurred during the implantation procedure, such as a
subdural hematoma or massive trauma to the brain tissue
resulting from displacement of the electrode.

Animals not

responsive to the stimuli in a manner similar to these just
described were rejected as experimental subjects.
B.

EXPERIMENTAL OBSERVATIONS

1.

Histological
Figure 30 reveals a blank thiocholine result following

the administration of 50.0 mcgm/Kg

i.v. of sarin and its

subsequent antagonism by atropine sulfate (5.0 mg/Kg

i.v.).

This result could not be differentiated from those brain
sections found in animals receiving only an irreversible
inhibitor (cf. figs. 6a, 6b, 6c).

Similar results were

noted with rabbits pretreated with sarin or DFP and subsequently exposed to convulsant doses of Eserine.

On the

other hand, irreversible inhibition of cholinesterase by
sarin (50.0-100.0 mcgm/Kg

i.v.) was blocked by the prior

administration of Eserine (50.0-150.0 mcgm/Kg

i.v.).

Convulsions and death occurred buthistochemically, the
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brain sections showed areas of intense staining

comparable

to controls (fig. 29, cf. figs. 5a, 5b, 5c).
2.

Biochemical
The effects of AntiChE 1 s on the activity of cholines-

terase are indicated in Table I and appendix A.
(20.0 mcgm/Kg
DFP.

Sarin

i.v.) markedly reduced AChE activity as did

Neither atropine sulfate nor atropine methyl nitrate

altered this effect as inhibition of enzyme activity continued at a high level.

BuChE activity also was greatly

reduced under these same conoitions and while the per cent
of reduction is less, again there was approximately 90% less
activity compared to that of AChE (cf. appendix A).

3.

Electrophysiological
Control tracings prior to the administration of sarin

are shown in figure 11.

The response to sound stimulation

was similar to that obtained previously (cf. fig. 7) and
indicated a satisfactory preparation.

Sarin (20.0 mcgm/Kg

i.v.) evoked a classical grand mal EEG convulsive pattern
as shown in figure 12.

A slight rise in mean arterial

blood pressure and bradycardia was noted.
(5.0 mg/Kg

Atropine sulfate

i.v.) given at the height of the convulsive

activity antagonized it and restored the tracings to a
non-convulsive pattern typical of that seen after atropine

Figure 11

CONTROL EEG- PRIOR TO ADMINISTRATION OF SARIN
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Initial Sarin Seizure:

IOOpVL-

Grand mal type convulsive pattern induced by the i.v.

administration of 20 mcgm/Kg of sarin.

This figure reveals the onset of the

seizure which quickly develops into a diffuse pattern of convulsive EEG activity.
Note the onset of the pattern at the right side of the tracings and the slight
rise in mean blood pressure.

Sarin was injected approximately 2 minutes earlier.
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Figure 13

ATROPINE ANTAGONISES SARIN
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Antagonism of the Sarin Seizure:

10011Vuc

Atropine sulfate 5.0 mg/Kg i.v. given at the

height of the anticholinesterase induced convulsion, antagonizes the seizure and
reveals a control pattern similar to that seen after only atropine.
brain wave tracings show slow waves and occasional 8-14 c/s spindles.
were made approximately 15 minutes after those seen in figure 12.

Uninterrupted
These tracings
Q)
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Figure 14
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Additional Dose of Sarin Provokes a Second Convulsion:

rec-

The administration of a

second injection of sarin (40 mcgm/Kg i.v.) in the presence of atropine as a
continuation of the previous record, again evokes a diffuse EEG seizure pattern
with a more marked presser response perhaps due to the higher dose.

Moreover,

atropine sulfate (5.0 mg/Kg i.v.) given at the arrow rapidly antagonizes the
convulsive pattern (cf. Figure 13 ).
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only (Longo 1962).

Blood pressure and heart rate changes

were also antagonized as shown in figure 13.

EEG con-

vulsions were readily initiated by the administration of
another dose of sarin (40.0 mcgm/Kg
figure 14.

i.v.) as seen in

Blood pressure was elevated and a slight brady-

cardia was detected.

The seizure pattern which began in

the hippocampus (left side of figure) spread to the rest of
the brain and a second dose of atropine sulfate (5.0 mg/Kg
i.v.) was given at the height of the convulsion (arrow).

The

EEG tracings showed a cessation of the grand mal waves in~

dicating the onset of antagonism (cf. right side of fig. 14).
However, shortly after atropine had been given, the brain
waves began to show an increased delta activity as indicated
in figure 15.

The rabbit then failed to respond to control

stimuli which indicated an atropinic blockade.
blood pressure was also at pre-sarin levels.
injection of sarin (40 mcgm/Kg

The mean
An additional

i.v.) again evoked a con-

vulsive EEG pattern but did not induce a pressor response
(fig. 16).
Ligation of the basilar artery had no effect on the
electrical activity of the brain which showed the same EEG
and reaction to stimuli as that seen in the control animals
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(figs. 19, 20, cf. fig. 7).

Injections of 2.0 ml of saline

at the rate of 1.0 ml/20 seconds into either the carotid or
the vertebral arterial circulation did not alter the spontaneous EEG activity or blood pressure.

Control tracings

of synchronized EEG activity are shown in figure 19 and of
desynchronized activity in figure 20.
The response to the intracarotid administration of subconvulsant doses of Eserine occurred in two stages shown in
figures 21 and 22.

Synchronized EEG activity appeared in the

cortices with a slight

transi~nt

decrease in blood pressure

that appeared within seconds after the drug administration
(arrow), and persisted for about 1 minute.

Desynchronized

EEG activity then appeared which was the second phase of the
response.

This EEG alert persisted for up to 15 minutes and

was accompanied by a pressor response that began after the
onset of the EEG arousal (fig. 22 (arrow)).

EEG tracings

resumed pre-drug characteristics 30 to 40 minutes after the
injection.
Sarin administered intravertebrally (10 mcgm/Kg , fig. 23)
evoked an initial convulsion in the hippocampus that was somewhat localized.

Figure 24 reveals the diffuse convulsive

activity that followed approximately 20 seconds after the
appearance of the limited seizure.

Figure 15

.

ATROPINE ANTAGONISES 2nd SARIN INJECTION
EKG

LAC-LN-

LN-BOA-_.."""""'..,_w--"'W'""".,..,.,,.,.....,..W.~,,,..,.,.,,.,,~~.fi,..J""""'-"~~..........,,._.....,,,.,.._..Jviv.-~""""'~~~~y,_.
LH-RF--

EEG Pattern of 2nd Atropine Antagonism of 2nd Sarin Seizure:

Brain wave tracings

taken shortly after the preceding Figure

show the antagonism of the sarin grand

mal seizure activity by atropine sulfate.

Note also the lowering of the mean

blood pressure to pre-convulsion levels.
\.D
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Figure 16

FINAL SARIN CONVULSION IN PRESENCE OF ATROPINE

LH-Rf'--'YTllU"'Ytl

BPIOOmmHQ

I

IOOpVLHC

Sarin (40 mcgm/Kg i.v.) Again Evokes a Convulsion in the Presence of Atropine:
The administration of an additional dose of 40 mcgm/Kg i.v. of sarin provokes a
seizure in the presence of atropine.
previous recordings.

This tracing is a continuation of the

Note that the seizure is evoked but that the level of

atropinization is sufficient to block the pressor response (See mean blood
pressure). The seizure developed approximately 2 minutes after sarin was given.
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Figure
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Basilar Artery Ligation

carotid

t1xl.

communicating post or/.

carotid comm.

carotid comm.

omoct1rvlca/ art

Legend for Figure 17
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Anatomical Considerations in Basilar Artery Ligation in the Rabbit: The
position of the ligation of the basilar artery is at the point of reference as
indicated in the figure for 'basilar art. ' The external carotid cannulation
extends to the bifurcation of the internal and external carotids.
subclavian artery is also cannulated.

The

The omocervical and internal

mammary arteries are tied while the innominate is raised by means of a
loop of suture thread at the time of injection.

This latter procedure pre-

vents injected materials from passing into the common carotid and then
into the forebrain via the internal carotid and Circle of Willis.

Injections

into the external carotid follow the flow of. blood into the internal carotid
and the Circle of Willis thus supplying the anterior brainstem and telencephalon.

The injection of substances into the subclavian artery with the

innominate temporarily occluded courses up the vertebral and basilar to
the position of the tie.

This type of administration will supply the bulbar

pontine reticular formation and those structures in the medulla and parts
of the pons (cf. Figure 18 Dye Distribution).

co
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Legend for Figure 18

Distribution of Monastral Blue Dye in Two Rabbit Brains with
Ligation of the Basilar Artery at the Mid-Pontine Level:

In

I
I

the brain represented by the upper section, the injection was
made into the vertebral artery.

!

Note that the distribution

of dye is restricted to the caudal pontine-medullary area

.

which includes the bulbar-pontine reticular formation .
The lower half of the figure is from a brain in which the
injection of the dye was made into the internal carotid from
the external carotid.

Note the limitation of the dye distri-

bution to those structures more anterior to include the
mesodiencephalic reticular substance.

i'
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Figure 19
EEG SYNCHRONIZATION-CONTROL
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Control EEG Pattern:

L__

sec

Synchronized or slow wave EEG sleep pattern in the resting

animal with the basilar artery ligated at the mid-pontine level.

Note the high

amplitude, slow frequency patterns primarily in the cortices (LAC-BOA, RAC-LN,
L-RPC) while the LN-BOA is primarily a low amplitude tracing and the leads from
the hippocampus reveal marked theta rhythm, (llI-LN and RH-BOA).
(BP) is recorded as a mean pressure.

The blood pressure

'°0\

Figure 20

EEG DESYNCHRONIZATION- CONTROL
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Control EEG Pattern:
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sec

Desynchronized EEG activity during the control phase reveals

a decreased amplitude and faster frequency of the tracings.
rhythm, especially in the leads from the hippocampus.

Note the marked theta

The basilar artery was

ligated at the mid-pontine level.
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Figure 21

INTRACAROTIO ESERINE-RESPONSE "A•
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Initial Response to an Intracarotid Injection of Eserine with the Basilar Artery
Tied:

Eserine (100 mcgm total dose) administered at the arrow elicits an increased

EEG sleep pattern shortly after the injection (right side of figure).
is accompanied by little if any change in mean blood pressure.
pattern is most evident in channels 2, 3, and 6.

This effect

The synchronized
\..0
OJ

Figure 22

INTRACAROTID E'SERINE- RESPONSE
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Pressor Response and EEG Alert after Intracarotid Eserine in the Basilar Tied
Preparation:

Subsequent to the previous record (-Response

11

A") an EEG de synchroni-

zation occurs followed by a rise in mean blood pressure (beginning at the arrow).
The time lapse between the two figures, Response "A" and Response "B", is approximately two minutes.
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Figure 23

INTRAVERTEBRAL SARIN-LOCAL CONVULSION
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Initial Response to the Intravertebral Arterial Administration of Sarin in the Rabbit
with the Basilar Tied:

Sarin (10 mcgm total dose) given intravertebrally to the rabbit

with the basilar artery ligated at the mid pontine level induces a biphasic response.
The initial phase consists of a localized seizure limited somewhat to the hippocampus
(LH-LN and RH-BOA).

Note the reflection of the seizure in the posterior cortices over-

lying the dorsal hippocampus.

The 2nd phase is in the following figure.
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Figure 24

INTRAVERTEBRAL SARIN TOTAL CONVULSION
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Second Phase of Intravertebral Sarin:

Subsequent to the previous response in

the preceding figure, grand mal type EEG seizure activity spreads to the entire
brain as is evident from these tracings.

Note the typical seizure activity as

intermittent spike activity is associated with high frequency burst activity.
The time between the tracings in figures 23 and 24 is approximately 20 seconds.
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Figure 25
INTRACAROTID SARIN AFTER ESERINE
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Convulsio~

in the Presence of Eserine:

The intracarotid administration

of sarin (50 mcgm ~otal dose) elicits a grand mal convulsion (right side of
tracings) in the presence of a subconvulsant dose of eserine.

Note the fall in

mean bloo5 pressure and the initial phase of its recovery on the far right side
of the

traci~g.

~

Eserine (100 mcgm/Kg i.v.) had been given approximately 10 minutes

prior to these tracings.

g

Sarin was given about 30 seconds before the seizure activity.

Figure 26

CONTROL- RECRUITMENT
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Recruitment During the Control Phase Prior to the Administration of Eserine
Followed by Sarin:

Stimulation of the anterior dorsal thalamic nulcei elicits

typical recruitment responses from the cortices.

The stimulus of 8.0 c/s, 0.8

!....!
0
VJ

msec and at a voltage greater than threshold was presented as indicated by the arrows.
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Intravenous Administration of Sarin Elicits Seizure in the Presence of Eserine:
Sarin was injected (50 rncgrn/Kg i.v.) in the presence of 100 mcgm/Kg i.v. of
Eserine.

Eserine had been injected 8.0 minutes prior to the administration of

the Sarin and the sarin induced convulsion appeared within one to two minutes.
Note the diffuse nature of the seizure and the artifact in the EKG which resulted
from the fasiculations elicited by the anticholinesterases.

Histocherni.:;al analysis

of this brain revealed absence of irreversible inhibition of acetylcholinesterase
( cf. Figure 29) •
I-'

Figure 28
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Legend for Figure 29

Sarin Convulsion Does Not Irreversibly Inhibit Cholinesterase in the Presence
of Eserine:

Histochemical analysis by the thiocholine procedure reveals

cholinesterase in the sagittal section of the rabbit brain.

Note the dense

areas representing sites of cholinesterase in the caudate nucleus, superior
colliculus, thalamic nuclei, amygdala, and medullary nuclei.

Pretreatment

with Eserine has prevented the irreversible inhibition as normally seen with
this dose of sarin (figure 6a ).

This figure represents the brain from the

animal used in the experiment shown in the figure 28 .
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Legend for Figure 30

Sagittal Section of Rabbit Brain Exposed to Sarin and
Atropine Sulfate and Processed by the Thiocholine Procedure
for Demonstration of Cholinesterase:

The brain used in this

figure represents the effect of treatment with an irreversible
inhibitor of cholinesterase, sarin.

A sarin induced con-

vulsion (50 mcgm/Kg i.v.) had been antagonized by atropine
sulfate (5.0 mg/Kg i.v.).

Note the absence of intense areas

of staining as compared with the control sections (cf. Figure
5a).

The photographic processing of these

11

blank 11 sections

required intense over-development while the control cholinesterase sections did not.
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On the other hand sarin, given by the carotid route of
administration, did not reveal a localized seizure followed
by a diffuse one but rather showed only a generalized con-

vulsive pattern (fig. 25).
mcgm/Kg

Pretreatment with Eserine (100

i.v.) had evoked a desynchronized EEG with an

elevated blood pressure (see left side of tracings fig. 25).
Sarin injected intracarotidly on this background of
reversibly inhibited AChE not only evoked seizure activity
but also induced a marked transient depressor response and
bradycardia.
Figure 26 shows cortical recruitment evoked by thalamic
stimulation as indicated in the legend (see also Part II).
A control response to the dose of Eserine that attenuated recruitment and induced a desynchronized EEG pattern was
obtained prior to the intravenous administration of 50.0
mcgm/Kg of sarin (fig. 27).

Diffuse EEG convulsive episodes

occurred after the administration of sarin (fig. 28) and the
animal died shortly after these tracings were made.
sequent histochemical analysis of the brain showed an
absence of irreversible enzyme inhibition (fig. 29).

Sub-
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IV.

DISCUSSION

Anatomical findings in the rabbit brain stained with
thionin and eosin agreed with the stereotaxic atlas of
Monnier and Gangloff (1961), but contained greater detail
(cf. Fifkova and Mar~ala 1960, Sawyer et al. 1954, Meesen
and Olszewski 1949, Young 1936, Kappers et al. 1936, and
Winkler and Potter 1911).

Tissue processing with frozen

sections permitted the determination of the sites of implantation of electrodes in less than an hour as compared
to a formalin-fixed, frozen sect.ion method (McBride and
Klemm 1968) .
The thiocholine procedure (Koelle 1955) was applied to
rabbit brain tissue and subsequently modified (see Methods).
Histochemical evidence of irreversible inhibition of
cholinesterase or of protection from irreversible enzyme
inhibition was of interest in the current studies.

There-

fore, only the thiocholine procedure that revealed all
cholinesterases was used.

Furthermore, the rabbit brain has

been reported to contain little BuChE in contrast to other
species (Gerebtzoff 1959).

But the brains of different

mammalian species appear to have greater AChE than BuChE
activity (Augustinsson 1948, Ord and Thompson 1950).
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Localization of cholinesterases in the non-drugged rabbit
brain (figs. 5a, 5b, 5c), agreed with previous observations
in rats (Koelle 1963) and in rabbits (Gerebtzoff 1959),
though the procedures differed.

No attempt was made to

evaluate cellular localization of the enzyme in the current
studies.

The thiocholine procedure of Koelle (1949, 1950,

1951, 1955) is basically an in vitro method that uses combinations of inhibitors and substrates that are specific for
AChE and BuChE.

Counterstaining as well as post-fixation

with formalin are included.

~

disadvantage of this method

is the diffusion artifact that appears following long term
incubation.

Prefixation in 10% formalin was introduced as a

modification of Koelle's method (Coers 1953, Couteaux 1958,
and Gerebtzoff 1959) and the diffusion artifact was minimized
as a result of inactivation of cholinesterase by the fixative
(Taxi 1952).

Bergner and Bayliss (1952) have proposed a mode

of action for the thiocholine histochemical process and this
appears in figure 4.
The biochemical study of Aprison et al. (1954) showed
variations in AChE activity in several parts of the rabbit
brain with the highest values appearing in the caudate
nucleus.

Our histochemical data (figs. 5a, 5b, 5c), in

general correlated with their observations and the most
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intense stain for AChE appeared in the caudate nucleus.

The

inhibition of brain cholinesterase by the organophosphates
(figs. 6a, 6b, 6c), corroborate previous biochemical
findings (Holmstedt 1963).

Also, the irreversibility of the

inhibition was reflected by the negative (blank) histochemical stain for cholinesterases (figs. 6a, 6b, 6c, 30).
Atropine sulfate and atropine methyl nitrate failed to
antagonize this inhibition of cholinesterases as seen with
histochemical observations (fig. 30) and biochemical
findings (Table I).

Atropine

~ulfate

has been shown to

produce a considerable increase in the release of acetylcholine from the cortices of several species (Beani et al.
1964, Polak 1967, Beaniet al. 1968).

However, the mechanism

for producing this effect is unclear and Beani et al. (1968)
summarized some of the tentative explanations.
proposed, include the following:

Mechanisms

(1) blockade of post-

synaptic sites to prevent uptake of released ACh (Celesia
and Jasper 1966), (2) blockade of a negative feedback
mechanism that results in an increased rate of firing of
corticopetal cholinergic paths (Mcintosh 1963), and (3)
blockade of a negative feedback mechanism that is located
intracortically and acts on cholinergic terminals (Polak
1967).

Furthermore, the anticholinesterase properties of
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atropine might be a factor (Vincent and Parant 1956,
Todrick 1954, and Gyermek 1955).

It has been shown that the

acute toxicity of anticholinesterases can be additive and
perhaps reveal potentiation (Frawley et al. 1952, 1957).
This would result in an increased accumulation of ACh.
Cholinergic desynchronization of the EEG would be blocked
by the competitive antimuscarinic actions of atropine at
post-synaptic sites.

While our data did not show an in-

creased inhibition of cholinesterases in the presence of
atropine, the enzyme was already maximally inhibited (fig.
29, cf. Koppanyi and Karczmar 1951).

Based on the observa-

tions cited above (Table I), the presence of the anticholinergics did not reduce cholinesterase inhibition.
The EEG of the rabbit at rest and during activation was
similar to that described by Longo (1962) (figs. 7, 8, 9,
10).

Intravenous sarin (20.0 mcgm/Kg, fig. 11), elicited

a convulsive pattern (cf. Longo 1962) and the dose approximated the LD 50 for rabbits (Holmstedt 1963).

Atropine

antagonism of the EEG response to sarin has been known
(Machne and Unna 1963) and present findings are similar.

The

reciprocal nature of this response (figs. 13, 14, 15) as
pointed out by Longo (1962) depends on the amounts given.
This reciprocal antagonism of anticholinesterases and anti-
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cholinergics at the central nervous system in terms of the
basic pharmacology of atropine (Goodman and Gilman 1965)
suggests a competitive antagonism.

The onset of anti-

cholinesterase-induced convulsions is accompanied by hypertensive blood pressure responses which persist for the duration of that paroxysmal EEG activity (Longo 1962).

This was

found to be the case in the presence of reciprocal antagonism concomitant with EEG changes.

However, at a sufficient-

ly high dose of atropine (fig. 16, 10.0 mg/Kg

i.v. total

dose), blood pressure failed bo rise though the EEG and
behavioral response to sarin was a convulsion.
Activity of brain cholinesterases after the first
injection of sarin and after the AntiChE had been antagonized
by atropine showed marked attenuation (Table I).

Further-

more, the histochemical evidence supported this finding
(figs. 6a, 6b, 6c).

Therefore, after the first injection of

sarin, cholinesterase was irreversibly inhibited and after
repeated reciprocal antagonism with atropine the irreversible
nature of the inhibition was unchanged (cf. Koppanyi and
Karczmar 1951).

Effects of the irreversible anticholin-

esterase, when produced in the presence of maximally
inhibited enzyme, cannot be attributed to irreversible
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inhibition.

Reciprocal antagonism of these effects with

atropine also occurred in the same manner as seen after the
initial dose of sarin and on a background of irreversibly
inhibited brain cholinesterase.
Experiments were then designed to protect brain choline sterases from irreversible inhibition (cf. Koelle 1957),
and this data is shown in figure 29.

Eserine readily

penetrated the BBB and produced a transient sequence of
effects on the EEG (Longo 1962 and Longo and Silvestrini
1957) which were also noted in the current studies (figs.
21, 22, and Part II).

Marked attenuation of thalamocortical

recruitment (see Part II) is a characteristic feature of the
action of Eserine in rabbits and the studies of Hance et al.
(1963) revealed that EEG desynchronization and marked
attenuation of the surface negative component of the recruited potentials were the most significant effects produced
in cats.

Figure 27 shows the degree of attenuation of re-

cruitment and the EEG arousal evoked by Eserine as compared
to a pre-drug state during a moderately desynchronized EEG
background (fig. 26).

These responses served as controls for

the effectiveness of that dose of Eserine.

In the presence

of Eserine, the administration of 50.0 mcgm/Kg

i.v. of sarin,

a dose that approximates 2 times the LD 50 for rabbits
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(Holmstedt 1963), evoked a convulsion (fig. 28).

At this

time, brain cholinesterase was reversibly inhibited by
Eserine (Long 1963).

Histochemical data (fig. 29), showed

that irreversible inhibition of the enzyme had not occurred
and areas of intense staining appear comparable to the untreated rabbit brain (figs. 5a, 5b, 5c).

Protection of

cholinesterase from irreversible inhibition by the prior
administration of a reversible inhibitor was used by Koelle
(1946, 1957).

He noted that the concentrations of AChE

varied according to the

activi~y

and dose of the reversible

inhibitors but not the irreversible ones.

In earlier studies,

Koelle (1946) suggested that Eserine could be displaced from
cholinesterase by DFP.

Our data indicates that brain AChE

reversibly inhibited by Eserine is not susceptible to marked
irreversible inhibition by sarin or DFP.

The lack of agree-

ment may be in the amounts of drugs given.

However, the time

of sacrifice after the administration of the irreversible
inhibitor may have greater importance.

Attenuation of

recruitment by DFP in the presence of Eserine is reversible
following the first exposure but repetition of this procedure
results finally in an EEG response and attenuation of recruitment that is consistent with irreversible inhibition (unpublished preliminary studies).

Histochemical evaluation of
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these rabbit brains revealed irreversible inhibition of
cholinesterase.

The seizure induced by sarin in the presence

of Eserine does not appear to be due to irreversible inhibition of that enzyme which normally occurs with sarin
given alone (cf. fig. 30).
The biphasic response to the intracarotid administration of Eserine was somewhat unexpected.

The transient fall

in blood pressure and concomitant synchronization of the EEG
could be attributed to a muscarinic action of Eserine (fig.
21).

.

The subsequent EEG arousal (fig. 22) could be due to

nicotinic actions of Eserine and/or the increased concentration of ACh that attends inhibition of AChE.

Silvette et

al. (1962), Domino (1967), and Longo et al. (1967) have
shown EEG desynchronization to be the initial response to the
intravenous administration of nicotine.
nization of activity may follow.

An increased synchro-

In addition, Schaeppi

(1968) injected nicotine intracarotidly or intravertebrally
into cats and found that either route of administration
elicited results similar to the intravenous injections.

How-

ever, the intravertebral injection appeared to be more effective and produced direct effects on cardiovascular centers
in the brain that were independent of the effects of nicotine
on the EEG.

Schaeppi attributed the EEG arousal to an action
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on an unspecified ascending desynchronizing system and the
subsequent EEG synchronization on another unspecified
ascending synchronizing system.

Longo (1966) showed that

atropine blocked the EEG and motor convulsions evoked by
cortical application of a combination of Eserine and acetylcholine.

Furthermore, Domino (1968) found mecamylamine to

be an ineffective antagonist of either Eserine or pilocarpine-induced EEG and behavioral arousal in cats.
readily blocked these responses.

Atropine

Responses to Eserine seen

in the current experiment (figs. 21, 22) may be the result
of muscarinic-cholinergic stimulation since atropine
antagonizes them (Longo 1962).

In addition, the pressor

response to the intracarotid administration of Eserine
supports the findings of Varagid

and Krstit

(1966).

These

authors noted that the Eserine evoked pressor response in
rats was blocked by lesions in the lateral hypothalamus.
Intravertebral administration of sarin produced a biphasic response (figs. 23, 24) of convulsive EEG patterns
that were initially localized and then developed into a
grand mal pattern.

Intracarotid administration of sarin in

the presence of Eserine (fig. 25) also elicited a seizure
pattern which had a diffuse and abrupt onset.

The convulsive

activity of sarin did not appear to be restricted to specific
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sites of the forebrain and hindbrain, and occurred in the
presence of Eserine-inhibited enzyme (fig. 29).

Micro-

injections of sarin given bilaterally into the lateral
reticular nucleus of the medulla of rabbits resulted in
apnea, which could be antagonized by atropine given intravenously (Stewart and Anderson 1968).

Hypotensive responses

also were evoked and were antagonized by atropine.

Micro-

injections of sarin into more medial areas of the reticular
formation produced tachypnea, bradycardia, and hypotension.
Tachycardia was not seen but hypertensive responses could be
evoked.

All of these responses were antagonized by atropine.

The bradycardia was of interest because it could be blocked
by a bilateral vagisection and could not be elicited by
microinjections of sarin into the area of the nucleus
solitarius or the dorsal nucleus of the vagus.

Stewart

suggested that rhythmicity of the medullary respiratory center is under a muscarinic inhibitory control in a way
analagous to the relationships found between vagus nerve and
cardiac pacemaker.
Cholinoceptive neurones of the ponto-medullary brainstem
of cats revealed excitatory nicotinic and inhibitory muscarinic responses to iontophoretically applied drugs (Bradley et
al. 1966).

Dihydro beta-erythroidine blocked the excitatory
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responses while atropine antagonized both excitatory and
inhibitory effects.

In addition, Bradley and co-workers

noted that the iontophoretic application of Eserine and
neostigmine potentiated the effects of ACh and also had
actions

per~

different from ACh.

Eserine had an

excitatory effect on neurons that were inhibited by ACh.
Cholinergicity of the ascending pathways of the CNS has
been implied by several lines of evidence.

Cholinoceptivity

of the brainstem neurons has been established (vide supra).
Cortical cholinergic mechanisms have been discussed by
Krnjevi6

(1967) who pointed out the presence of ACh sen-

sitive cells in the cortex as well as choline acetylase and
AChE.

Evidence for cholinergic innervation arriving from

subcortical origins was based on electrophysiological,
histochemical, and biochemical data.

ACh-sensitive cortical

cells responded to thalamic stimulation and these responses
were potentiated by ACh or Eserine.
these responses.

Atropine antagonized

AChE-staining fibers that projected to

the forebrain could be traced to several subcortical sites
to include the septum pellucidum, lenticular nucleus, and
the midbrain reticular formation.

cortical release of ACh,

measured biochemically, showed that as cerebral activity
decreased during anesthesia, so did the amount of ACh being
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released.
Shute and Lewis (1966J 1966a) have compared their
findings for cholinergic pathways in the rat brain with the
histochemical fluorescence data for monoaminergic pathways
(Dahlstrom and Fuxe 1964).

Shute and Lewis concluded that

the 2 ascending systems paralleled one another but that
electrocortical arousal was more likely a cholinergic event
rather than monoaminergic.

They cited as evidence their

observations that monoaminergic cells did not extend to the
forebrain telencephalon as diq the cholinergic ones.

How-

~

ever, Anden et al. (1966) proposed a forebrain extension of
monoaminergic pathways.

Cuculic et al. (1968) postulated

that the final link in the electrocortical arousal was a
cholinergic one.

They arrived at their conclusions from

data obtained by the direct application of cholinolytic
substances on the cortex.

Atropine antagonized both

cholinomimetic and adrenomimetic agonists (cf. White and
Daigneault 1959).
Therefore, the evidence of cholinergic pathways from
the reticular formation to the cortex presents multiple
sites of action for anticholinesterases.

Anticholin-

esterases can act not only indirectly, by enhancing the
action of ACh, but also directly as was shown by Bradley

--
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et al. (1966) at the cellular level and also in the current
-study where it was demonstrated that anticholinesterases
could evoke responses in the presence of inhibited enzyme.
The presence of parallel monoaminergic and cholinergic pathways suggests cholinergic-adrenergic interrelationships.
Part II of the dissertation presents evidence for an
adrenergic-cholinergic interaction at the thalamocortical
level.
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V.

SUMMARY

Figure 31 reviews histochemical, electrophysiological,
and biochemical evidence for the direct action of anticholinesterases.

The "Histochemical Data'' shown in the

column on the left hand side of the figure (read down) indicates that Eserine evoked an EEG alert at which time the
administration of sarin or DFP evoked a convulsion and
death.

The thiocholine procedure for cholinesterase re-

vealed a stain which indicated non-irreversible inhibition
of the enzyme.

On the other hand, histochemical data also

showed that if sarin or DFP were given first (2nd column
Histochemical Data) then an EEG alert would also be evoked
during which time the administration of Eserine evoked a
convulsion and death as before.

However, the thiocholine

procedure now revealed a blank result which indicated irreversible inhibition of enzyme.
The "Electrophysiological Data" shown in the middle
column reflects the reciprocal antagonism between anticholinesterase and anticholinergic drugs.

Sarin evoked an

EEG alert which led to a convulsion and was antagonized by
atropine.

Subsequent injections of sarin (2nd Sarin In-

jection; 3rd Sarin Injection) again evoked EEG alert patterns
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and convulsive episodes which were similarly antagonized by
atropine.

Biochemical Data (right hand column) revealed

that the activity of ChE was irreversibly inhibited approximately 95% after the first injection of sarin and that
atropine antagonism did not change this effect of sarin.
Thus, after the initial, irreversible inhibition of ChE, the
interaction between sarin and atropine occurred in the
presence of maximally inhibited enzyme.
Therefore, in summary:
(1)

EEG responses to the

adm~nistration

of anticholinester-

ases were evaluated in the presence of (a) irreversibly
inhibited enzyme and (b) in the presence of cholinesterase that was protected from an irreversible inhibitor by the presence of a reversible inhibitor.
(2)

Reciprocal antagonism between sarin and atropine was
repeatedly demonstrated in the same animal.

Biochemical

and histochemical findings indicated maximal irreversible inhibition of brain cholinesterase after the first
injection of sarin.
(3)

Sarin evoked grand mal seizures and death when given
after Eserine.

Histochemical data showed that sarin

failed to irreversibly inhibit brain cholinesterase.

-
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Figure 31

DIRECT ACTION OF ANTICHE'S

Histochemical Data

Eserine

Sarin-DFP

Elect rophysiolog ica I
Data
Sarin

Biochemical Data

ChE Inhibition After Sarin:
> 953

EEG Alert -i>Convulsion
EEG Alert

EEG Alert
Atropine -Antagonism.

ChE Inhibition After Sarin
and Atropine:

> 953
Sarin-DFP

Eserine

Convulsion
and
Death

Convulsion
and
Death

Thiocholine
Stain

Thiocholine
Blank

2nd Sarin Injection

EEG Alert -1>Convulsion

Atropine-Antagonism

3rd Sarin Injection

EEG Alert -1>Convulsion
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(4)

A direct action of anticholinesterases is proposed in
addition to inhibition of enzyme.
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PART II.

EVIDENCE FOR AN ADRENERGICALLY MEDIATED ACTION

OF ANTICHOLINESTERASES IN THE CENTRAL NERVOUS SYSTEM
OF RABBITS

131
I.

INTRODUCTION

Electrocortical desynchronization by cholinomimetics
and anticholinesterases with the demonstration of antagonism
by antimuscarinic drugs has suggested cholinergicallymedia ted events (Wescoe et al. 1948, Funderburk and Case

1951, Bradley and Elkes 1953).

Mediation by adrenergic

mechanisms has also been proposed (Bonvallet et al. 1954,
Dell 1961).

However, difficulty in interpretation of results

has occurred since the administration of norepinephrine (NE)
or epinephrine (EPI) resulted in_EEG desynchronization, or
synchronization or no effect (see Longo 1962 and Baust and
Niemczyk 1964 for reviews).

The monoamines, NE, EPI, and

dopamine (DA) penetrate the blood brain barrier (BBB) to
little if any extent (Weil-Malherbe 1961) and therefore CNS
responses attributable to a direct action following intravenous administration is questionable.

Adrenomimetic drugs

such as amphetamines and other phenylethanolamines that
readily gain access to the CNS showed EEG desynchronization
consistently which was associated with behavioral arousal
in unanesthetized preparations (Longo and Silvestrini 1957,
Bradley 1968).

Inhibition of monoamineoxidase followed by

the administration of L-DOPA, the precursor of NE and EPI,

......
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resulted in an EEG and behavioral arousal associated with
marked increases in brain biogenic amine levels (Everett

1961).

Furthermore, reserpine-depletion of biogenic amines

and behavioral sedation in monkeys has been reversed by the
administration of a monoaminoxidase inhibitor (MAOI) plus
L-DOPA (Everett et al. 1963).
EEG responses to cholinomimetics and adrenomimetics
were readily blocked by atropine (White and Daigneault 1959)
as well as by the alpha blockers phenoxybenzamine and
chlorpromazine (Goldstein and Munoz 1961, MuNoz and Goldstein 1961).

Though anticholinergics and adrenergic

blockers may share similar effects there are notable
differences including the failure of amphetamine to reverse
the EEG synchronization induced by scopolamine (Longo 1962).
Interrelationships between cholinergic and adrenergic systems
associated with EEG desynchronization and behavioral arousal
have been suggested by White and Daigneault (1959), Bradley

(1961), Dell (1961), and White et al. (1965).

Desynchronizatior

of the EEG by anticholinesterases is presumably evoked
through cholinomimetic mechanisms that may be indirect via
increases in acetylcholine (ACh) concentrations as well as
direct actions (Bradley et al. 1966, cf. Part I).

Ampheta-

mine also evokes an EEG arousal through adrenomimetic
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mechanisms that may be indirect as well as direct (Bradley
1961).

Both classes of drugs have been demonstrated to act

at a level of the mesodiencephalic activating system
(Rinaldi and Himwich 1955a, 1955b, Van Meter and Ayala 1961).
The threshold of thalamocortical recruitment evoked by
stimulation of the anterior nuclei of the thalamus was increased by EEG arousal (Longo 1962).

EEG desynchronization

evoked by stimulation of the midbrain reticular formation or
by anticholinesterases was a more effective antagonist of recruitment than amphetamine-induced EEG arousal, which did
not attenuate recruitment (Longo and Silvestrini 1957).
The present studies were undertaken to evaluate the
interrelationship between cholinergic and adrenergic
mechanisms in the attenuation of thalamocortical recruitment by an anticholinesterase.

-
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I.

LITERATURE REVIEW

Early studies on evoked thalamocortical potentials in
cats revealed augmenting potentials which followed high
frequency stimulation (up to 120 c/s) of the lateral
thalamic nuclei.

These potentials were localized to the

sensorimotor cortices and showed a biphasic positivenegative waveform.

Stimulation frequencies of 5-15 c/s

applied to midline thalamic nuclei evoked recruited potentials of 20-34 msec latency with a surface negativity and
wide distribution over the cerebral cortex (Morison and
Dempsey 1941-42, Dempsey and Morison 1941-42).

Cortical

and subcortical sites of action for generating recruited
potentials were proposed (Verzeano et al. 1953).

Ajmone-

Marsan (1958) used cats anesthetized with pentobarbital and
observed that the characteristic latency of recruitment was
a function of the waxing and waning of the evoked responses.
He concluded that thalamocortical recruitment resulted from
activation of either longer or shorter chains of neurons
and that the latency was not a function of conduction time
between thalamus and cortex but occurred at the thalamic
level.

He postulated that during recruitment two separate

but interrelated electrical fields arose in the brain and
that these could account for the recruiting phenomena.
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Jasper (1949) noted a diffuse projection system that ascended
from the lower brain stem to cerebral cortex which included
thalamocortical pathways necessary for recruitment.

Longo

(1962) gave a description of recruitment in rabbits and
pointed out that Stoupel and Terzuolo (1954) also found recruited potentials in response to caudate nucleus stimulation.

Bishop et al. (1961) observed that thalamic augmenting

potentials and recruiting potentials were mutually occlusive,
had similar excitation characteristics and distribution in
the various layers of the cortex.

They concluded that the

difference between thalamocortical recruitment and augmenting potentials was an operational one in that stimulation of
thalamic relay nuclei evoked augmenting potentials along
with primary sensory projection responses.

Velasco and

Lindsley (1965) suggested that orbital cortex played a
crucial role in regulation of thalamocortical recruitment in
cats.

They based their conclusions on ablation studies in

which removal of orbital cortex alone abolished recruited
potentials.

Involvement of the limbic system was revealed

by Sparks and Powell (1966) who observed that conditioning
stimuli to the hippocampus, mamillary bodies, or septal
nuclei attenuated late components of recruited potentials that
had been elicited by stimulation of the anterior dorsal

-
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nuclei of the thalamus.

Sparks and Powell concluded that

limbic projection to the anterior thalamus modified its
excitability and this in turn influenced the level of
cortical excitability.

Spindle bursts during EEG slow wave

sleep were also found to be abolished by orbito-frontal
cortical ablations in gallamine immobilized cats (Velasco
et al. 1968).

It was concluded that the orbito-frontal

cortex was an essential anatomical link in a thalamocortical
synchronizing system for spindle bursts and recruitment.
With the introduction of,fast wave or paradoxical sleep
hypotheses (Dement 1958, Jouvet 1962), Yamaguchi et al.

(1964) noted that elicitation of recruitment during paradoxical sleep was questionable.

They also observed that the

degree of attenuation of recruitment during paradoxical
sleep was greater than that seen during relaxed wakefulness.
In addition, these authors noted that high frequency stimulation of the thalamus evoked EEG and behavioral arousal.
Giaquinto (1968) divided sleep and wakefulness into 4 cycles:
(1) strong arousal, (2) relaxed wakefulness, (3) slow wave
sleep, and (4) rapid sleep (paradoxical).

He found a high

threshold for recruitment, a high level of electromyographic
activity and a desynchronized EEG during strong arousal; no
paradoxical sleep, but low voltage fast EEG activity with
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moderate electromyographic activity during relaxed wakefulness; a low threshold for recruitment during slow wave
sleep; and paradoxical sleep revealed no difference in
threshold for recruitment from that seen during relaxed
wakefulness, a threshold which had been relatively high.
Abeles (1967, 1967a, 1967b) evaluated the excitability
of brainstem (nucleus solitarius) and thalamic neurons involved in elicitation of EEG synchronization and desynchronization.

He found that the chronaxie of "desynchronizing"

neurons was less than that of ,"synchronizing" ones and concluded that desynchronization was more readily obtainable
than synchronization.

He postulated that there were not

two different sets of neurons but probably a common set that
responded to synchronizing or desynchronizing stimuli.
Serotonergic sleep (Koella and Czicman 1966, Jouvet
1967, Koella et al. 1968) has been induced by the intracarotid administration of serotonin which penetrated the
blood brain barrier at the area postrema.

Koella and

Czicman postulated that the injected serotonin then stimulated the nucleus solitarius

and serotonergic sleep was

mediated via the tractus solitarius to the midline nuclei
and diffuse projection system of the thalamus.

-
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Anderson and Curtis (1964) found ACh-sensitive neurons
of the ventro-lateral thalamus to respond with inhibition
followed by excitation and the excitation was a mixed
muscarinic and nicotinic type.

However, Mccance et al.

(1968) evaluated the responses of the ventral thalamic nuclei
to iontophoretically applied carbachol, ACh, acetyl betamethacholine, butyrylcholine, propriocholine, nicotine,
Eserine, neostigmine, tensilon, dihydro beta-erythroidine,
hexamethonium, atropine, and hyoscine.

These authors found

.

that muscarinic agonists were more effective than the nicotinic ones.

Atropine blocked most of the responses but di-

hydro beta-erythroidine was much less effective.

Anti-

cholinesterases enhanced the responses and Mccance et al.
concluded that cholinoceptive responses of the ventral
thalamic nuclei of the cat were pharmacologically muscarinic.
Correlation of activity from reticular and thalamic
units with states of sleep, wakefulness, and anesthesia showed a general decrease in activity with variable patterns of
bursts but no unique differences in activity that could be
associated with any given state (Goodman and Mann 1967).

It

was concluded that the characteristics of spontaneous firing
of thalamic and reticular units could not be used to
differentiate between wakefulness, sleep, or anesthesia.
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However, Phillis and Tebecis (1967) found that pentobarbital
blocked the ACh excitatory and the NE inhibitory effects on
thalamic neurons without altering the levels of excitation
of the neurons which remained responsive.

In addition,

Findlay and Hayward (1966) noted bimodal firing of massa
intermedia neurons of rabbits during synchronized sleep but
electrical silence during desynchronization.
Recent studies of Andersen et al. (1967, 1967a) and

--

Andersen and Andersson (1968) have revealed that the thalamus
served as a pacemaker site during barbiturate anesthesia.
Independent rhythmic discharges were generated through their
respective projections to the cortex, to control the
rhythms of that cortical "column".

The thalamic origin of

recruitment and spindle burst activity was postulated to
occur as the result of post inhibitory excitation which induced an increasing synchronized discharge of thalamic neurons
and this accounted for the waxing of potentials seen during
recruitment.

Eventually, these inhibitory neurons get "out

of phase" and the waning of potentials results.

Increased

unit firing was demonstrated to correlate with increased
amplitude of cortical response.

In addition, a functional

relationship between thalamus and caudate was implied by the

.......
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presence of caudate responses to thalamic stimulation.
Kaji et al. (1968) established the existence of connections from anterior thalamic nuclei to the caudate with
their studies on recruiting responses in caudate nucleus.
They observed that caudate recruitment depended on the level
of cortical activity much in tbe same manner as thalamocortical recruitment.

Unit analysis of caudate-cortical

excitatory fiber tract responses in cats disclosed caudatocortical connections of a direct nature rather than collateral or corticopetal tracts from lower levels (Rocha-Miranda

1965).

This data contrasts with that of Demetrescu and

Demetrescu (1962), who had found the activating or facilitatory effects of caudate activity seen during light barbiturate anesthesia, suppressed by reticular formation lesions.
At the same time, depressant effects of the caudate were not
altered by the lesions of the reticular formation.
Single shock stimulation of the caudate evoked spindle
bursts, the threshold of which was raised by pentylenetetrazole and decreased by chlorpromazine, pentobarbital and
alpha blockers (Tokizane et al. 1957).

It was concluded

that reticular formation activity influenced the threshold
of caudate spindles and that the spindles were a reflection
of the state of cortical excitability.

In a sequence of

--
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studies on the caudate spindle (Buchwald et al. 1961,
Heuser et al. 1961, Buchwald et al. 196la, Buchwald et al.
196lb), it was found that (1) caudate spindles evoked by
single shock stimuli to the head of the caudate nucleus
were attenuated by high frequency stimulation of the midbrain reticular formation, hypothalamus, globus pallidus,
or centrum medianum, as well as by catnip.

High frequency

stimulation of the mid-amygdaloid area, rostral, midline,
and relay nuclei of the thalamus failed to block caudate
spindles; (2) cortical sites of caudate spindling and recruitment were the same; (3) functional integrity of the
anterior ventral nuclei of the thalamus was necessary for
caudate spindle activity as well as for electrocortical
arousal induced by stimulation of the caudate; and (4) ether
and locally applied procaine blocked spindles while pentobarbi tal and sleep facilitated then.

A "Caudate Loop" was

proposed in the path from the reticular formation to the
cerebral cortex.

Afferent connections from anterior ventral

thalamic nuclei to the caudate and back formed the loop.
Ventral thalamic afferents also projected to the cortex.

Low

frequency stimulation of this loop antagonized the ascending
arousal system and evoked spindle bursts and behavioral inhibition.

It was suggested that this caudate inhibitory
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loop functionally balanced the alerting system proposed by
Morruzzi and Magoun (1949).

Frequency, intensity, and

anatomical site of stimulation were considered as critical
factors.
Horvath et al. (1964) compared caudate-spindle thresholds with those evoked by internal capsule stimulation in
flaxedilized cats, and found a lower threshold in the caudate.
Goldring et al. (1963) had not been able to evoke caudate
spindles in monkeys and had noted a neuroanatomical
difference between the cat and the macaque monkey.

Afferent

sensorimotor cortical fibers of the cat run adjacent to the
caudate while the sensorimotor cortex of the monkey was
caudal to the caudate nucleus.

These authors noted that

internal capsular stimulation evoked recruitment and concluded that caudato-cortical responses should not be used as
evidence for anatomical pathways.
An ascending inhibitory system that included the caudate
nucleus was proposed by Demetrescu and Demetrescu (1962).
Evoked potentials from optic tract and optic radiations of
the visual system; from

medl~l

geniculate body stimulation

of the auditory system; and from stimulation of the ventral
posterior thalamic nuclei of the somesthetic system; were
all depressed by 40-100 c/s stimulation of the caudate.

On

-
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the other hand, stimulation of the midline thalamic nuclei
facilitated evoked potentials from all of the above areas
where caudate stimulation had shown depression of responses.
Caudate depression of responses was not antagonized by
lesions of the reticular formation.

I

Demtrescu and Demetrescu

1l

(1962a) proposed an ascending inhibitory path that extended
from the pontine-reticular formation to the caudate nucleus
and the cerebral cortex.

This ascending inhibitory path

was ventral to, and paralleled the ascending reticular
activating system.

The inhibitory system was under control

of the activating one and operated via a feedback servo
I

:i

I

mechanism.
Eserine injected into the caudate nucleus, was found to

I I
11:

! I
,I'

block spindling and subsequently could evoke seizures
(Rakic et al. 1962).

These seizures could be antagonized

by unilateral lesions in the cortex and rostral extralaminar
thalamus, as well as bilateral lesions in the posterior
hypothalamus and the posterior intralaminar thalamus.

These

findings were interpreted to mean that Eserine interrupted
the inhibitory influence of the caudate and permitted the
excitatory one to obtain (cf. Demetrescu and Demetrescu
1962).

The result was a lowered seizure threshold.

.........
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Traczyk and Sadowski (1962) noted that slow intravenous
infusion of Eserine increased spontaneous spindling followed
by a desynchronization of the EEG.

In subsequent studies

Traczyk and Sadowski (1964) compared ACh concentrations in
caudate with EEG activity in cerveau isole' cats.

They

found that EEG synchronization in midbrain transected animals
was associated with high ACh concentrations and that desynchronization of the EEG was attended by low ACh content
of the caudate.
tions were low in

On the other hand, caudate-ACh concentradesynchroni~ed

controls; in cerveau isole'

preparations receiving caudate stimulation at 5 c/s and 50
c/s; and after atropine.

Eserine or caudate stimulation at

high frequencies (300 c/s) in cerveau isole' preparations resulted in high concentrations of ACh in caudate nucleus.
They concluded that the lack of agreement between stimulus
response and drug actions on caudate nucleus was explained
by the existence of and the operation of different (undefined)
transmitter systems.
Collins and Simonton (1967) observed that caudate
conditioning stimuli depressed responses in the limbic system
of chloralosed cats.

Extracellular microelectrode studies

showed that caudate stimulation inhibited centrum medianum
unit activity and this effect could be antagonized by strych-
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nine and picrotoxin more than by pentylenetetrazole.

Ampheta-

mine, caffeine, imipramine, chlorpromazine, and mephenesin
were without effect on the caudate inhibition of the centrum
medianum.

Caudate-induced inhibition of evoked responses in

the limbic system was not antagonized by strychnine.

These

authors concluded that caudate conditioning of limbic responses
resulted in strychnine-like action.
Neurons of the caudate as well as the hypothalamus have
been shown to respond to iontophoretically-applied ACh with
either inhibition or excitatiDn (Bloom et al. 1963, Bloom
et al. 1964).

High concentrations of ACh (Aprison and

Nathan 1957) along with high synthesis rates (Feldberg and
Vogt 1948) have been reported for caudate nucleus.

Marked

concentrations of AChE are also evident (see Part I).
Stimulation of the ventral anterior thalamic nuclei evoked
the release of ACh from the caudate.

Also, the response to

cholinergic stimulation of the caudate and the response to
stimulation of the ventralis anterialis was the same
(McLennan and York 1966).

Therefore, a "cholinergic link"

may exist between the thalamus and the caudate.
The Burn-Rand Concept (Burn and Rand 1959, Burn and
Rand 1962, Burn and Rand 1965), suggested that stimulation
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of postganglionic sympathetic nerve fibers evoked the release of ACh which then promoted the entry of calcium into
the nerve ending and enhanced the release of bound NE.
Norepinephrine then acted as a neurotransmitter having been
released by a

11

cholinergic link".

The cholinergic link

hypothesis has been included in recent reviews (Burn 1966,
Ferry 1966, Karczmar 1967, Marczynski 1967).
Karczmar (1967) pointed out evidence obtained by the
use of anticholinesterases for a cholinergic link but
limited most of his comments
system.

~o

the peripheral nervous

Burn (1968) suggested that if acetylcholine was

released by the stimulation of postganglionic sympathetic
nerve stimulation and in turn released NE, then anticholinesterases should enhance the observed responses.

Further-

more, anticholinesterases should reveal a greater facilitation of response at low frequencies of stimulation than at
high ones, since the low frequency of stimulation would
permit more opportunity for AChE-hydrolysis of ACh.
following evidence was presented by Burn (1968):

The

Eserine

increased the response of the atropinized cat nictitating
membrane by 51 per cent at stimulation frequencies of 1 c/s,
by 8 per cent at 10 c/s, and by 2 per cent at 20 c/s; con-

.......
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tractions of the atropinized taenia of the guinea pig was
similarly affected; stimulation of the sympathetic fibers
to the isolated rabbit nerve-heart preparation showed an
enhanced chronotropic response to the administration of
Eserine in the presence of atropine; results with contraction of the dog rectractor penis muscle preparation showed
a greater enhancement of contraction at low frequency
stimulation than at high, after the administration of
Eserine in the presence of atropine; reduction of femoral
arterial blood flow following.sympathetic nerve stimulation
was enhanced by the administration of Eserine in the
atropinized dog and low frequency stimulation was affected
more than high; rabbit ear vasoconstriction was similarly
enhanced by Eserine in the absence of atropine; and finally,
renal blood flow, following sympathetic nerve stimulation,
reflected greater vasoconstriction in presence of Eserine
at stimulation frequencies of 1/sec than at 10 per sec.
Hemicholinium reversed these responses and choline antagonized the effect of hemicholinium.

In addition, hemi-

cholinium has been shown to block the response to stimulation of postganglionic fibers in cat atria, guinea pig
colon, rabbit ear vessels, and cat spleen, all of which
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could be reversed by the administration of choline.

Finally,

botulinum toxin has been shown to block the response of cat
tail pilomotor muscle to sympathetic stimulation (cited in
Burn 1968).
Ferry (1966) reviewed the cholinergic link concept and
concluded that the evidence was not strong enough to support
the hypothesis.

He pointed out that while the presence of

ACh had been shown to result in the release of NE from the
spleen, antidromic impulses could have been initiated in
the

"c"

fibers.

These antidromic impulses would pass up the

splenic nerve to then act as a postganglionic stimulant
which resulted in the passage of impulses back down the
splenic postganglionic nerve and the release of NE at the
nerve ending.

In other words, ACh first stimulated post-

ganglionic fibers which in turn released NE.

Electron-

microscopic investigations of Thoenen et al. (1966) revealed
that the spleen of the cat showed only adrenergic nerve
endings on the basis of osmiophillic granules that were
observed, while the vas deferens of the guinea pig showed
both adrenergic and cholinergic elements lying membrane to
membrane and encased in the same Schwann cell.

They studied

the effect of anticholinesterases on sympathetic nerve
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stimulation and ACh injection in the perfused spleen of
the cat and found no change to nerve stimulation but an
enhanced response to injected ACh.

It was concluded that

while the Burn-Rand Hypothesis may apply in some cases it
should not be assumed to apply in all cases.

Karczmar

(1967) also pointed out that the cholinergic link concept
may not apply to all species particularly in view of the
evidence of Koelle that some sympathetic tracts of the cat
histochemically demonstrate very little ChE as compared to
the rabbit.

Boura and Green (1965) suggested that the

effects of the xylocholine and bretyllium were poor evidence
in support of the cholinergic link since their duration of
action was so brief in comparison with other adrenergic
neuron blocking drugs.

They pointed out that the contrac-

tion of the cat nictitating membrane to stimulation of the
sympathetic nerve was not effectively blocked by hemicholinium but was blocked by adrenergic neuron blocking
drugs.

The histochemical data of Koelle would support this

observation (vide supra).

Birmingham (1966) interpreted

the results of his experimental data to mean that a cholinergic link was not required to evoke a response in the postganglionic adrenergic nerve following preganglionic stimula-
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tion.

He concluded that anticholinesterase enhancement of

guinea pig vas deferens response could be explained by
alternative mechanisms.

One suggestion was a purely

cholinergic sequence of events involving postganglionic
nerves and muscarinic smooth muscle receptors, while the
other interpretation was a cholinergic mechanism with the
preganglionic cholinergic nerves increasing the release of
postganglionic NE.
Histochemical evidence has been put forward by
Jacobowitz (1965) and Jacobowitz and Koelle (1965).

Their

studies have shown the existence of AChE and catecholamine
fluorescence in the same nerve trunk, the guinea pig vas
deferens.

Koelle's Percussive Theory was invoked to explain

the existence of presynaptic AChE in the ganglion (Koelle

1961, 1962).

Rand and Wilson (1967) noted that bretylium

and guanethidine antagonized the effects of ACh on the
rabbit colon, responses to sympathetic and parasympathetic
stimulation; blocked the response to vagal stimulation of
rabbit atria; and blocked the effects of ACh on guinea pig
ileum, rat bladder, and chick biventer cervicis muscle.
They interpreted their results as being in agreement with
a cholinergic link hypothesis.

Varagid et al. (1962) and

Varagic and Krstic (1966) noted that the hypertensive
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response to Eserine seen in rats was blocked by reserpine,
and lateral hypothalamic lesions.

They concluded that the

hypertensive response to Eserine was mediated via the CNS.
Kaul and Grewal (1968) observed that Eserine increased the
catecholamine output of the adrenals of rats by a factor
of 3 to 4 times and that this effect was not seen in pithed
animals.

They concluded that peripheral release of cate-

cholamines played little role in the hypertensive response
to Eserine seen in rats.

This conclusion was strengthened

by their observation that adrenalectomy failed to decrease
Eserine-induced hypertension and if anything increased it.
Guth and Amaro (1969) suggested a possible cholinergic link
in olivocochlear inhibition since atropine and nicotinic
blocking agents failed to antagonize the blockade while
hemicholinium was effective.

Choline reversed the hemi-

cholinium antagonism of inhibition of VIIIth nerve action
potentials.
Van Meter and Karczmar (1967) proposed that the Eserine
attenuation of thalamocortical recruitment was dependent on
endogenous catecholamines in the CNS.

In the presence of

amines depleted by reserpine or aMPT, Eserine failed to
attenuate recruitment while MAOI plus DOPA restored brain
biogenic amines and also restored the effectiveness of

--
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Eserine as a blocker of thalamocortical recruitment.

It

was concluded that an "adrenergic link" was involved in
the Eserine antagonism of recruitment.
At about the same time, Marczynski (1967) expressed
the opinion that some of the CNS responses of Eserine might
be explained by the Burn-Rand Hypothesis.

He pointed out

that the optimal frequency for thalamocortical recruitment

(5-7 c/s) had been shown to produce maximal release of ACh
from the caudate.

Therefore, the inhibitory "Caudate Loop"

as proposed by Heuser et al. (1961) and the studies of
Buchwald (1961) could well be the site of the "adrenergic
link" for the anticholinesterase induced antagonism of
thalamocortical recruitment as seen in the present studies.
Tremorine, a muscarinic agonist has been shown to
evoke a release of brain catecholamines (Friedman and Anton

1967), and to antagonize reserpine or chlorpromazine
induced sedation in rabbits (Leslie 1965).

George et al.

(1966) have shown that the active metabolite of tremorine,
oxotremorine, induced tremor following microinjection into
pontomedullary sites of the rat brain.

Other sites of

action were proposed and included the basal forebrain area.
All effects were antagonized by atropine.

On the other hand,

........
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connor et al. (1967) have noted that intracaudate injection
of carbachol induced tremor which was antagonized by the
subsequent administration of catecholamines into the caudate
nucleus.

Alpha agonists and blockers were without signifi-

cant effects while beta agonists antagonized carbachol
tremor and beta blockers inhibited that antagonism.

In

addition intracaudate administration of ATP blocked the
tremor and thus indicated a beta "metabolic'' effect.

The

authors concluded that a neurohumoral balance was necessary
in the caudate for the regulation of physiological tremor.
In other words, a cholinergic-adrenergic balance.
Interactions between cholinergic and adrenergic mechanisms in the CNS have been implicated in a series of studies.
Longo (1956) noted that while atropine and scopolamine
failed to antagonize the neurovegetative responses to direct
electrical stimulation of the hypothalamus, EEG arousal was
antagonized.

White and Daigneault (1959) observed that

atropine could block the EEG desynchronization resulting from
brain stem lesions, from cholinomimetic agonists and from
adrenomimetic agonists.

They concluded that the same area

of the brain stem was involved in EEG desynchronization
evoked by cholinergic or adrenergic stimulation.

Later

-
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studies have shown that Eserine antagonized alpha blockade
(White et al. 1965).

Malcolm et al. (1967) have shown

an interrelationship between cholinergic and adrenergic
mechanisms at the level of the cerebral cortex.

They

interpreted their data to represent a scheme similar to
that proposed by Eccles and Libet for the superior cervical
ganglion of the rabbit (cited in Eccles 1964).

That is, that

the adrenergic "P" wave acted as a modulator to decrease
sensitivity.

Cuculic et al. (1968) studied the action of

drugs applied to the cortices.of rabbits and observed that
cholinolytic agents applied to the cortex blocked desynchronization evoked by peripheral stimulation, and by intravenous anticholinesterases, or amphetamine.

These workers

suggested that the final corticopetal link in EEG desynchronization was located near the cortical surface and was
cholinergic in nature.
Jouvet (1967) proposed that paradoxical sleep was
mediated by NE.

Microinjection of oxotremorine or carbachol

into the ponto-mesencephalic reticular formation also induced paradoxical sleep and this was antagonized by atropine
sulfate (George et al. 1964).

Ledebur and Tissot (1966)

induced paradoxical sleep by the administration of DOPA into

-
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the bulbo-pontine reticular substance, while 5 hydroxytryptophan induced either a synchronized or a desynchronized
EEG when it was given locally into the sleep centers of
"Moruzzi" or of "Jouvet".

Post-pontine transection of the

medulla of rabbits resulted in an EEG arousal and Bueno et
~·

(1968a) proposed the existence of a synchronizing center

in the lower brainstem.

Precollicular decerebration of cats

induced the random appearance of paradoxical sleep
(Matsuzaki et al. 1967).

The administration of Eserine

evoked episodes of paradoxical sleep and atropine sulfate,
but not atropine methyl nitrate, was an effective antagonist.
Sterman et al. (1965) had observed that slow wave sleep
and paradoxical sleep showed circadian patterns.

Reis et al.

(1968) found circadian rhythm of NE concentrations to exist
regionally in cat brain.

A comparison of these two studies

showed that peaks of NE concentration occurred in the
superior colliculi, pons and substantia nigra that coincided
with the paradoxical sleep patterns.
The study of the effects of intravenously administered
NE, EPI, or DA in the CNS is limited because of the BBB
(Weil-Malherbe 1961).

The administration of a MAOI plus

L-DOPA promotes the synthesis of these catecholamines and
their effects on the CNS can be observed (Everett 1961).
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Depletion of brain biogenic amines can be accomplished by
the administration of tetrabenazine (Quinn et al. 1959),
reserpine (Costa et al. 1962), or inhibition of synthesis
by CMPT (Spector et al. 1965).
Hemicholinium (HC-3) has been shown to alter the synthesis of ACh by decreasing the availability of choline
with a resulting depletion of transmitter.

Stitzel et al.

(1965) evaluated the effect of HC-3 on catecholaminedepleting actions of reserpine and other drugs.

They re-

ported that HC-3 had no effect on the depletion of catecholamines from the CNS but did alter the release from adrenal
medulla.

Their conclusion was that HC-3 had no effect on the

release of NE from the brain.

However, no considerations

of the BBB were made and there was absence of controls on
ACh levels in the brain in the presence of HC-3.

Domino et

al. (1968) found that HC-3 had little effect and was unpredictable when given intravenously in amounts of 5-10 mg/
Kg as compared to the 10 mcgm/Kg dose reported by Stitzel
et al. (1965).
Frazier et al. (1969) applied HC-3 to the inside of squid
axons, blocked the action potential and could not reverse
the block by giving choline.

They concluded that HC-3

antagonized the early transient and late steady state com-
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ponents of the membrane ionic conductances.

In other words,

they proposed that the effect of HC-3 was on membrane conductances rather than a cholinergic mechanism.
Nicotinic stimulation of the CNS is dependent on the
dose of alkaloid being used.

Nicotine

per~

in repeated

low doses of 2 mcgm/Kg i.v. over a period of 20 minutes has
been reported to evoke an electrocortical arousal with an
increase release of ACh, while higher doses reversed this
effect and induced a sleep pattern with a decreased ACh
release (Armitage et al. 19691.

Longo et al. (1967) had

found a species variability in response to nicotine.

EEG

convulsions were evoked in rabbits, guinea pigs, and rats
but not in cats.
not EEG paroxysms.

Cats revealed only motor convulsions and
Mecamylamine was a more effective

antagonist of the nicotinic actions of both nicotine and
arecoline than was dihydro beta-erythroidine.

Westfall et

al. (1967) concluded that nicotine released NE in the CNS
and noted that DA concentrations were also down 30 minutes
after injection.

However, Domino (1967) pointed out that

nicotine also released ACh, serotonin, and vasopressin in
addition to the release of catecholamines in the CNS.

He

noted that a low dose of nicotine evoked an EEG desynchronization that correlated with a behavioral arousal but
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felt that actions of nicotine were too wide spread and that
it was a poor drug of choice for determination of specific
effects.
While the concept of steady state synthesis rate of
NE (Brodie et al. 1966a) has proved useful in evaluation of
catecholamine action in the CNS, the determination of
synthesis rates must be viewed with some caution.
et al.
--

Thoenen

(1969) have found that tyrosine hydroxylase activity

after the administration of drugs could be increased.

Phe-

noxybenzamine administration s.howed an increased NE synthesis
which they attributed to an increased membrane transport of
tyrosine and not due to increased enzyme activity.

Nerve

stimulation also evoked the same response, and according to
Thoenen et al. two mechanisms could be involved, (1) rapid
regulation by end product inhibition, tyrosine transport and
cofactor concentrations and (2) increased enzyme activity
due to an increased amount of enzyme protein, which would
require several hours before an increased enzyme activity
appeared.
Finally, the adrenergic mechanisms in the CNS have
been chiefly concerned with DA and NE but recently evidence
has been presented that suggests the synthesis of EPI in the
CNS (Ciaranello et al. 1969 and Pohorecky et al. 1969).

If
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these results are

accurate~

the response of the EEG to the

administration of alpha blockers such as chlorpromazine and
phenoxybenzamine could be explained on the basis of an unmasked beta effect and additional considerations for the
role of EPI and the proposed beta receptor cyclic 3'5'
adenosine monophosphate must now be considered for the
central nervous system as well (Robison et al. 1967 cited
in Burn 1968).
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II.
A.

METHODS AND MATERIALS

GENERAL
The experimental subjects and their maintenance was the

same as described in Part I.

In cases where chronic drug

administration was indicated the animals were dosed in their
cages in the animal quarters and were brought to the
laboratory on the day of the experimental recording.
B.

PHYSIOLOGICAL

1.

Electroencephalography
>

EEG recordings were obtained from the animals as described
in Part I.
2.

Evoked Potentials
Thalamocortical recruited potentials were evoked by

electrical stimulation of the anterior dorsal nuclei of
the thalamus.

Square wave pulses were delivered from Tek-

tronix type 161 and 162 pulse and waveform generator combinations (see appendix B) and were monitored by CRO.

Stirn-

ulus artifact was attenuated by means of a Bioelectric ISA
stimulus isolation unit.

Stimulus parameters consisted of a

frequency of 8.o-8.5 c/s at durations of l.O msec or less.
Threshold voltages varied from animal to animal, as well as,
from that required during a synchronized background of EEG
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activity compared with that required during a background
of desynchronized EEG potentials.

A stimulus voltage was

determined that was sufficient to evoke recruitment during
EEG alert tracings induced by peripheral alerting stimuli
(see Part I), or even by direct electrical stimulation of
the reticular substance.

Stimulus parameters for reticular

formation stimulation were 200 c/s, 0.2 msec, for 5-10
seconds.

The voltage that was adequate to evoke recruit-

ment during a period of EEG desynchronization was referred
to as suprathreshold.

The recruited potentials were re-

corded from the cortices and with the EEG were displayed on
a Grass Model IIID electroencephalograph.

In addition,

recruitment was amplified and monitored by CRO.

The

experimental animals received no anesthesia except for 2%
procaine applied to the wound sites.

Restriction of move-

ment was obtained by use of the animal restraining board
fitted with a headholder as described in Part I.
placement was verified as before (see Part I).

Electrode
Either

arterial blood pressure (femoral artery) or heart rate
was monitored with the EEG tracings.
Integrator analysis of recruited potentials was obtained by a relay controlled integration unit (see appendix
B).

The integrator was normally off except during the
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stimulation and was triggered by the stimulator just prior
to the appearance of the stimulus train at the electrode.
The CRO sweep was also triggered in the same manner.

In

the case of data integration, the stimuli were presented
for a period of two seconds which was adequate for showing the rising phase and the peak amplitude of the recruited potentials.

Data from one channel was selected for ana-

lysis by this method and the selection of the channel was
based on control observations from the leads exhibiting the
most evident thalamocortical recruitment.

Responses to the

various drugs were evident and attempts to quantify them
were not necessary.

During any given observation period,

the stimuli were presented once every 10 seconds for a
period of 2 seconds.
Supra threshold voltages for evoking recrui tment··were
kept constant in any given experiment for the pre- and
post-drug conditions.
C.

HISTOLOGICAL

1.

Thionin and Eosin Staining Procedure
The general staining procedure as outlined in Part I

and appendix A was used to verify electrode placement.
Also, electrode tracts were identified during the sectioning procedure that was carried out in the cryostat as

described in Part I.
D.

BIOCHEMICAL

1.

Fluorometric
Determination of norepinephrine (NE) levels was made

by the method of Shore and Olin (1958) and is outlined in
appendix B.

The following brain parts of each of 54

animals were used:

(1) cerebral cortex, (2) hippocampus,

(3) cerebellum, (4) midbrain, and (5) medulla-pons.

Animals

were sacrificed either by air embolism or by decapitation.
Control samples included

untr~ated

rabbits not subjected

to other experimental procedures; as well as animals subjected to the experimental procedures excluding electrical
stimulation and drugs.

Determinations were also made in

animals subjected to depletion of brain NE by reserpine or
alpha methyl para-tyrosine, as well as animals in which NE
levels had been raised by the administration of MAOI and
L-DOPA (vide infra) (see Tables II and III).
E.

PHARMACOLOGICAL

1.

Drugs and Dosages
Brain catecholamines were depleted by the administration

of reserpine (2.0 mg/Kg

i.v.) daily for two days prior to

the recording day (Table III).

Inhibition of synthesis at
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the tyrosine hydroxylase step was also used as a specific
method of lowering brain levels of NE.
tyrosine (200 mg/Kg

Alpha methyl para-

i.p.) was given as a liquid suspension

in tragacanth for two days preceding the recording day
(Table III, cf. Table II, and cf. Spector et al. (1965).
Following depletion of catecholamines, the tissue levels
in the brain were restored by the administration of
pargyline (12.5 mg/Kg

i.v.) given one hour prior to the

injection of L-DOPA (100 mg/Kg

i.p.).

tissue levels of brain

amines could be raised by

biogen~c

In addition, normal

the combination of the monoamine oxidase inhibitor and
L-DOPA (Table III, cf. Everett 1961).
Eserine salicylate was given intravenously in amounts
of l00.0-150.0 mcgm/Kg

This dose range was found to be

adequate to evoke an EEG arousal and to markedly attenuate
or block recruitment in control animals (fig. 34).
Similarly, doses of (0.5-1.0 mg/Kg
mcgm/Kg

i.v.) DFP and 10.0-15.0

i.v. of sarin were found to be adequate in

eliciting the above effects.

These anticholinesterases were

given to animals with modified tissue levels of NE.
concentrations in the brain were modified by:

NE

(1) reserpine

or alpha methyl para-tyrosine induced depletion, (2) depletion followed by the restoration of NE concentrations

induced by the combination of pargyline and L-DOPA, and
(3) by the combination of pargyline and L-DOPA without

prior depletion of biogenic amines.
EEG tracings were made routinely and thalamocortical
recruitment was evoked during control periods, in the presence
of physostigmine, of DFP, and of sarin.

These electro-

physiological recordings were also obtained during conditions of NE depletion, as well as after the restoration
of depleted NE.

AntiChE's were administered in the presence

of these altered states of

br~in

NE concentrations.

Tissue

levels of brain NE were monitored in each case and these,
along with the EEG and recruitment data, were correlated
with the pharmacological procedures (Table III).
D(-) - INPEA, (D(-)-l-(4 1 Nitrophenyl)-2-isopropylaminoethanol HCl) was administered to evaluate the effects of
beta adrenergic blockade on EEG activity and on thalamocortical recruitment.

Alpha adrenergic blockade was achieved

by intravenous phenoxybenzamine (5.0 mg/Kg).
mcgm/Kg

Eserine (100

i.v.) was selected to evaluate antagonism of the

EEG effects of the blockade of adrenergic receptors by an
anticholinesterase.

Thalamocortical recruitment was also

evaluated in the presence of alpha blockade and in the
presence of subsequent antagonism by an anticholinesterase.
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Gross behavioral observations of the animals in their
cages were made prior to the electrophysiological or biochemical observations in order that central and autonomic
nervous system activity could be evaluated.

Criteria

used were (1) pupillary diameter, (2) GI tract activity
(defecation), and (3) the general motor activity of the
experimental animals compared to control subjects or to
their own premedication activity.

III.
A.

CONTROL OBSERVATIONS

1.

Histological

RESULTS

The results of the thionin and eosin staining procedure
are presented in Part I together with the designation of
the sites used for stimulation of the brain and for recording.
2.

Biochemical
Norepinephrine concentrations from the brains of 5

control animals are presented in Table II.

These values

served as a reference for brain NE concentrations in untreated animals (see Table III).
Inhibition of synthesis with alpha methyl para-tyrosine
showed a progressive decrease in NE concentration in rabbits
sacrificed at 4, 16, and 24 hours after the drug (Table II).
These values served as a reference for rabbit brain NE
depletion

by

alpha methyl para-tyrosine in subsequent studies

(see Table III).
Table II shows that reserpine induced a rapid fall in
brain NE at 4 hours and that this degree of depletion was
maintained in animals sacrificed at 16 and 24 hours after
injection.

These values served as a reference for brain NE

TABLE II.

CONTROL BRAIN NE CONCENTRATIONSa

Time

Brain Site
·· Hippocampus

Cortex

(Hours)
0:00
(N=5)

238 (±105)

469 (±130)

Mi db rain

Medulla Poffs

360 (± 81)

505 (±135)

- -Cerebellum

235 (±56)

Reserpine (2.0 m~/K~. i.v.~
4:00
(N=3)

89 (±

7)

122 (± 54)

73 (± 94)

133 ( ± 31)

106 (±23)

16:00
(N=3)

87 (± 24)

154 (± 34)

93 ( ± 30)

105 (±

8)

199 (± 6)

24:00
(N=3)

53 (± 25)

66 (± 28)

56 ( ± 18)

62 ( ± 24)

65 (±55)

aMPT (200 mg/K~. i.p.~
4:00
(N=3)

54 (± 47)

16:00
(N=3)

48 (± 33)

24:00
(N=3)

25 (±

1)

267 (±154)

191 ( ±142)

209 ( ±164)

106 (±89)

8)

70 ( ± 16)

126 (± 36)

76 (±33)

61 (± 17)

62 (± 17)

33 ( ± 19)

33 (± 1)

99 (±

1--J

m

a

())

Expressed as ng/Gm tissue

depleted by reserpine in subsequent studied (see Table III).

3.

Electrophysiological
Control EEG patterns and responses to stimuli were the

same as described in Part I.

In addition, thalamocortical

recruitment was evoked during a background of synchronized
and desynchronized EEG activity (figs. 32 and 33).

Presen-

tation of the stimuli is indicated in the figures and the
parameters of stimulation are stated in Methods and
Materials (vide supra).
B.

EXPERIMENTAL OBSERVATIOES

1.

Biochemical
Table III reveals that reserpine markedly depleted

brain NE concentrations while reserpine treatment followed
by pargyline and L-DOPA restored these concentrations towards
control levels.

Alpha methyl para-tyrosine, also markedly

depleted brain NE and this was likewise restored by the
combination of monoamineoxidase inhibitor and L-DOPA.
Finally, the MAOI and L-DOPA treatment resulted in an increase in brain NE.
2.

Electrophysiology
The administration of physostigmine (150.0 mcgm/Kg

i.v.) was followed by a period of approximately 2 minutes

170

of continuous slow wave EEG sleep.

An uninterrupted

desynchronized EEG pattern followed and maximal intensity
appeared at about 5 minutes after the injection.

During

the period of maximal intensity of EEG desynchronization,
the supra-threshold stimulus of the pre-drug state failed
to evoke a response and the recruited potentials were
attenuated (fig. 27, Part I).
Eserine (100 mcgm/Kg

During the recovery from

i.v.) recruitment reappeared while the

EEG was still desynchronized (fig. 35).

EEG tracings re-

sumed pre-drug characteristiQs after 30-40 minutes.

DFP,

on the other hand, elicited a desynchronized EEG pattern
that endured for more than 2 hours during which time recruitment was attenuated (fig. 36).
Kg

Scopolamine (100 mcgm/

i.v.) readily antagonized both the EEG desynchroniza-

tion (fig. 37) and the attenuation of recruitment (fig. 38)
evoked by DFP.

Chlorpromazine was also an effective

antagonist (fig. 39).

Atropine sulfate (3.0 mg/Kg

i.v.)

induced a slow wave EEG sleep pattern but did not alter
recruitment as is seen in figure 40.
tration of sarin (15 mcgm/Kg

However, the adminis-

i.v.) after that dose of

atropine resulted in an EEG alert pattern and attenuated
recruitment (fig. 41).

Figure 32
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RECRUITMENT - SYNCHRONIZED EEG
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Control Thalamo-Cortical Recruitment:
a period of synchronized EEG activity.
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Figure 33
RECRUITMENT-DESYNCHRONISED EEG

LN-BOA~ . .

•,,. ......... - ............. · -~..

LAC-BOA
RAc-LN

t

~.......

........ , ... , ..,,,.,.

•

-·-~ ...~· ... ~""'"'"""'•"wi.l~M .... ,A<t·•..,..;L~

~J1J1M:l1~1~:~1w~~j~,mµ~'~~,~~

1

//~J/ l/Jf 1A)t,• ,,, "'' 1.L11.1l •• 11A111l1l1jiJ/1l/l/JilJU

~~~....,...._lf';11r:;;:1 1 111,11'H~_,..,.,._'W'/'l.,,~.rN1Mi1il1'W#W.~
•

.11, ,J/

LH-LN---#/~~M""~~\Yti~WvVit/--Af1~,"r.~~11w,wM~1r,\~'tw1w~1~~"'v\,~··1V~\~;1/1,'N1~'w,\,1w~~,~~\W1,,.N,~\\\~w(l\~~1\~\w~~~,~~l~~~w~~~
V,W~W·M'Ml!·\'1~\\\1JA,W#/1V'\11~.\W1i,\\:1i#i\\\~~v.,\\\\\\\\\\\\WHNJl;'1\\W1V1l\W1~i'1\W,•:·,\,Wi~.',Y1~\~\~Wi\\\~'l.W1WAWtffiW!mA\

RH-BOA-\

JhjvifvJv,/vvv..;.,;v,,-vv/1.(">A/-.l-'~~..,../\i</Wvv..•11J};,Mvv·t./l'N/'.NJVvl/ti-Mf""'~1J,h.\',~.\',iMl/-.,1,:./'f')~J~~t~/~~Mt'Vv'i/'f'~

L-RPC---'·<-..

t

l'oo,vm-

~~,W..11~~UJ»~~~~~~w.w~~u,.;.u.AMJ-1

EKG--

Control Thalamo-Cortical Recruitment:

Thalamo-cortical recruitment evoked during

a period of EEG activity that is desynchronous or alert.

The waxing and waning

of the recruited potentials appears during the period of stimulus application
(bet~\een

the

arrows) and is elicited by the same stimulation parameters as seen in

co~trol

thalamo-cortical recruitment during a period of synchronized EEG
J-l

activity.
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TABLE III.

CORRELATION OF PHARMACOLOGICAL, BIOCHEMICAL AND ELECTROPHYSIOLOGICAL
DATA

PharmacologicaJ
Procedure

NE Brain Concentrations 1
CTX

HPC

MB

MP

EEG Pattern
CBL

Recruitment
with
Eserine

Synchronized
Attenuated
231(±94) 468(±118) 348(±73) 496(±123) 233(±51) Desynchronized

Control
(N=6)
Reserpine
(N=5)

55(±20)

64(± 21)

38(±14)

83(± 37)

83(±43) Synchronized

Present

Reserpine
followed
Present
by MAOI &
followed by
L-DOPA
(N=5)
160(±39) 335(± 31) 233(±27) 347(± 41) 146(±21) Desynchronized Attenuation
aMPT
Present
(N=5)
36(±17) 48(± 11) 63(±17) 36(± 14) 47(±14) Synchronized
aMPT
followed
by MAOI &
Present
L-DOPA
followed by
(N=5)
142(±36) 333(± 31) 246(±36) 406(± 34) 156( ±33) Desynchronized Attenuation
MAOI &
L-DOPA
(N=5)

306(±61) 603(±174) 609(±40) 604(±140) 239(±io7 Desynchronized Attenuated
1

Expressed as ng/Gm tissue

I-'
~

w

174
Legend for Table III
Surrunary Correlation of Pharmacological, Biochemical and
Electrophysiological Data:

The table represents experiments

in which pharmacological, biochemical, and electrophysiological data were correlated.

The left side of the table

represents the pharmacological procedure used to alter brain
levels of catecholamines and in particular, norepinephrine.
The values of brain tissue concentrations are represented
as pg/Gm tissue for the selected brain parts as shown in the
table.

The effect of Eserine on thalamo-cortical recruit-

ment in rows three and five is interpreted as meaning that
the recruited potentials that were evoked in the presence of
Eserine after depletion of norepinephrine by reserpine or
alpha methyl para-tyrosine, were attenuated by Eserine after
norepinephrine levels had been restored by the administration of MAOI and DOPA.

See text for complete description.
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Figure 35
RECOVERY OF RECRUITMENT PRIOR TO EEG AFTER ESERINE
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Appearance of Recruitment Prior to a Synchronized EEG after Eserine:

During the

course of recovery following the administration of 100 mcgm/Kg i.v. of Eserine,
recruited potentials can be evoked (arrows) while the EEG tracings are still
desynchronized.

The pressor response is still evident (see BP).

as in the previous tracing.

Stimulus parameters

Tracings were made 20 minutes after injection.
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Figure 36

DFP ANTAGONISM OF RECRUITMENT
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Persistent EEG Desynchronization and Attenuation of Thalamo-Cortical Recruitment
Induced by DFP:

DFP (2.0 mg/Kg i.v.) administered approximately three hours prior

to this tracing.

Desynchronization of the EEG was evident at approximately three

minutes after the injection and persisted.
same period of time.

Recruitment was also attenuated for the

The stimulus applied between the arrows is 8.0 c/s, 0.9 msec, ~
--:]

and a voltage greater than the threshold.

.

Figure 37

SCOPOLAMINE ANTAGONISM OF DFP
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Scopolamine Reversal of DFP Induced EEG Desynchronization:

iec--

Scopolamine (100

mcgm/Kg i.v.) antagonizes the EEG alert pattern elicited by the anticholinesterase
and evokes a synchronized pattern. DFP (2.0 mg/Kg i.v.) two hours earlier and these
tracings were made approximately twenty minutes after the injection of scopolamine.
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Figure 38

RECRUITMENT AFTER SCOPOLAMINE
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Scopolamine Antagonism of DFP Fails to Alter Recruitment:
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Thalamo-cortical

recruited potentials are readily evoked by the same stimulus parameters as used
earlier (arrows).

These tracings were made 5 minutes after those seen in figure 37.
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Figure 39

ESERINE ATTENUATION OF RECRUITMENT ANTAGONIZED
BY CHLORPROMAZINE
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Legend for Figure 39

f_hlorpromazine Reversal of Eserine Desynchronization and
Blockade of Recruitment:

Chlorpromazine (2.0 mg/Kg i.v.)

administered two minutes after the intravenous administration
of Eserine (100 mcgm/Kg i.v.) prevents the EEG alert pattern
and antagonizes the depression of recruitment seen at this
dose of the anticholinesterase.

Stimulation was applied

between the arrows and stimulus values are 8.0 c/s, 0.8 msec
and a voltage greater than threshold.

A previous dose of

Eserine had been administered as a control and was effective
in desynchronizing the EEG and in attenuating the thalamocortical recruited potentials.

This figure was taken at

eight minutes after the injection of Eserine.

Figure 40

RECRUITMENT IN PRESENCE OF ATROPINE
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Failure of Atropine to Block Recruitment:
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Atropine sulfate (3.0 mg/Kg i.v,) fails

to markedly attenuate the thalamo-cortical recruited potentials presented between
the arrows.
threshold.

St irnulus parameters are 8. 0 c/s, 0. 6 msec with a voltage greater than
Tracings were made 20 minutes after the atropine had been given.
l-'

CD
f\)

Figure 41

SARIN ATTENUATION OF RECRUITMENT PRECEDED BY
ATROPINE
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Sarin Reverses Atropine EEG Sleep and Attenuates Recruitment:

Sarin (15.0 mcgm/Kg

i.v.) given subsequent to the atropine from the previous record reverses the atropine
induced synchronization and elicits a persistent desynchronized pattern.

Note that

thalamic stimulation to evoke cortical recruitment, with the same stimulus values,
is markedly attenuated.

The stimuli were effected between the arrows. Tracings

were made 15 minutes after the injection of sarin.
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Figure 42

CHRONIC RESERPINE CONTROL EEG
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Rabbit EEG after Two Days Pretreatment with Reserpine 2.0 mg/Kg per Day:

Note the

predominant slow wave sleep pattern apparent in all leads, with random 8-14 c/s
EEG sleep spindles.

Catecholamines are at markedly low levels (cf. Table III).
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Figure 43

RECRUITMENT AFTER RESERPINE DEPLETION OF NE
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Recruitment in the Chronically Reserpinized Rabbit:

Thalamo-cortical recruitment

is evoked (channel 3, RAC-OC) by stimulation of the thalamic nuclei 8.0 c/s, 0.9
msec at a voltage greater than threshold (arrows).
background activity (cf. Table

Note the synchronized EEG

for depleted levels of norepinephrine).
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Figure 44
RECRUITMENT AFTER ESERINE WITH CATECHOLAMt£ DEPLETION •A•
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Effect of Eserine on Chronically Reserpinized Rabbit:
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(cont) Eserine 100 mcgm/Kg.

1.v. fails to attenuate the recruited thalamo-cortical potentials approximately
eight minutes after the administration of the anticholinesterase.
recruitment was not observed at this dose.

A decrease in

Note the desynchronized EEG pattern.

The stimulus was 7.5 c/s, 0.8 msec, at voltages greater than threshold and was
applied as indicated by the arrows.
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Figure 45
RECRUITMENT AFTER ESERINE
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Effect of Eserine on Chronically Reserpinized Rabbit:

l
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(cont) Eserine 200 mcgm/Kg

i.v. fails to alter the recruited thalamo-cortical potentials at approximately
eight minutes after the administration of the cholinesterase inhibitor.
parameters as in the previous figure.
animal.

Stimulus

This figure represents data from the same
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Figure 46

RECRUITMENT AFTER DFP WITH DEPLETION OF CATECHOLAMINES
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Effect of DFP on Chronically Reserpinized Rabbit:

DFP 2.0 mg/Kg i.v. fails to

alter the recruited potentials after two days of reserpine pretreatment.
parameters are the same as in the previous figures.
was persistent for greater than two hours.
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Stimulus

The desynchronous EEG pattern

This figure was taken at ten minutes

after the administration of the anticholinesterase.
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Figure 47

RECRUITMENT IN PRESENCE OF MAOI
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Pargyline Fails to Block Recruitment:

Pargyline 12.5 mg/Kg i.v. fails to attenuate

the recruited potentials at 40 minutes after injection.
previous figure and was presented between the arrows.

Stimulus unaltered from the
Note the artifact on the right

side of the tracings due to movement of the unanesthetized animal.
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Figure 48

ESERINE ATTENUATION OF RECRUITMENT AFTER
MAOI AND DOPA
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Legend for Figure 48

Effect of Eserine with Restored Catecholamines:

Eserine

100 mcgm/Kg i.v. is effective in attenuation of recruitment
in the chronically reserpinized rabbit after the catecholamine stores have been restored by the administration of
pargyline and DOPA {100 mg/Kg i.v.).

The norepinephrine

precursor was given 40 minutes prior to the administration
of the anticholinesterase.

The figure was taken at approxi-

mately eight minutes after the administration of Eserine.
Stimulus parameters are unchanged from the previous figures
and are presented as indicated by the arrows in the figure
(cf. norepinephrine values in brain tissue Table III).

Figure 49
EEG AFTER

aMPT INHIBITED SYNTHESIS OF NE
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EEG Activity in Presence of Low Levels of Norepinephrine:

The ongoing EEG activity

of the rabbit after markedly low levels of norepinephrine are established following
the administration of alpha methyl para tyrosine.

Note the slow wave EEG sleep

pattern with 8-14 c/s activity but this can be interrupted by a sound stimulus
resulting in a desynchronization (left center of figure) of the tracings.
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Figure 50
RECRUITMENT AFTER oMPT INHIBITED SYNTHESIS OF NE
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Recruitment in the Presence of Low Levels of Norepinephrine:
following stimulation of the thalamus is evident.

Cortical recruitment

Note the response in the lead

from RAC-OC, as the cortical potentials wax and wane in a typical recruited pattern.
The rabbit had received aMPT (200 mg/Kg i.p.) for two days prior to these tracings.
See Table III for brain NE concentrations (cf. also Table II).
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Figure 51
RECRUITMENT AFTER ESERINE WITH NE DEPLETION
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Eserine Fails to Block Recruitment in the Presence of Depleted Norepinephrine:
Physostigmine (100 mcgm/Kg i.v.) fails to attenuate the recruited cortical
potentials while inducing a desynchronous EEG pattern (note, lead RAC-OC).
Tracings were made

8.o minutes after the administration of Eserine.
J-1
\D
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Reserpine (2.0 mg/Kg/day i.v.) administered for two
days evoked an EEG pattern that was predominantly slow wave
sleep (fig. 42) and did not alter thalamocortical recruitment (fig. 43).

Eserine (100.0 mcgm/Kg

i.v.) then failed

to attenuate the evoked cortical response (fig. 44) and
induced an EEG arousal pattern (cf. fig. 34).
dose of Eserine (200.0 mcgm/Kg

Doubling the

i.v.) also failed to block

the recruited potentials (fig. 45).

Finally, DFP (fig. 46)

as well was ineffective in antagonizing thalamocortical
recruitment.

However, restoDation of brain NE levels to

control levels by the administration of a combination of
MAOI and L-DOPA (figs. 47 and 48) did not alter recruited
responses per

~,

but the effectiveness of Eserine to

attenuate recruitment was restored (fig. 48, cf. fig. 34).
The chronic administration of alpha methyl paratyrosine resulted in the appearance of a predominantly slow
wave EEG sleep pattern, during which time peripheral
stimulation (see Part I), could evoke an arousal response
(fig. 49).

Recruitment was not attenuated by alpha methyl

para-tyrosine (fig. 50), and Eserine (150 mcgm/Kg

i.v.)

failed to attenuate the evoked recruited potentials (fig.
51).

If brain NE levels were restored by the administra-

tion of pargyline and L-DOPA (Table III), Eserine was again

196

effective and attenuated the thalamocortical recruited
potentials in the same manner as was seen in the reserpine
sequence (vide supra) (cf. fig. 48).
The results of the effects of increased brain NE on the
Eserine induced attenuation of thalamocortical recruitment
are shown in figures 52, 53, 54, and 55.
that 50.0 mcgm/Kg

Figure 52 reveals

i.v. of Eserine was insufficient to

antagonize recruitment.

The evoked responses were most

evident in channel number two (RAC-LN) and served as a
control.

Inhibition of MAO with pargyline (25 mg/Kg

i.v.)

failed to alter the effectiveness of this low dose of
Eserine (fig. 53).

However, L-DOPA, (100 mg/Kg

i.p.) in

combination with the MAOI, increased the effectiveness of
the low dose of Eserine and the recruited potentials were
attenuated (fig. 54, RAC-LN).

Partial recovery of recruit-

ment occurred 40 minutes to one hour after the Eserine
injection (fig. 55) at a time when NE levels were being increased (cf. Table III).
Adrenergic blockade affected EEG activity, thalamocortical recruitment, and the effects of AntiChE's on these
potentials as indicated in figures 56 through 65.

Integra-

tion of the evoked potentials was carried out and control

Figure 52
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Legend for Figure 52

Low Dose of Eserine Elicits Desynchronization of EEG but
Fails to Attenuate Recruitment:

Eserine (50 mcgm/Kg i.v.)

induces an EEG alert pattern but does not depress thalamocortical recruitment.

The stimulus is 8 c/s, 0.8 msec,

and a voltage greater than control.

The stimulus is once

every ten seconds for a duration of two seconds as indicated
by

the solid bars.

Note the recruited potentials from the

second channel (RAC-LN).

This tracing was taken at approxi-

mately seven minutes after the administration of the
cholinesterase inhibitor.

Figure 53
RECRUITMENT WITH 50 mcgm/Kg ESERINE
IN PRESENCE OF MAOI
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Pargyline Fails to Enhance the Effect of Eserine:

Pargyline ( 25. 0 mg/Kg i. v.)

given one hour prior to the administration of 50 mcgm/Kg of Eserine does not
provoke a marked attenuation of recruitment at seven minutes after the administration of the latter drug.

Stimuli are unchanged from the previous Figure 52 and

are presented as indicated by the solid bars.
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Figure 54
'·
ESERINE ATTENUATION OF RECRUITMENT
IN PRESENCE OF MAOI 8 DOPA
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Legend for Figure 54

Increased Brain Level of Norepinephrine Enhances Effect
of Eserine:

DOPA (100 mg/Kg i.v.) administered one hour

after pargyline and 40 minutes prior to the time of these
tracings reveals an enhancement pf the effect of 50 mcgm/Kg
i.v. of Eserine on the thalamo-cortical evoked recruitment
at eight minutes after injection.

While the potentials

are still present, note the attenuation most evident in
the second channel (RAC-LN).

Note the movement artifacts

appearing as slow wave excursions particularly in the first
four channels.
figure.

Stimulus is unaltered from the previous

""
Figure 55

PARTIAL RECOVERY OF RECRUITMENT AFTER
ESERINE IN PRESENCE OF MAOI

a

DOPA
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Decrease of Attenuation of Recruitment as the Duration of Action of Eserine Elapses:
Forty minutes after the administration of 50 mcgm/Kg i.v. of Eserine the thalamocortical recruited potentials begin to reappear (note channel 2 RAC-LN).

Stimulus

parameters are the same as previously shown in the preceding figures.
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Figure 56

CONTROL RECRUITMENT- SYNCHRONIZED EEG
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Legend for Figure 56

Integrator Analysis of Thalamo-Cortical Recruitment:

Control

period of thalamo-cortical recruitment on a background of
synchronous EEG activity.

Channel 2 {LAC-BOA) is being

analysed by integration and the result appears in channel 7
in this and in subsequent

figur~s

{INTGR.).

Also, the dotted

line has been drawn to indicate the peaks during the control
period, and is the reference level in the subsequent figures
utilizing integration analysis of recruited potentials.
Stimulation parameters are: 8.0 c/s, 0.8 msec, for two
seconds at a voltage greater than the threshold.
stimulus was presented once every ten seconds.

The
Note the

relative constancy of the amplitude of the response as
reflected by the integrator.

Figure 57

CONTROL RECRUITMENT- DESYNCHRONIZED EEG
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Integrator Analysis of Thalamo-Cortical Recruitment:

IOOpV L NC - - -

Control period of thalamo-

cortical recruitment during a phase of desynchronous EEG activity.

Note that

the integrated response from channel 2 appears slightly greater than that seen
during EEG sleep patterns.

Stimulus parameters are as previously stated.
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Figure 58

ESERINE ANTAGONISM OF RECRUITMENT

LAC-BOA~fr-w.o,_...,W>l"_..~_,,W>l""""..JJl.~~~,_,.._.....,,~W""VoW.,.,..,_~~~~W+/ill\lt'."'ww.""""_,..MM~W'W'f"JW~"""1~\llOIN~W""......,.oA/./
RAC-LN~~~~-.V,i/1.it~--~·"""'v..,.,,~~~

~~~'il'IVN,"~J~\~\~~\\\w.ri.~\\iMWJ~\i..W\l\\\\;w/1WN~.,w,;~WN,·iw.w.~~\w1.wh~.\\\~l.\i.-N.v11.w1\\~v\~.'A\\W.~W1~~M.\W,\w~\~1.~,~1ti~~w,w..1tti\~W~1\~~'w>H4,\Wi~~\-MWrWi'
RH - aOA-·N,\l~,\~~i,hN
1\li~~~i/.:li1111(,\\l~\'l.l~~-,,~.~l\.1~~1\1lt~W1 \, \'1 1 ~.'.U.1,.( :r:11.u1:\\\ 1.•'.\\lll1it 1 1 '.,\1:\jl\I,~'. 111:1 \.•\i.'l•,'1'.~\\.1.;11~11; \~ '. \11.W.\\; ~l\\J\11.\\1 \1 \'·~;,1w~,1w11w1; ~1H,,l,~,w:. (\~'.,"l.l,\~ll !11.~.Ll),\,\\i ~J~lil
.,,11 11 11 ''\•1, ar1.,,~i'1,• 1 1,, 11 ,) ,,, .1,;•;,, ··~,, iiin 'inr,,, ~:.r:1 :1, ,.,,,,,11•1"11ii''"1i;11 "·"•'il'11.1\•i''"'''i ,1it,·1;1• ,,,.1111•,· 111Hl"'11.,,,,"111·1•f:1111,i11 1•. ,,:n1m

LH-LN

1

1

1

1 1

11

-~-----~~~f......-~_,,,_.~...........~--.............."l\llW(~i..l.-~~~~~~~......,,,~~~~~~~~~----111~~~~IOOµV

L- RP C
__ _ __ _ _ __ ___ _ __ _ _ __ _ __ _ _ _ _ __ _ _ __ _ _ _ _ _ _ _ _ _ __ ___ _ _ _ _ _ __ _ __ _ _ __ __ _ _ _ _ _ __ _ _

L_

sec

- - - - - - -

INTGR.

Drug Attenuation of Recruited Potentials:

The effect of 100 mcgm/Kg i.v. of

eserine on thalamo-cortical recruitment shows a marked attenuation of the
integrated potentials.

Control level is indicated by the dotted line.

tion parameters as presented in the previous tracings.
approximately 7.0 minutes after injection.

Stimula-

Tracings were made
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Figure 59

ATROPINE METHYL NITRATE FAILS TO ALTER ESERINE
ANTAGONISM OF RECRUITMENT
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Eserine Attenuation of Recruitment in the Presence of Atropine Methyl Nitrate:
Eserine (100 mcgm/Kg i.v.) markedly attenuates thalamo-cortical recruitment when
given after the quaternary atropinic agent.
data below the control levels (dotted line).
from the previous recordings.

Note the marked decrease of integrated
Stimulus parameters are unchanged
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Figure 60
;(A) EFFECT OF PHENOXYBENZAMINE ON RECRUITMENT
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Initial Effect of Phenoxybenzamine on EEG and Thalamo-Cortical Recruited Potentials:
Phenoxybenzamine, 5.0 mg/Kg i.v. induces an initial transient EEG arousal lasting
a few minutes that also attenuates the evoked thalamo-cortical recruitment response.
The pre-drug control level of integrated signals is indicated by the dotted line.
Stimulus parameters are 8.0 c/s, 0,8 msec, two seconds duration and the stimulus is
presented once every ten seconds.
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Again, channel 2 is being utilized for integration.

Figure 61
',CB) EFFECT OF PHENOXYBENZAMINE ON RECRUITMENT
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Persistent Effect of Phenoxybenzamine on EEG and Thalamo-Cortical Recruited
Potentials:

Following the initial transient effects as seen in the previous

figure for phenoxybenzamine 5,0 mg/Kg i.v., a persistent synchronous EEG pattern
ensues and the attenuation of recruitment is reversed as indicated by the integrated data in channel 7.

Note that the amplitudes of the signals are greater

than those seen during the control period (dotted line) of synchronous activity.
Stimulation parameters as in the previous phenoxybenzamine recording.
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Figure 62

ESERINE ANTAGONISM OF RECRUITMENT IN PRESENCE
OF PHENOXYBENZAMINE
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Eserine Reversal of the Phenoxybenzamine Enhancement of Thalamo-Cortical Recruitment:
Eserine (100 mcgm/Kg i.v.) reverses the synchronous EEG pattern elicited by the
administration , of phenoxybenzamine and induces a pronounced attenuation of the
evoked recruitment.

Note the desynchronized EEG pattern and the integrated

potentials values below control levels (dotted line).

Stimulation parameters are
~

the same as in the previous tracings. Recordings were made 7,0 minutes after Eserine.~
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data during synchronized and desynchronized EEG background
activity is shown in figures 56 and 57.

Amplitudes of the

integrated responses were relatively constant and recruitment evoked during the EEG alert appeared to be somewhat
greater than that seen during the slow wave EEG sleep
pattern.

Eserine (100 mcgm/Kg

i.v.) antagonism of recruit-

ment was reflected by a marked transient reduction in
integrated response that was at a maximal stage 7 minutes
after injection (fig. 58).
mg/Kg

Atropine methyl nitrate (1.0

i.v.) failed to antagonize the effect of Eserine

(100 mcgm/Kg

i.v.) on EEG activity as well as on the

evoked potentials (fig. 59, cf. fig. 58).
Phenoxybenzamine elicited a biphasic response on
recruitment and EEG activity (figs. 60 and 61).

The initial

effect (fig. 60) was an EEG desynchronization that lasted
approximately 2 minutes during which time thalamocortical
recruitment was attenuated.

Synchronized EEG patterns

followed (fig. 61) and the integrated response to recruitment exceeded control levels.

This alpha adrenergic

blockade was readily antagonized by Eserine (100 mcgm/Kg
i.v.) and EEG desynchronization as well as attenuation of
recruitment occurred (fig. 62).

The subsequent adminis-
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tration of phenoxybenzamine in a lower dose (2.5 mg/Kg

i.v.) elicited antagonism of the AntiChE-attenuated
recruitment, but not the EEG alert pattern of Eserine
(fig. 63).
Control responses prior to beta blockade are shown
in figure 64.

After the administration of 2.0 mg/Kg

i.v. of D(-) INPEA an EEG arousal was evoked and recruitment was attenuated as is shown in figure 65.
Proposed intracellular pathways for the biosynthesis
and fate of NE are included f0r reference in figures 66
and 67 (cf. Wurtman 1966).

Figure 63
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Phenoxybenzamine Reversal of the Eserine Antagonism of Thalamo-Cortical Recruitment:
Phenoxybenzamine (2.5 mg/Kg i.v.) antagonizes the attenuation of recruitment induced
by Eserine but does not evoke a synchronous EEG pattern.

Note that the amplitude

of the integrated potentials (channel 7) is somewhat greater than the control levels
as indicated by the dotted line.

Stimulus parameters are unchanged.

Tracings were

made 10 minutes after injection.
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Figure 64

CONTROL EEG-DESYNCHRONISED- PRIOR TO DH- INPEA
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Control Thalamo-Cortical Recruitment:

Evoked potentials during a phase of

desynchronous EEG activity prior to the administration of D(-) - INPEA.

Stimulus

parameters are 8.5 c/s, 0.9 msec for two seconds at voltage greater than threshold.
The stimulus uas presented once every ten seconds.
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Figure 65

D (-)- INPEA EVOKED EEG DESYNCHRONIZATION ANU
ANTAGONISM OF RECRUITMENT
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Effect of D(-) - INPEA on EEG and Recruitment:

Marked EEG arousal patterns are

evoked by the intravenous administration of 2.0 mg/Kg of D(-) - INPEA.

Note the

attenuation of the recruited potentials in the data integrated from channel 2 and
reco~ded

in channel 7.

previous record.
after injection.

The dotted line represents the control level from the

Stimulus parameters are unaltered. Tracings were made 15 minutes
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Figure 66

NE BIOSYNTHESIS - INTRACELLULAR PATH
1

Circulation
TYROSINE

Brain or Sympathetic Nerve Endino
Tyrosine Conce(ltrating Mechanism - (Active Transport)

Mitochondria

TYROSINE HYDROXYLASE

DOPA
-DOPA
DECARBOXYLASE
DOPAMINE

I

Granule

DOPAMINE
Beto OXIDASE

NE

217

Legend for Figure 66

Proposed Intracellular Pathway of Biosynthesis of Norepinephrine in Brain
and Peripheral Nerve Tissue: Circulating tyrosine is proported to be picked
up by an active transport mechanism into the neuron or sympathetic nerve
ending.

After entry into the mitochrondria the tyrosine is hydroxylated by

tyrosine hydroxylase and the DOPA thus formed is decarboxylated to form
dopamine.

Dopamine is then oxidized by dopamine beta oxidase to form the

postulated neurotransmitter norepinephrine.

-
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Figure 67
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Legend for Figure 67

Proposed Intracellular Pathway of Fate of Norepinephrine in
Brain and Peripheral Nerve Tissue:

Within the brain or

sympathetic nerve ending, norepinephrine exists in the
bound state (NE) which is in equilibrium with the free
state (NE).

Also an equilibrium exists between the free

norepinephrine and the oxidative enzyme within the
mitochondria, MAO.

The release of NE follows the arrival an

impulse and this released NE can be either rebound back into
the nervous tissues; react with the receptor; be converted
to normetanephrine by COMT of the parenchymal cells and
then picked up by the circulation; or incorporated directly
into the circulation.

If the NE is shunted into t£1e MAO

pathway, the DHMA or DHPG thus formed may also be acted upon
by COMT of the parenchymal cells and then incorporated into
the circulation as DHMA, DHPG VMA or MHPG.
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IV.

DISCUSSION

The increased parasympathetic activity in rabbits after
chronic biogenic amine depletion included miosis, ptosis,
diarrhea and decreased spontaneous motor activity.

Similar

effects have been noted by Malhotra and Pundlik (1959) and
Haggendal et al. (1967).

Bhargava (1967) suggested that

alpha methyl DOPA and reserpine promoted the release of ACh
and facilitated parasympathetic activity.

In the present

studies, hypotension, bradycardia, and death appeared in
response to doses of Eserine that were not lethal in the
presence of normal autonomic nervous system balance.

There-

fore, an evaluation of the effects of anticholinesterases
in the CNS of animals with depleted biogenic amines required
protection of the cardiovascular system.

The antimuscarinic

properties of atropine methyl nitrate were effective as a
prophylactic measure for the potentiated cardiovascular
responses subsequent to intravenously administered anticholinesterases.

However, attenuated responses to periph-

eral and direct CNS stimulation have been attributed to
methyl atropine (Riehl et al. 1960).

An increased EEG

arousal threshold to reticular formation stimulation in the
presence of atropine methyl nitrate was observed.

Unlike
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Riehl et al. (1960), the present experiments showed atropine methyl nitrate did not attenuate EEG arousal responses
nor thalamocortical recruitment.

Quaternary amines of

poor lipid solubility have restricted access to the CNS
due to the blood brain barrier (BBB) (Weil-Malherbe 1961).
Methyl atropine was selected as a prophylactic agent since
its antimuscarinic properties are primarily restricted to
the periphery.

Moreover, Hance et al. (1963) noted that

atropine methyl nitrate (0.05-5.0 mg/Kg i.v.) had no consistent effect on EEG

activi~y

of cats and had minimal, if

any effects on cortical evoked responses.

Rosecrans et al.

(1968) found hyoscine but not atropine methyl nitrate
effective in depression of conditioned response pole
jumping in rats.

Also, methyl atropine partially antag-

onized the effect of Eserine on the conditioned response.
They concluded that drug action occurred in the periphery
and suggested that peripheral cholinergic blockade may influence CNS responses and must be considered in the
evaluation of central effects of anticholinesterases.
Although quaternary anticholinesterases such as neostigmine fail to penetrate the BBB and reveal little or no
direct CNS activity (Longo 1962), Paulet et al. (1957)
suggested that neostigmine along with parathion and
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octamethylpyrophosphoramide (OMPA) increased the permeability of the BBB to another drug, sulfanilamide.

How-

ever, this effect was not attributable to inhibition of
cholinesterase.

Aasseth and Barstad (1968) revealed that

quaternary anticholinesterases did not increase existing
brain cholinesterase inhibition.

Mazel and Bush (1969)

concluded that the Eserine-induced increased onset and
duration of barbital sleep was not due to an increased
permeability of the BBB but was mediated through the
peripheral nervous system.

~inally,

Koelle and Steiner

(1956) demonstrated that tertiary cholinesterase inhibitors
did not enhance the penetration of quaternary anticholinesterases through the BBB.
Reserpine depletion of brain NE occurred rapidly and
was maintained by chronic administration (Table II, cf.
Table III, Pletscher et al. 1956, Weil-Malherbe and Bone

1959, Costa et al. 1962, Brodie et al. 1966,
et at. 1967, and Kety 1967).

H~ggendal

The values for depletion of

brain NE seen in Table II served as control references for
subsequent experiments in which reserpine-induced NE
depletion was desired (cf. figs. 42 through 46).
of reserpine has been described as "hit and run".

The action
It is

.....
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metabolized and disappears from brain tissue in 1-2 hours
(in rabbit) while a marked depletion of biogenic amines
continues for up to 36 hours (Hess et al. 1956).
~

Costa

al. (1962) reported that rabbit brain NE was depleted

to 12 per cent of control value at 4 hours after 1.5 mg/
Kg i.v.

However, Anden (1967) observed a differential

depletion of rat brain monoamines after acute reserpine
treatment.

Low doses of reserpine (l.O mg/Kg i.p.) re-

sulted in resistance to depletion in some brain areas while
a high dose (10.0 mg/Kg i.p.} uniformly depleted brain NE.
Furthermore, Liebmann and Mattheis (1964) in a study on the
influence of reserpine on cholinomimetic toxicity observed
an increased toxicity at 1-2 hours after reserpine and
maximal toxicity at 18-24 hours.

This fluctuation in

toxicity may be related to the circadian rhythm of the endogenous biogenic amines (Sterman et al. 1965, Reis et al.
1968, Friedman and Walker 1968).

Therefore, chronic admin-

istration of reserpine was employed in the present study
and a uniform depletion was obtained.
Depletion of brain NE by aMPT was linear with time and
was maintained by chronic administration (Table III, cf.
Table II).

These findings are also in agreement with

current literature (Spector et al. 1965, Brodie et al.
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1966, Kety 1967).

The values shown in Table II served as

control references for subsequent experiments in which
brain NE was depleted by aMPT (cf. figs. 49 through 51).
The linear decrease of brain NE by aMPT is dependent on
maintaining an adequate tissue level of the rate-limiting
enzyme inhibitor (Brodie et al. 1966a) compared with
reserpine-induced depletion of biogenic amines which was
rapid and associated with a rapid disappearance of the
drug from the tissues.

Single large doses of aMPT have

been reported to cause renal. toxicity but repeated lower
doses resulted in no toxicity and a decreased catecholamine
concentration (Moore et al. 1967).

/

Anden (1967) observed

that dVIPT uniformly depleted brain NE compared with reserpine and that the level of nerve activity had a greater
influence on aMPT-NE depletion than on reserpine-NE depletion.

In addition, Smookler and Buckley (1969) found

that aMPT depleted NE 85% in male rats stressed by light,
sound, and oscillation while non-stressed animals were
depleted 45%.
rates.

Stress also markedly increased NE turnover

Moreover, concentrations of endogenous amines have

been implicated as factors in NE depletion.

Nagatsu and

Takeuchi (1967) showed that high concentrations of
phenylalanine inhibited NE synthesis 80% in vitro.

It was
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concluded that since tyrosine hydroxylase catalyzed the
hydroxylation of phenylalanine to tyrosine as well as
tyrosine to DOPA, abnormally high concentrations of
phenylalanine would compete with tyrosine for tyrosine
hydroxylase, thus decreasing the amount of NE being synthesized.
Restoration of depleted brain biogenic amines
necessitated consideration of mechanisms of biogenic amine
depletion in the CNS.

The mechanisms by which reserpine

depleted endogenous NE (Holz4auer and Vogt 1956) throughout
the neuron (Dahlstrom and Fuxe i964) and blocked reuptake
of NE (Glowinski and Axelrod 1965, 1966) differ from aMPTNE depletion (Spector et al. 1965, Brodie et al. 1966a,
Corrodi and Fuxe 1967).

Depletion of the catecholamines,

DOPA, dopamine (DA), NE and epinephrine (EPI), occurred after
aMPT while reserpine depleted both catecholamines and indoleamines to include serotonin (Hess et al. 1956, Pletscher et
al. 1956, Brodie et al. 1957, Shore et al. 1958, WeilMalherbe and Bone 1959, and Kety 1967).

Reserpine-induced

sedation has been correlated with the initial rate of release
of serotonin but not final concentrations (Brodie et al.
1966).

Koella and Czicman (1966) and Koella et al. (1968)

suggested that serotonin was the mediator associated with

.........
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EEG synchronization and behavioral sedation (cf. also
Marczynski 1967 for additional references).

Jouvet (1967)

postulated that serotonin-containing neurons supported
slow wave sleep while paradoxical sleep was a function of
NE neurons of the locus coeruleus.

Pirch and Rech (1968),

on the other hand, concluded that the depletion of brain
NE or DA was a critical factor in behavioral sleep and
electrocortical responses to aMPT and reserpine.

Both

catechol- and indoleamines may be involved in the mechanism
of action of reserpine.

At

~resent

the issue is unre-

solved (Kety 1967).
Restoration of brain biogenic amines by the parenteral
administration of the putative transmitters DA, NE, or EPI
failed to yield consistent results, and because of the BBB
it is doubtful that direct CNS effects are observed (Longo

1962, Baust and Nleczyk 1964, Wurtman 1966, Barchas et al.
1968).

Intravent~icular

administration has been used to

circumvent the BBB (Feldberg and Sherwood 1954) but results
are difficult to interpret.

The CNS stimulant effects of

sympathomimetic amines such as amphetamine as well as other
phenylethanolamines that penetrate the BBB, revealed desynchroniza tion of the EEG and behavioral arousal when
given by different routes of administration (Van Meter and

-
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Ayala 1961, Bradley 1968).

Serotonin, which penetrates

the BBB only to a slight extent, evoked an initial EEG
arousal followed by an EEG synchronization while its
precursor 5 hydroxytryptophan (5 HTP) readily gained access
to the brain and caused an increased EEG synchronization,
behavioral sleep and an associated rise in brain serotonin
concentrations (Longo 1962, Koella 1966, Brodie et al.

1966, Bradley 1968).

Bradley (1968) noted that the action

of amphetamine when applied iontophoretically to CNS
neurons, resembled NE but not ACh, serotonin or histamine.
He concluded that amphetamine induced central excitation by
releasing endogenous NE but pointed out that catecholamines
injected into immature animals with poorly developed BBB as
well as intraventricular injections, resulted in sedation
or sleep.

Matsuda (1968) found similar responses to

ventricular administration of EPI in rabbits where EEG and
behavioral sleep appeared without changes in threshold of
thalamocortical recruitment.
There is evidence that the uptake-storage mechanism for
catecholamines may be altered by reserpine.

H~ggendal

and

Malmfors (1969) observed that adrenergic nerves of rats
failed to take up exogenous NE and failed to show functional responses when stimulated 16 hours after reserpine-NE
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depletion and monoamineoxidase inhibition.

However, nerve

stimulation in the presence of exogenous DA revealed
functional responses and synthesis of NE from that precursor.

Furthermore, DA uptake has been shown to exceed

that of NE in rat brain homogenates and there was evidence
for a common uptake path for NE and DA (Snyder and Coyle

1969).

In fact, dopaminergic transmission and pathways

have been postulated in both the periphery and CNS
(Hornykiewicz 1966, and Takagi et al. 1968).

On the other

hand, L-DOPA restored NE to aMPT-NE depleted but not
reserpine-NE depleted rats unless a MAOI was used (Corrodi
and Fuxe 1967).

These authors observed that inhibition of

MAO also increased the recovery level of NE in the aMPTDOPA treated animals and they concluded that the uptakestorage mechanism was intact after aMPT-NE depletion but
that the mechanism may have been altered by reserpine.
Administration of the monoamine precursor

L-DOPA in the

presence of MAO inhibition effectively restored depleted
brain biogenic amines and reversed reserpine depression
of behavior (Everett 1961, Everett et al. 1963).

In the

present experiments, pargyline plus L-DOPA successfully
reestablished depleted NE levels in brain and increased NE
levels in non-depleted animals (cf. Table III and figs. 48,
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54).
Background EEG activity alters the stimulus threshold
for evoking thalamocortical recruitment.

Longo (1962)

and Giaquinto (1968) showed that desynchronized EEG activity
raised the threshold required for elicitation of thalamocortical recruitment.

This was also noted during pre-

liminary studies in the present research.

Therefore,

stimulus voltage for recruitment was established with background of desynchronized EEG activity (figs. 3.3, 57).
Threshold values for thalamQcortical recruitment established
prior to the administration of the particular drug in
question were maintained during post-drug observations.

The

stimulus threshold required to evoke recruitment during
periods of EEG arousal was effective in the presence of synchronized EEG activity (figs. 33, 57, 64).
Eserine (100-150 mcgm/Kg i.v.) induced an initial, slow
wave, EEG sleep pattern of approximately 2 minutes duration
followed by a transient desynchronized EEG pattern.

The

greatest intensity of the desynchronous EEG response
occurred between 5 to 10 minutes after the injection.

The

same sequence of synchronized EEG activity followed by desynchronized activity was noted after the intracarotid
administration of Eserine (vide supra, Part I) with the
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exception that the slow wave sleep pattern was of much
shorter duration and lasted only a few seconds.

Thalamo-

cortical recruitment was attenuated during the maximal
intensity of desynchronization (fig. 34) but reappeared
about 20 minutes later during recovery from the Eserine injection.

The recovery of thalamocortical recruitment occur-

red prior to the reappearance of a synchronized EEG pattern
(fig. 35).

The EEG pattern resumed pre-injection charac-

teristics 30-40 minutes after the cholinesterase inhibitor
had been given.

The initial

~low

wave EEG pattern was not

reported previously in descriptions of the reversible
effects of Eserine on the EEG of rabbits (Longo and
Silvestrini 1957, Longo 1962).

In addition, the present work

revealed the reappearance of thalamocortical recruitment
prior to the recovery of the synchronized EEG activity after
Eserine.

Similarly, DFP also evoked a desynchronized EEG

pattern and attenuated thalamocortical recruitment (fig. 36)
at least two hours at which time experiments were terminated.
These events are probably closely associated with the inhibition of cholinesterase and the increased brain ACh concentrations.

In an evaluation of the interrelationship of

inhibition of cholinesterases, increases in brain ACh concentrations and cholinomimetic toxicity, Holmstedt et al.

......
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(1967), noted lethal doses of organophosphates were not
required to induce marked increases in brain ACh concentrations.

Classical toxic responses to organophosphate

poisoning occurred only when cholinesterases were inhibited
and after ACh levels in the brain attained values of 60
per cent or greater than controls.

A similar relationship

was noted with Eserine but the inhibition of enzyme was
reversible.

On the other hand, oxotremorine and arecoline

provoked salivation, lacrimation, and tremor at brain ACh
levels that were elevated only 20 per cent above control
values.

Leslie (1965) observed that oxotremorine and are-

coline were the most potent antagonists of drug-induced
sedation in rabbits.

Oxotremorine was the only cholino-

mimetic that produced prolonged excitation when iontophoretically applied to ACh-excitable neurons of the ponsmedulla of the cat (Bradley et al. 1966).

The effects of

Eserine on the EEG and thalamocortical recruitment in cats
have been described as muscarinic

(Hance et al. 1963).

They reported that atropine sulfate (l.O mg/Kg i.v.) was
an effective antagonist of the EEG response to Eserine but
had minimal action on evoked cortical potentials.

While

an accumulation of ACh may result from the inhibition of
cholinesterases (as pointed out in Part I), other actions of
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AntiChE's aside from enzyme inhibition should be considered, particularly during states of pronounced drug intoxication (cf. figs. 11 through 16).

Moreover, as pointed out

by Friedman (1967), oxotremorine was only one of a
chemically and pharmacologically diverse group of compounds
that promoted the release of ACh and other endogenous amines
including DA as well as NE and EPI.

In fact, low doses of

nicotine (5.0-20.0 mcgm/Kg i.v.) have been shown by Domino

(1967) to evoke an EEG arousal pattern in rabbits with
midpontine brainstem transeations.

Nicotine induced an EEG

desynchronization that was concomitant with a behavioral
arousal.

However, Domino suggested that because nicotine

released ACh, catecholamines, serotonin and vasopressin and
evoked a cholinergic blockade in higher doses, its mechanism
of action was obscured.

Furthermore, in an earlier study,

Monnier and Romanowski (1962) found that ACh, Eserine, and
pilocarpine all evoked an EEG arousal in rabbits, induced
an increased arousal reaction to sensory and reticular
formation stimulation and increased the cortically evoked
potential from caudate or hippocampal stimulation, but decreased thalamocortical recruitment.
were blocked by atropine.

These drug effects

Also, Domino (1968) revealed that
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the muscarinic receptors had a greater sensitivity to
evoked EEG desynchronization than did nicotinic cholinergic receptors and he concluded that the cholinergic
mechanisms for inducing arousal were more muscarinic than
nicotinic.
Reciprocal antagonism between anticholinesterases and
anticholinergics was demonstrated in Part I and is reiterated in figure 37 that shows the scopolamine antagonism of
DFP-induced desynchronization (cf. Longo 1962).

Antagonism

of the EEG arousal by scopolamine did not attenuate thalamocortical recruitment per se (fig. 37, Hance et al. 1963)
but antagonized the attenuation of recruitment by DFP (cf.
Longo 1962).
Chlorpromazine antagonized the transient attenuation
of recruitment seen after Eserine (fig. 39) and the antagonism may be the result of alpha adrenergic blocking properties.

Boakes et al. (1968) found that chlorpromazine

was the most effective blocker of the excitatory effect of
iontophoretically applied (-) norepinephrine on brainstem neurons.

Rinaldi and Himwich (1955a, 1955b) have

proposed anticholinergic properties for the chlorpromazine
block of anticholinesterase evoked EEG desynchronization.
Imipramine has properties similar to those of chlorpromazine
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and Monnier and Krupp (1959) observed an increased threshold to electrocortical arousal following the administration of either drug while Rinaldi (1967) noted convulsive
activity subsequent to administration of high doses.

Dasberg

and Feldman (1968) investigated the EEG arousal blocking
effect of imipramine.

These authors found that imipramine

raised the threshold for EEG arousal evoked by the i.v. injection of Eserine and that the threshold for EEG arousal
evoked by amphetamine was lowered.
imipramine acted by a

cholin~rgic

They concluded that
blocking mechanism.

If a

cholinergic-link concept is considered, Dasberg and Feldman's
results could be interpreted to mean that Eserine promoted
the release of biogenic amines in the CNS (Rosecrans et al.

1968, cf. Marczynski 1967) which elicited the EEG arousal.
The anticholinergic effect of imipramine antagonized the
EEG alert by blocking the action of Eserine and ACh on the
adrenergic component.

Amphetamine would still act at the

CNS by releasing NE (Bradley 1961, Bradley 1968).

The

decreased threshold for amphetamine-induced desynchronization seen after imipramine could either be the result of
cholinergic blockade or inhibition of catecholamine uptake
(Glowinski and Axelrod 1966), by blockade of membrane
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transport of amines (Giachetti and Shore 1966).

Imipra-

mine antagonism of Eserine-induced EEG arousal could also
be attributed to the later adrenergic blocking effect.
Furthermore, imipramine-antagonism of reserpine-induced
sedation depended on the presence of catecholamine stores
in the CNS.

Depletion of brain catecholamines resulted in

failure of imipramine-antagonism of benzoquinolazine
sedation (Sulser et al. 1964).

Chlorpromazine, similar to

imipramine, probably antagonized the effects of Eserine by
a combination of cholinergic and adrenergic blocking
effects.

The brain stem reticular formation is a site of

cholinergic activity (Rinaldi and Himwich 1955a, Rinaldi and
Himwich 1955b).

Cholinergic mechanisms are also implicated

in EEG desynchronization at the level of the cerebral
cortex, particularly with slow and prolonged excitatory
effects (Krnjevit1967).

Krnjevid (1967) also observed that

repetitive responses of cortical neurons to thalamic
stimulation were markedly enhanced by ACh or Eserine.
Therefore, the antagonism of Eserine by chlorpromazine
occurs in the cortex as well as brain stem and there is
probably not a specific locus of action.
Atropine evoked a synchronized EEG (fig. 40) and this
has been reported to be dissociated from behavioral sleep
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(Wikler 1952).

However, thalamocortical recruitment was

not attenuated.

This finding with the observation that

atropine also failed to alter caudatocortical recruitment
has been shown in rabbits (Longo 1962).

On the other hand,

Domino et al. (1968) studied cholinergic mechanisms in
sleep and wakefulness in cats.

They found that physostig-

mine evoked an initial EEG desynchronization in both
neocortical and limbic areas and that this response was
associated with a behavioral arousal.
suggested that early

findin~s

These authors

of dissociation between EEG

responses and behavior attendant to the administration of
cholinergic agonists and antagonists (Wikler 1952, Bradley
and Elkes 1957, Bradley and Nicholson 1962) were noted
before the concepts of paradoxical or fast wave sleep
cycles in cat were well established (Dement 1958, Jouvet

1961).

The observation of a fast wave sleep pattern then

would be acceptable as a concurrent event with behavioral
sleep.

Moreover, in an earlier study, Yamamoto and Domino

(1967) had shown in cats that the initial EEG alert after
Eserine was associated with a behavioral arousal and that
paradoxical sleep appeared after a delay of 30 minutes or
longer, during the recovery from the injection.
carpine also showed the same result.

Pilo-

Furthermore, denial of
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paradoxical sleep in rats has been noted to evoke a rebound increase in paradoxical sleep after the period of
denial (Pujol et al.

1968).

Turnover of cerebral NE was

increased during the rebound phase of paradoxical sleep.
Jouvet (1967) proposed that slow wave sleep depended on
serotonergically-mediated events while paradoxical sleep
appeared to be related to catecholaminergic mechanisms.
The atony associated with fast wave sleep could be blocked
by atropine and yet DOPA induced normal paradoxical sleep
in cats treated with reserptne.

Jouvet (1967) concluded

that both cholinergic and adrenergic mechanisms were required to produce paradoxical sleep with total atony.
A subconvulsant dose of sarin antagonized the EEG
effects of atropine sulfate (3.0 mg/Kg i.v., fig. 41, cf.
fig. 14 Part I).

Thalamocortical recruitment was markedly

attenuated (arrows) and this blockade persisted for two
hours at which time the experiments were terminated.

These

observations are in agreement with Longo (1962) but not
White (1966).

The latter worker noted that 100 mcgm/Kg

i.v. of Eserine in rabbits failed to evoke an EEG desynchronization if given after l.O mg/Kg i.v. of scopolamine.
The lack of agreement of the effects of an anticholinesterase
in the presence of an atropinic anticholinergic blockade
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undoubtedly lies in the doses used.

Scopolamine is

approximately 10-15 times more potent than atropine as an
antagonist of EEG arousal in the rabbit and the effective
dose for total inhibition of the EEG arousal response
elicited by direct electrical stimulation of the reticular
formation was found to be 0.04-0.05 mg/Kg i.v. (Longo

1956).

Furthermore, the reciprocal and competitive nature

of the interaction between antimuscarinic and anticholinesterase drugs necessitates a consideration of the doses
used, as well as the duratiqn of inhibition of cholinesterases.
Chronic administration of reserpine effected (1) EEG
activity (fig. 42), (2) brain levels of biogenic amines
(Tables II, III), and (3) behavior (vide supra).

EEG

activity changed from alternating slow wave sleep and alert
tracings to prolonged synchronization during which EEG
arousal and thalamocortical recruitment were evoked (figs.

42, 43).

Initial

disag~eement

on the EEG re5ponse of

laboratory animals to reserpine (Longo 1962) resulted from
observations taken under markedly different conditions.
Reserpine like amphetamine initially promoted the release
of stored NE from nerve granules and brain (Vogt 1954).
During this time there was a brief period of continuous

--
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EEG desynchronization that began about 45 minutes after
intravenous administration and persisted for about 2 hours
(Rinaldi and Himwich 1955).

The pattern of behavior was

one of depression with the animal in a sleep-like state,
attributable to paradoxical sleep (Jouvet 1967a) or perhaps
due to interneuronal deamination of reserpine-liberated
catecholamines which rendered them physiologically less
active (Glowinski and Axelrod 1965, 1966).

Only after 4-6

hours, the synchronized EEG predominated and the brain
catecholamines were

beginnin~

to show marked depletion

(fig. 42, Table III). Haggendal et al. (1967), in a recent
study of the effects of chronic reserpinization on monoamine metabolism and behavior, noted that the first signs
of reserpine activity appeared approximately one hour after
injection at a time when the major part of the monoamines
were still present.

In the current work (Table III), long

term treatment with reserpine revealed brain levels of
monoamines similar to those seen at 4 hours through 24
hours (Table II).

Haggendal and co-workers (1967) were

unable to restore brain biogenic amine levels to control
values by DOPA alone.

Everett (1961) and Everett et al.

(1963) showed that DOPA plus a MAOI rapidly restored
biogenic amine levels in brain tissue.

Bueno et al.

r
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(1968) found that the appropriate combination of a MAOI
and reserpine could evoke prolonged periods of alert EEG
activity in rabbits.
amines per

~,

Brain concentrations of biogenic

could not be correlated with the EEG

response but an increased ratio of concentration of serotonin to NE was seen with behavioral excitement and EEG
desynchronization.

Furthermore, as pointed out by Costa

(1966) and Brodie et al. (1966a), synthesis rate and turnover time of tissue biogenic amines may correlate with
physiological and behaviora1- activity more significantly
than does actual tissue concentration.

Moreover, turnover

time as well as synthesis rate can be influenced by a
variety of factors to include gonadectomy which increased
brain NE turnover in rats (Anton-Tay and Wurtman 1968) and
physical stress (Smookler and Buckley 1969).

Gal (1961)

found that reserpine evoked a greater prolonged depletion
of serotonin and NE in rats fed on a tryptophan deficient
diet than with animals fed a normal diet.

Therefore, while

changes in turnover and synthesis rate may be of value in
correlation of experimental observations, the experimental
conditions are of critical importance.
Reserpine per

~

cruitment (fig. 42).

did not depress thalamocortical reGal et al. (1961) observed that
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reserpine did not alter arousal threshold nor recruitment
threshold in rats.

White (1966) observed that reserpine

facilitated the indirect action of mephenteramine and
induced a desynchronized EEG but failed to depress evoked
potentials in the reticular formation.

In the same study,

pretreatment with reserpine followed by mephenteramine
failed to alter the Eserine-induced EEG desynchronization
and blockade of reticular evoked potentials, while
scopolamine in an extremely high dose (l.O mg/Kg i.v.)
blocked the effects of Eseripe (vide supra).

In the present

studies, brain biogenic amine depletion by chronic administration of reserpine failed to alter the desynchronized
EEG and attenuation of thalamocortical recruitment evoked
by Eserine at doses of 100 mcgm/Kg i.v. (fig. 44) or 200
mcgm/Kg i.v. (fig. 45).

DFP (2.0 mg/Kg i.v.) also failed

to block thalamocortical recruitment but evoked an EEG
desynchronization (fig. 46).

Restoration of brain bio-

genic amines by the combination of a MAOI, which by itself
did not attenuate recruitment, and L-DOPA restored Eserineblockade of recruitment.

While Everett (1961) pointed out

that MAOI and DOPA combinations could evoke an EEG alert,
the current study showed that thalamocortical recruitment
could still be evoked and that Eserine could block this

242

response.

In fact, increased brain concentrations of NE

by the administration of the MAOI and L-DOPA reduced the
dose of Eserine required to attenuate recruitment, to
50 mcgm/Kg (vide infra).
Depletion of brain NE by chronic inhibition of
synthesis (cMPT) also evoked a marked increase in synchronized EEG activity with evoked EEG arousal and recruitment
responses (figs. 49 and 50).

Eserine also failed to

attenuate thalamocortical recruitment though an EEG desynchronization was evoked

(fig~

51).

Restoration of brain

amines by MAOI and DOPA resulted in the same response as
seen above for reserpine-NE depletion and restoration.

While

depletion of brain biogenic amines following the chronic
administration of either reserpine or qvIPT is through
different mechanisms, results were similar.

EEG patterns

showed a marked increase in slow wave sleep activity.

Rats

have also demonstrated an increase in integrated voltage of
the electrocorticogram after multiple doses of aMPT and this
response was antagonized by MAOI (Pirch and Rech 1968).
These latter authors concluded that the effect of ctVIPT was
similar to reserpine and that a decrease in brain-NE concentration was an important factor in the behavioral and EEG
response induced by either drug.

.......
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Depletion of brain biogenic amines altered the response
to cholinomimetics.

In particular, the depletion of the

catecholamines, DOPA, DA, NE, and EPI appears to be implicated.

Reserpine depleted both catecholamines and indole-

amines and thus either serotonin or the catecholamines may
be involved.

However,

~PT-NE

depletion provides evidence

that the catecholamines are an essential factor in Eserineattenuation of thalamocortical evoked potentials.

Electro-

cortical activity of sleep may be associated with serotonin
(Koella 1966, Koella et al. ;968, cf. Marczynski 1967), but
it is unlikely that serotonin is an essential factor for
the Eserine-attenuation of recruitment.

In fact, with the

marked depletion of serotonin that follows the administration of reserpine (Hess et al. 1956), recruitment can still
be evoked and EEG sleep patterns are enhanced (cf. figs. 42
and 43).
In addition to the observation of responses in the
presence of depleted brain NE and its subsequent restoration,
the responses of drugs and stimuli in the presence of increased brain NE in non-depleted animals were observed.
Recruitment was not attenuated by 50 mcgm/Kg i.v. of Eserine,
a dose which evoked an EEG desynchronization (fig. 52, cf.
Longo 1962).

Inhibition of MAO alone did not facilitate
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Eserine-attenuation of recruitment (fig. 53).

However,

L-DOPA in the presence of inhibited MAO increased brain NE
(cf. Table III, and Everett 1961), and enhanced Eserineattenuation of recruitment (fig. 54).

Moreover, a transient

blockade of thalamocortical recruitment was seen (fig. 55)
which was attributable to the reversible nature of the anticholinesterase (Longo and Silvestrini 1957, Longo 1962).
While complete recovery of the evoked potential was not
observed, levels of brain NE were increasing and contributed
to the decrease in EEG arou$al threshold (Everett 1961,
Kety 1967) and to the increased threshold of recruitment.
Therefore, instead of depletion of brain NE with subsequent
restoration of levels by MAOI plus L-DOPA, brain NE raised
above control values in non-depleted animals (Table III,
cf. Table II), enhanced behavioral and EEG arousal and
lowered the dose of Eserine necessary to attenuate thalamocortical recruitment.
Phenoxybenzamine evoked a biphasic EEG response consisting of a transient EEG desynchronization of less than
two minutes followed by a continuous EEG synchronization
(figs. 60 and 61).

The initial desynchronization (fig. 60)

was probably an alpha response and the EEG synchronization
was the result of a beta response unmasked by alpha
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blockade (Goldstein and

1961).

Mu~oz

1961,

Mu~oz

and Goldstein

On the other hand, beta blockade by INPEA (Teotino

et al. 1963) (fig. 65) unmasked only the alpha EEG response
of desynchronization (Goldstein and Munoz 1961, Munoz and
Goldstein 1961), and blocked recruitment.
Integration of thalamocortical recruitment was carried
out by a stimulator-controlled, relay operated unit.

Inter-

recruitment EEG background activity was excluded since the
integration unit was in operation only during the presentation of stimuli (cf. Koella and Czicman 1966).

Supra-

threshold stimuli evoked potentials that were relatively
constant in the presence of synchronized or desynchronized
EEG background activity (figs. 56 and 57).

The amplitudes

of the integrated potentials appeared constant but there
was no determination made of the area under the curve and
this may have varied.

Eserine markedly attenuated the

integrated thalamocortical potentials (fig. 58) which
atropine methyl nitrate failed to antagonize (fig. 59).
Eserine antagonized the EEG synchronization induced by
phenoxybenzamine and blocked recruitment as well (fig. 62).
An increase in the dose of phenoxybenzamine also blocked
the EEG desynchronization evoked by Eserine.

On the other
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hand, beta blockade, attenuated the integrated thalamocortical potentials similar to Eserine (fig. 65, cf. fig.
58).

White et al. (1965) noted that Eserine,catechol and

amphetamine induced EEG arousal patterns and reticular
evoked responses in rabbits.

They found that phenoxy-

benzamine induced EEG synchronization but did not antagonize
the reticular evoked potential nor the responses to Eserine.
It was concluded that the reticular formation was not
pharmacologically homogenous and there were examples of a
drug-induced "dissociation" op responses.

In an earlier

study, White and Daigneault (1959) found that atropine
antagonized adrenomimetic CNS stimulants and concluded that
an interaction between cholinergic and adrenergic elements
was involved in the action of the drug.
Attenuation of thalamocortical recruitment by an anticholinesterase is dependent on the maintenance of brain
catecholamine levels but the mechanism is not clear.
Eserine evoked an EEG desynchronization that enhanced the
duration of paradoxical sleep in decerebrate or in pontine
transected animals, yet evoked behavioral arousal in intact preparations (Jouvet 1967a).

Lederbur and Tissot

(1966) noted that local injections of 5HTP or L-DOPA into
the bulbo-pontine somnogenic structures described by Jouvet
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(1962) and Morruzzi (Magni et al. 1962) evoked a synchronized EEG when 5HTP was given into the

11

center"

described by Morruzzi, but EEG desynchronization when
administered into the "center" described by Jouvet.

DOPA

evoked an EEG alert pattern when given into either center,
and the response was attended by a marked decrease in
muscular activity.

It is of interest that 5HTP could

evoke either slow wave sleep or paradoxical sleep patterns.
Jouvet (1967, cf. Marczynski 1967) suggested that serotonergic mechanisms were inv9lved in the processes of
falling asleep while noradrenergic mechanisms supported
paradoxical sleep.

Furthermore, sleep spindles were non-

existent during paradoxical sleep and the elicitation of
recruitment during activated sleep was markedly attenuated
(Yamaguchi et al. 1964).

Early descriptions of thalamo-

cortical recruitment led to the conclusion that recruitment
and rhythmical 8-14 c/s spindle bursts involved the same
structures and were the same events (Morison and Dempsey
1941-1942, Dempsey and Morison 1941-1942).

Cortical and

subcortical sites for the mechanism of recruitment were
described by Verzeano et al. (1953).

Ajmone-Marsan (1958)

concluded that recruitment resulted from activation of
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longer or shorter chains of neurons and that the latency
characteristic of recruited potentials was not due to
conduction times between thalamus and cortex.

Latency was

a result of events occurring at the level of the thalamus.
On the other hand, Velasco and Lindsley (1965) observed
that only ablation of the orbital cortex abolished recruitment in thalamus and cortex and they concluded that orbital
cortex played a crucial role in the regulation of thalamocortical recruitment in cats.
~

In a later study, Velasco

al. (1968) showed that thaJ.amocortical recruitment and

spindle bursts after mesencephalic reticular formation
lesions, were abolished only by orbital-frontal cortical
ablations.

It was concluded that the orbito-frontal cortex

was an essential link in the synchronizing systems of
thalamocortical nature responsible for spindle bursts and
recruitment.

On the other hand, Demetrescu and Demetrescu

(1962a) proposed an active ascending inhibitory pathway from
the pontine reticular formation to the caudate nucleus and
then to the cortex.

The ascending inhibitory pathway

paralleled and was ventral to the ascending excitatory
reticular formation pathway and operated in a feedback
servo manner.

Rocha-Miranda (1965) showed caudate-cortical

,
249

connections of a direct nature not dependent on collateral
or corticopetal pathways from lower levels.

Furthermore,

limbic projections to the anterior thalamic nuclei have
been demonstrated that altered their excitability and
that of the cortex (Sparks and Powell 1966).

It has been

shown that septal neurons may act as pacemakers for
rhythmic activity of the hippocampus (Gogolak et al. 1967),
and the latter structure has been proposed as a pacemaker for thalamic neurons (Manzoni and Parmeggiani 1965).
Furthermore, Abeles (1967, 1967a, 1967b) in a series of
studies on the excitability of thalamic and brain-stem
neurons associated with EEG, synchronization and desynchronization, observed that desynchronizing cells had lower
chronaxies.

He concluded that there were not two sets of

neurons; one for synchronization and another for desynchronization but rather one set that responded to both kinds
of stimuli with desynchronization being more readily obtainable.

Yamaguchi et al. (1964) also had noted that low

frequency stimulation of the thalamic nuclei evoked recruitment while high frequency stimulation evoked both EEG
desynchronization and behavioral arousal (cf. Longo 1962).
Sleep-wakefulness cycles have been categorized into
4 groups:

(1) strong arousal with desynchronized EEG, a
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high level of EMG (electromyographic) activity and a high
threshold for recruitment, (2) relaxed wakefulness with
desynchronized EEG, no paradoxical sleep and a slightly
elevated threshold for recruitment, (3) slow wave sleep
with synchronized EEG activity, low EMG activity, and a
low threshold for recruitment, and (4) paradoxical sleep
with a desynchronized EEG, low EMG activity and a threshold for recruitment similar to that seen during relaxed
wakefulness.

An evaluation of the multiple unit activity

of thalamic and reticular nevrons during wakefulness, sleep
and stages of anesthesia led Gobdman and Mann (1967) to
conclude that there were no unique differences in levels
of activity among them and that characteristics of spontaneous unit firing from the thalamus and reticular formation could not be used to differentiate between waking
states, sleep or anesthesia.

However, Phillis and Tebecis

(1967) found that pentobarbitone blocked the ACh excitatory
and the NE inhibitory effect on thalamic neurons without
altering the level of excitation of the neuron, which
remained responsive.

Findlay and Hayward (1966) observed

that unit activity from the massa intermedia of the
thalamus of rabbits fired biomodally during slow wave sleep
but was silent

~uring

EEG desynchronization.

Pharmacolog-
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ical studies on thalamic neurons have revealed a mixed
muscarinic-nicotinic type of excitation (Andersen and
Curtis 1964) in ventrobasal nuclei of cats.

However,

McCance et al. (1966) found that muscarinic agonists were
the most potent and that atropine sulfate blocked more
readily than dihydro beta-erythroidine.
The role of the hippocampus as a pacemaker for the
rhythmic activity of the anterior dorsal nuclei of the
thalamus has been suggested (Manzoni and Parmeggiani
1965).

Intrathalamic pacemaker function has also been

proposed by Andersen et al. (1967, 1967a).

These authors

concluded that the rhythm of the cortical spontaneous
barbiturate spindles was under thalamic control while
voltage was a function of cortex.

And, that during

barbiturate anesthesia small assemblages of thalamic
neurons generated independent rhythmic discharges that
paced the rhythm of the cortexes via thalamocortical
columns.

It has been reported that rhythmic thalamic unit

activity was blocked by electrophoretic application of
serotonin and initially by ACh (Andersen and Andersson
1968).

However, a secondary excitatory response to ACh

appeared during which rhythmic activity was increased.
Also, these authors observed that single shocks in the

252

thalamus as well as electrophoretic application of glutamic
acid, evoked rhythmic discharges in the ipsilateral
nucleus caudatus.

The caudate neurons are depressed by the

electrophoretic application of NE, (Bloom et al. 1964).
Herz and Ziegelgansberger (1968) observed that DA blocked
firing of neurons in the caudate and putamen and that
glutamate antagonized DA.

Serotonin, NE, and oxotremorine

inhibited unit discharges and ACh showed both excitation
and inhibition.

It was concluded that since the effect of

DA and hyperpolarizing currents were the same, that the

action of DA on the cell membrane was one of hyperpolarization.

ACh content of the caudate has been shown to be

increased during periods of increased sleep spindle activity
and to be decreased during EEG desynchronization (Traczyk
and Sadowski 1964).

Chlorpromazine lowered the threshold

to single shock-caudate spindles (Tokizane et al 1957),
as well as, pentobarbital and synchronized EEG activity
(Buchwald et al. 1961).

On the other hand, stimulation of

the reticular formation, or ablation of the nucleus ventralis
anterialis of the thalamus blocked the caudate spindles.

A ttcaudate loop" has been described in the pathway from
reticular formation to ventralis anterialis, to caudate,
back to ventralis anterialisand then to cortex (Heuser et
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al. 1961).

Caudate spindles as well as caudate induced

EEG arousal depended on the integrity of the thalamic
nucleus.

Cortical sites that showed spindling in response

to caudate stimulation were the same as recruitment sites
(Buchwald et al. 196la), and Buchwald et al. (196lb)

--

--

proposed an inhibitory caudate circuit to balance the
mesodiencephalic activating system.

Caudate recruitment

has been shown to be dependent on cortical activity and
anatomical connections from the anterior thalamic nuclei to
the caudate have been established
(Kaji et al. 1968).
,

--

How-

ever, Goldring et al. (1963) found that caudato-cortical
recruitment differed between monkey and cat.

In the

macaque monkey, caudate stimulation failed to evoke cortical
recruitment whereas stimulation of the internal capsule
was successful.

It was suggested that caudato-cortical

recruitment in the cat was due to spread of the electrical
stimulation of the caudate to the afferent sensorimotor
cortical fibers in the internal capsule.

These fibers lie

adjacent to the caudate nucleus in the cat but are located
more caudally in the monkey.

While the work of Goldring

et al. (1963) may explain neuroanatomical relationships in
monkey it does not exclude the existence of caudato-thalamo
fibers in the cats.
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Cholinergic stimulation of the caudate nucleu.s evoked
responses similar to those seen after stimulation

of the

ventralis anterialis of the thalamus both of whicl-l were

II

~
'1'

11

~

11\
'.11,

blocked by atropine (McLennan and York 1966).

These

workers had also found that stimulation of the ventralis
anterialis evoked a release of ACh from the caudate nucleus
and concluded that a cholinergic link existed betw-een the
thalamus and caudate.

While a cholinergic link hypothesis

is highly controversial (Burn 1966, Ferry 1966, Boura and
Green 1965, Burn 1968), a cholinergic-adrenergic interrelationship may be involved in the mechanism of action of
anticholinesterases on thalamocortical recruitment, with
resulting implications on mechanisms of sleep and wakefulness.

The presence of cholinergic pathways ascending from

(1) the dorsal mesencephalic reticular formation,

through

the dorsal tegmentum to specific and non-specific

nuclei

of the thalamus, to cortex and from the thalamus to caudate
nucleus and then to cortex and (2) from the substantia
nigra through the ventral tegmentum, hypo- and subthalamus
to basal forebrain area, from which fibers project through
the olfactory bulb and cerebral cortex, has been established
in rats (Shute and Lewis 1963, 1965, 1966).

KrnJevi~ and

Silver (1965) confirmed these pathways in primates and Kania

'!
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and Szerb (1965) showed that ACh was released from the
cortex during arousal evoked by stimulation of the midbrain reticular formation.

The cholinergic nature of the

mesodiencephalic activating system was described in early
papers of Rinaldi and Himwich (1955a, 1955b).

Frazier

and Boyarski (1967) observed that DFP or Eserine first
stimulated and then blocked evoked potentials in the
thalamus and cortex.

While atropine antagonized these

actions, its administration prior to either anticholinesterase did not prevent these effects.

It was concluded

that cholinergic responses were present at junctional sites
of the primary afferent pathway.
Monoaminergic pathways have also been established in
the CNS.

Andln et al. (1966) described 4 different ascend-

ing monoamine neuron systems beginning from the lower brain
stem and ascending to the diencephalon and telencephalon:
(1) Nigro-neostriatal DA system, (2) Mesencephalic to median
forebrain bundle to olfactory tuberculum DA pathway, (3)
NE pathway from bulbo-pontine reticular formation to limbic
forebrain structures, neocortex and hypothalamus via the
median forebrain bundle, and (4) a serotonergic pathway
from the mesencephalon to the limbic forebrain and hypothalamus via the median forebrain bundle.

Histochemical
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evidence has also been presented that demonstrates the
presence of AChE and catecholamines in the same nerve trunk
in guinea pig vas deferens (Jacobowitz 1965).

Walker

(1969) has demonstrated the presence of possible ACh
vesicles at synaptic sites and adrenergic granules in the
same terminal of hypothalamic neurons.
Norepinephrine has been implicated in the mechanism
underlying paradoxical sleep (vide supra).

In addition,

oxotremorine or carbachol administered by microinjection
into the ponto-mesencephalic'reticular formation induced
paradoxical sleep and was antagonized by atropine (George
et al. 1964).

Precollicular decerebration in cats induced

subcortical paradoxical sleep and this activity appeared at
random intervals.

Eserine evoked the same pattern of para-

doxical sleep and this was antagonized by atropine (Matsuzaki et al. 1967).
Malcolm et al. (1967) showed an interrelationship
between adrenergic and cholinergic mechanisms in the cerebral
cortex of rats and interpreted it to be similar to the
Eccles-Libet scheme of transmission at the superior and
cervical ganglion of the rabbit (Eccles, R. M. and Libet,
B. cited in Eccles 1964).

Phenoxybenzamine blocked the

effect of NE, carbachol, Eserine, and ACh on the P wave
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of evoked cortical potentials arising from stimulation of
the fore paw of the rat, whereas atropine did not block
effects of NE.

Furthermore, both atropine and phenoxy-

benzamine enhanced the evoked potential, but phenoxybenzamine did not increase the effect of atropine while atropine
increased the effect of phenoxybenzamine.

Therefore, the

effect of adrenergic blocking agent was enhanced by the
presence of an anticholinergic while the reverse condition
did not obtain.
In the present studies

~n

the CNS, the effect of the

catecholaminergic system on the AntiChE-induced attenuation
of recruitment could be interpreted as in figures 68 and 69.
Eserine initially induces synchronization followed by a
desynchronized pattern which is enhanced by NE.

A more

intense EEG alert is evoked and finally thalamocortical
recruitment is attenuated.

The direct effects of Eserine

may also be contributing by acting on thalamic neurons
(Bradley et al. 1966).

The effect of Eserine is transient

due to its rapid metabolism while that of an irreversible
inhibitor such as DFP or sarin maintains an attenuation of
recruitment (figs. 68 and 69).

Adrenolytics, and anti-

cholinergic drugs antagonize this effect of anticholin-

-
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esterases as does the marked depletion of catecholamines
by reserpine of aMPT.

Restoration of depleted biogenic

amines by MAOI plus L-DOPA restores the action of Eserine
on recruitment.

Finally, the effective dose of Eserine

required for attentuation of thalamocortical recruitment is
lowered by increases in brain levels of catecholamines.
The Burn-Rand hypothesis (Burn and Rand 1959, 1962, 1965)
suggested that the presence of unbound acetylcholine
released, for example by nerve stimulation, promoted an
increased permeability of the presynaptic neural membrane to
calcium ions and this in turn promoted the release of
bound norepinephrine.

Moreover, this hypothesis may be

viewed as an "adrenergic-link" (Van Meter and Karczmar 1967)
as well, in which case the action of acetylcholine may be
contingent upon the availability of NE or even a monoaminergic substrate such as DA (Takagi et al. 1968).

If the

Burn-Rand concept as proposed for sympathetic postganglionic
nerves :ill supported by further experimentation, a similar
concept could apply to the CNS as well, and explain the
results presented here.

However, the Burn-Rand theory may

not apply to all systems (Thoenen et al. 1966, Pscheidt et
al. 1967).

Moreover, it is apparent that the interaction

of the systems is not a simple two-step "acetylcholine-
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norepinephrine" process.

Depolarization of neurons,

ionic dependent release of NE (Burn 1966) as well as the
possibility of a dopaminergic system (Takagi et al. 1968)
may be only 'a few of the additional factors to be taken
into consideration.

Recent observations of Pohorecky et

al. (1969) have shown that phenylethanolamine-N-methyl transferase activity in the brains of rats, cats, hens, and
turtles increased in the presence of the epinephrine substrates, NE and phenylethanolamine.

However, the enzyme

activity was not homogenous .and the greatest activity was
seen in the olfactory tubercle and bulb.

Hypophysectomy

abolished the effects while dexamethasone, which induces the
synthesis of phenylethanolamine-N-methyl transferase, resulted in an increased enzyme activity.

Intraventricular

administration of 3HNE resulted in the synthesis and
storage of 3HEPI.

These authors concluded that the activity

of phenylethanolamine-N-methyl transferase activity in
mammals was the same in brain and in the adrenals though the
distribution and activity in the CNS appeared to be concentrated in olfactory areas.

In other studies, evaluation

of crude pellet fractions disclosed that the rostral brainstem which consisted of hypothalamus and diencephalon, had
the highest synthesis rate of EPI in rats and dogs
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Figure 68
I:,:

REVERSIBLE INHIBITION
Eserine - - - - . . . . - - - - - - - . . . - - - - - -........- - - - <Active l

Direct Action

AntiChE

Recruitment

Increased ACh

EEG Sleep
Increased

Present

NE Released

( Inactive

l

Control

Desynchronized
EEG

Attenuated

Control

Present
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Figure

69

IRREVERSIBLE INHIBITION
DFP-Sarin
(Active)

Direct Action

AntiChE

Recruitment

Increased ACh

1

EEG Sleep
Increased

Present

NE Released

(Sustained Effect)

(Sustained Effect)

Desynchronised
EEG
(Sustained)

Attenuated
(Sustained)

(Ciaranello et al. 1969).

Differential untracentri-

fugation studies with the crude pellet revealed distribution of enzyme activity throughout subcellular fractions
with highest activity in the 22,000g fractions.

Ciaranello

and co-workers concluded that the mcgm EPI formed per hour
per gram tissue in vitro correlated with brain concentrations in vivo and that regulation of endogenous brain EPI
could be controlled by an inhibitor found in the particulate
fraction as well as by metabolism.
These findings suggest that EPI may also be a factor
in the CNS as a neuroregulator or transmitter substance.
Alpha blockade by chlorpromazine or phenoxybenzamine would
then reflect an unmasked beta activity.

Likewise, beta

blockade then results in alpha desynchronization with the
attenuation of thalamocortical recruitment (cf. fig. 65 ).
Amphetamine has been shown to evoke an EEG arousal
but not attenuate thalamocortical recruitment (Longo and
Silvestrini 1967).

It has also been reported (Barnes 1966)

that while both Eserine and amphetamine evoke EEG alert
patterns, the effect of both given together was less than
that of either given separately.

Either Eserine or

amphetamine antagonized barbiturate EEG patterns, but when
one was given in the presence of the antagonism induced by

the other, then the degree of antagonism was lessened.
Furthermore, in the presence of this attenuated antagonism,
atropine always reversed the lessened antagonism and induced a more desynchronized EEG.

Barnes concluded that

Eserine and amphetamine acted on the ascending reticular
activating system on two separate "pools", one adrenoceptive and the other cholinoceptive.

The action of

amphetamine is probably dependent on the biosynthesis of
NE (Bradley 1968), and it has been demonstrated that inhibition of NE synthesis in t,he CNS blocks its psychomotor
stimulant effect (Dingell et

al~

1967).

Gessa et al.

(1969) has recently shown that p-hydroxynorephedrine, a
metabolite of amphetamine, replaced NE stores in sympathetic
nerve endings and acted as a false transmitter.

They also

noted that p-hydroxynorephedrine was released in preference
to NE by subsequent administration of amphetamine and prevented the entrance of the parent drug into the adrenergic
granules.

They concluded that amphetamine tolerance was

the result of these actions.

The presence of a false

transmitter, p-hydroxynorephedrine may account for:

the

less intense desynchronization of the EEG seen with
amphetamine as compared with that of beta blockers; increased endogenous NE; and the failure of anticholinester-
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ases, as well as the failure of amphetamine to attenuate
thalamocortical recruitment.
At this time it is not possible to specify that NE
has an absolute role and is the only factor involved in the
mechanism of anticholinesterase-induced desynchronization
and attenuation of recruitment.

But this study does indi-

cate that one of the actions of anticholinesterases that
is, the attenuation of recruited potentials from stimulation of the anterior dorsal nuclei of the thalamus, may
depend on the maintenance of.a catecholaminergic system that
includes norepinephrine.

V.

SUMMARY

Effects of anticholinesterases on the EEG and thalamocortical recruitment were evaluated in rabbits in which
brain biogenic amines had been altered.

Chronic reserpine

treatment resulted in a marked and maintained depletion of
NE which was measured in selected brain parts.

aMPT evoked

a linear decrease in brain NE that was maintained by chronic
administration and also was measured in selected brain
parts.

Restoration of depleted amines was achieved by the

administration of a MAOI and L-DOPA.
EEG activity during states of depleted brain biogenic
amines was predominately slow wave sleep with some 8-14 c/s
burst activity from the cortices.

Peripheral tactile,

pain and sound stimuli evoked an EEG desynchronization.
Thalamocortical recruitment was present.
Eserine evoked a transient EEG desynchronization but
failed to attenuate thalamocortical recruitment.

DFP in-

duced an enduring EEG arousal but also failed to attenuate
thalamocortical recruitment.

The restoration of depleted

catecholamines (vide supra) induced an EEG desynchronization during which thalamocortical recruitment could be
evoked.

Anticholinesterases intensified the desynchroniza-
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tion and attenuated recruitment.
Low doses of Eserine (50.0 mcgm/Kg i.v.) that did not
attenuate recruitment in the control periods attenuated
recruitment after brain biogenic amine levels had been
raised by MAOI plus L-DOPA.
Atropine and scopolamine antagonized the EEG effects
and blockade of thalamocortical recruitment induced by the
anticholinesterases.

Alpha receptor blockade by phenoxy-

benzamine and chlorpromazine antagonized the EEG effects and
attenuation of
Eserine.

thalamocortic~l

recruitment induced by

Phenoxybenzamine evoked a biphasic response con-

sisting of an initial brief EEG desynchronization followed
by a maintained synchronized pattern.

Chlorpromazine in-

duced a prolonged slow wave sleep pattern and also antagonized the effects of the anticholinesterases.

Beta receptor

blockade by INPEA, evoked an EEG desynchronized pattern with
an attenuation of recruitment.
These results are discussed in terms of cholinergic and
adrenergic relationships and it is concluded that the
attenuation of thalamocortical recruitment by an anticholinesterase may be dependent on a catecholaminergic system.

APPENDIX A
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APPENDIX A
ELECTRODE CONSTRUCTION
Formvar insulated 0.005 inch diameter nichrome wire
was used for the preparation of depth electrodes.

A two

foot length of the wire was formed into a loop, the free
ends of which were placed into the jaws of a small table
top vise.

This loop was straightened by applying a steady

upward force with a small rod placed in the loop.
vise was then released from

~he

The

table and by carefully

spinning it, the two sides of the nichrome wire loop were
uniformly twisted together and the twisted pair remained
linear.

Twisted pairs of these wires were cut into

cm lengths.

8.o

One end was untwisted for about l.O cm and the

insulation scraped off so that the bared wires could be
soldered to a pair of two foot lengths of #37 gauge
stranded cable.
flux

To solder the nichrome alloy, a Chromalloy

was required.

Small pieces of 3/64 inch diameter

heat shrinkable tubing were used to insulate the solder
joints.

Electrode assemblies were constructed out of brass

hubs and stainless steel tubing shanks according to the
dimensions in figure 1 in the text.

A short length of

PE# 60 tubing was inserted into the stainless steel shank
and trimmed flush with the twisted pair of nichrome wires
which was subsequently inserted into the assembly (cf.
fig. 2).

Prior to the installation of the PE tubing, an-

other two foot of #37 gauge cable had been soldered to the
brass hub.

The cavity of the hub with the depth electrodes

in place was then carefully filled with dental acrylic which
was allowed to harden.

A single piece of 1/8 inch diameter

heat shrinkable tubing was used to cover the completed
electrode.

Several of these.electrodes were prepared in

advance and trimmed to the desired stereotaxic coordinates.
These electrodes could be used repeatedly for periods of
several months in acute experiments.
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STEREOTAXIC COORDINATESl
Brain Site

Lateral

Anterior

LAC

6.5

4.o

2.0

RAC

6.5

2.0

2.0

LPC

6.5

4.5

2.0

RPC

6.5

4.5

2.0

RF

2.0

8.5-9.0

12.0

THAL

1.5

3.0

10.0

oc

2.0

8.5-9.0

2.0

LC

1.5

3.0

2.0

BOA

6.5

4.o

12.0

LN

6.5

2.0

9.0

LH

6.5

4.5

4.5-5.5

RH

6.5

4.5

4.5-5.5

1

Depth

Posterior

The coordinates are given in mm and are applicable to

New Zealand albino rabbits of 2.5-3.5 Kg body weight.
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STAINING SCHEDULE:
A.

THIOCHOLINE FOR FROZEN SECTIONS

Reagents:
Incubation solutions were prepared from the following

reagents.
1.

Copper glycine

glycine
CuS04°5H20
dist. H2o qs

3.75 Gm
2.5 Gm
100.0 ml

2.

Maleate buffer

NaH Maleate
NaOH (N)
dist. H2o qs

9.6
51.2
100.0

MgCl2

9.52 Gm
100.0 ml

di~t.

Na2S04

H20 qs

Gm
ml
ml

40% (w/v) adjust
to pH 6.0; store
at 38° C

5.

AThCh

6.

BuThCh

Butyrylthio50.0 mg
choline I
dist. H2 o
2.4 ml
CuS04 (0.1 M)
o.8 ml
Centrifuge for 20 min. Save decanted supernatant.

7.

Ammonium Sulfide NH40H (con.)
100.0 ml
dist. H2o
50.0 ml
H2S
saturate
Store in refrigerator as a stock solution. For
use, dilute 1:25 (v/v) with distilled water, and
prepare daily prior to use. Test for activity by
adding a few drops of O.l M CuS04 solution to a
few drops of the (NH4)2 S, a brownish black
precipitate indicates usable strength.

acetylthio46.o mg
choline I
dist. H2 o
2.4 ml
CuS04 (0.1 M)
o.8 ml
Centrifuge for 20 min. Save decanted supernatant.
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8.

B.

CuThCh

Copper thiocholine the reaction
produce was obtained by initially
running control samples through
the procedure which saturated the
solutions with the reaction product.

Solutions:
1.

Storage solutions for slides prior to incubation.
(a)

1.5 ml
9.0 ml
4.5 ml

DFP

prepared from stock solution of O.l M
prior to use.

DFP

(b)

All cholinesterases (solution "A") and
butyrylcholinesterase (solution "c").
10.5 ml
4.5 ml

Na2S04 (40%)
dist. H20
(c)

Acetylcholinesterase (solution "B") and
control (solution "D").
9.0 ml
ml

6.o
2.

Incubation solutions for slides after appropriate
storage solution treatment.
All ChE
AChE
BuChE
Control
(solution "A") ( solutio~ 11 Btr) (solution" Ctr) (solution 1tn1t)

Reagents:
CuGlycine o.6 ml
o.6 ml
H20
Mal.
Buff er
1.5 ml
ml
10.5
Naeso 4
o.6
ml
Mg l&
CuTh
trace
AThCh
1.2 ml
Bu.Th Ch

o.6

ml
2.1 ml

1.5 ml
9.0 ml
o.6 ml
trace
1.2 ml

o.6
o.6

ml
ml

o.6

ml
2.1 ml

1.5 ml
10.5 ml
o.6 ml
trace

1.5 ml
9.0 ml
o.6 ml
trace

1.2 ml

1.2 ml
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DFP pretreatment was carried ogt for solutions B and D
where the concentration of 10- M specifically inactivated
BuChE. Incubation time for brain sections was maintained
at 60 minutes.
C.

Staining Schedule:
Frozen sections were cut in the cryostat at 16 microns,

placed on slides and dried at room temperature for 5-10
minutes prior to staining schedule:
1.

Appropriate storage solution for 30 minutes.

2.

Incubation solution for 60 minutes at 38°

3.

Rinse solution b20% Na 2S04 saturated with CuThCh)
5 minutes at 38 C.

4.

Rinse solution (10% Na 2so4 saturated with CuThCh)
1 minute at room temperature.

5.

Distilled water 1-2 sec.

6.

Ammonium sulfide developer solution (20 sec).

7.

Rinse solution (distilled water or 15% EtOH).

8.

Fixation in 10% formalin if desired.

9.

35% alcohol (15 sec).

10.

50% alcohol (15 sec).

11.

70% alcohol (15 sec).

12.

80%

13.

95% alcohol (15 sec).

14.

abs. alcohol (1 min).

15.

abs. alcohol (1 min).

alcohol (15 sec).

c.
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16.

Xylol (1 min).

17.

Xylol (1 min).

18.

Mount in permount cover and read.
absence of light.

Store in
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STAINING SCHEDULE:
A.

THIONIN FOR FROZEN SECTIONS 1

Solutions:

1.

Thionin (o.5% in 20% alcohol)
Thi on in
Distilled water
95% EtOH

2.

475.0 mg
150.0 ml

4o.o ml

Eosin Y
Eosin Y
Distilled water
95% EtOH

2.0 Gm
25.0 ml
475.0 ml

(Filter into staining dish and use as needed.)
B.

Staining Schedule:
Frozen sections were cut in the cryostat at 32 microns

thickness, placed on slides and dried at room temperature
for 5-10 minutes prior to staining.

1

1.

Thi on in (30-60 sec)

2.

Distilled water (wash at least 1 min)

3.

35% alcohol (15 sec)

4.

50% alcohol (15 sec)

5.

70% alcohol (15 sec)

6.

80% alcohol (15 sec)

Conn, H. J., Darrow, M. A., and Vector M. E. Staining
Procedures, second edition, 1960. pp 7. The Williams
and Wilkins Co., Baltimore, Maryland.

4
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7.

95% alcohol (15 sec)

8.

Eosin Y (dip)

9.

95% alcohol (15 sec)

10.

Abs. alcohol (1 min)

11.

Abs. alcohol (1 min)

12.

Xylol (1 min)

13.

Xylol (1 min)

14.

Mount in permount, cover, and read.
absence of light.

Store in
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ENZYME ACTIVITY1
Control

2

DFP

211.98(192.92-229.36)
2
1.69( -1.61-8.92)
17.75( 15.28-20.22) 2

Control

176.54(161.53-200.01) 3

Sarin

Sarin

&

22.57(19.49-25.65)

2

6.83( 3.58-10.07) 2
3.58( 3.00-4.70) 2
24.53(23.41-25.65)3

13.85( 10.07-20.20)3

4.81(0.0-9.62)3

18.71( 13.34-24.20)3

8.421(-----)3

AMN
Sarin

&

AtS04
1.

Cholinesterase activity is expressed as microliters
of

co 2

of a 1:50 brain to bicarbonate (0.03M)

buffer dilutions from one-half brain samples
divided at the midsaggital section.

AChE deter-

minations were made in triplicate and the BuChE
determinations in duplicate.
2.

Figures represent the average values at 60 minutes
with the range expressed in parenthesis.

3.

Figures represent the average values at 40 minutes
with the range expressed in parenthesis.
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APPENDIX B

BLOCK DIAGRAM - STIMULATOR
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FLUOROMETRIC ASSAY
A.

Reagents:
1.

n-Butanol, purified with HCl and distilled water
and the aqueous phase removed with NaCl.

2.

n-Heptane, washed with NaOH, HCl and distilled
water.

3.

Iodine reagent 0.1 N (in abs. alcohol)

4.

Sodium thiosulfate 0.05 N

5.

Acetate buffer, 2.0 M, pH 5, prepared by 2:1
(v/v) 2.0 M sodium acetate and 2.0 M acetic acid

6.

Acetate buffer, 2.0 M, pH 3, prepared by 50:1
(v/v) acetic acid (2.0 M) and sodium acetate
(2.0 M)

7.

Alkaline ascorbate solution.

Prepared just before

use by 2:1 5.0 N NaOH and 1% aqueous ascarbate
solution.

8.

Standard NE solution.

A stock solution of 0.005%

is prepared and refrigerated in a light tight
container.

From this concentration of 50.0

mcgm/ml working standards are prepared.
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B.

Procedure:
1.

Chilled homogenization of weighed brain parts in
2.0 ml of 0.01 N HCl.

2.

Homogenate transferred to 35 ml reaction vessel
containing 2.0 Gm NaCl and 20.0 ml n-Butanol.

3.

Shake for one hour.

4.

Centrifuge 10 minutes at 1500 rpm.

5.

Butanol aliquotes (10.0 ml) are transferred to
reaction vessels with 2.0 ml 0.01 N HCl and 15.0
ml of n-Heptane and are shaken for 15 minutes.

6.

Centrifuge 15 minutes at 1500 rpm.

7.

Transfer 1.5 ml aliquote to test tube.

8.

Add 0.5 ml of pH 5.0 acetate buffer for NE.
Add 0.5 ml of pH 3.0 acetate buffer for E.

9.
10.

Add 0.05 ml of O.l N iodine reagent.
Inactivate iodine with O.l ml sodium thiosulfate
(0.05 N).

11.

Add 0.5 ml of alkaline ascorbate to all test
tubes except reagent blank and tissue blank.

12.

Add 0.3 ml of 5.0 N NaOH to each of the tissue
blanks and reagent blanks.

13.

Use 1.0 mcgm NE to determine reagent blank.

14.

Incubate 45 minutes.

15.

Add 0.2 ml of ascorbate solution 10 minutes prior
to reading.

16.

Read in Aminco-Bowman spectrophotofluormeter at
400 u activating wavelength and at 520 u fluorescent
wavelength.

17.

Calculation:
Tissue Factor (TF)
Corrected Reading

= 1000/wt

(mg)

= Initial

Reading Tissue Blank

Corrected NE Reading

= Initial

Reading of
Standard-Reagent
Blank Reading

Standard NE Constant - Kn = Total mg NE/
total corrected NE
readings
NE Concentration

= (TF)

(K e) (Corrected
= NE mcgm/Gm

Reading~
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